2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces
Abstract
This is the eighth annual summary of the International Liaison Committee on Resuscitation International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations; a more comprehensive review was done in 2020. This latest summary addresses the most recent published resuscitation evidence reviewed by the International Liaison Committee on Resuscitation task force science experts. Members from 6 International Liaison Committee on Resuscitation task forces have assessed, discussed, and debated the quality of the evidence, using Grading of Recommendations Assessment, Development, and Evaluation criteria, and their statements include consensus treatment recommendations. Insights into the deliberations of the task forces are provided in the Justification and Evidence-to-Decision Framework Highlights sections. In addition, the task forces list priority knowledge gaps for further research.
This is the eighth in a series of annual International Liaison Committee on Resuscitation (ILCOR) International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations (CoSTR) summary publications summarizing the ILCOR task forces’ analyses of published resuscitation evidence since ILCOR began the more continuous process of evidence evaluation in 2015. Summarizing the work from the 6 task forces over the past year, this year’s review includes 19 systematic reviews (SysRevs) with new or updated treatment recommendations. Although only SysRevs can generate a full CoSTR and new treatment recommendations, 14 scoping reviews (ScopRevs) and 30 evidence updates (EvUps) are also included.
Draft CoSTRs for all topics evaluated with SysRevs were posted on a rolling basis between December 1, 2023, and January 24, 2024, on the ILCOR website.1 Each draft CoSTR includes the data reviewed and draft treatment recommendations, with public comments accepted for 2 weeks after posting. In some cases, if requested, public comment was permitted for longer. Task forces considered public feedback and provided responses. The 33 draft CoSTR statements and ScopRevs were viewed ≈18 200 times, and 38 comments were provided. All CoSTRs are now available online, adding to the existing CoSTR statements.
This summary statement contains the final wording of the treatment recommendations and good practice statements as approved by the ILCOR task forces, but it differs in several respects from the online CoSTRs. The language used to describe the evidence is not restricted to standard Grading of Recommendations Assessment, Development, and Evaluation (GRADE) terminology,2 making it more accessible to a wider audience, and in some cases only the high-priority outcomes are reported. The Justification and Evidence-to-Decision Framework Highlights sections are generally shortened but aim to provide a transparent rationale for treatment recommendations. The complete evidence-to-decision frameworks are provided in Appendix A. Finally, the task forces have prioritized knowledge gaps requiring future research studies. Links to the published reviews and full online CoSTRs are provided in the corresponding sections.
The CoSTRs are based on analysis of the data using the GRADE approach.2 SysRevs are conducted by expert systematic reviewers or by task force members, always with the involvement of ILCOR content experts. The GRADE approach guides the rating of the certainty of evidence that supports the intervention effects (predefined by the population, intervention, comparator, outcome [PICO] question). Certainty is categorized as high, moderate, low, or very low. Randomized controlled trials (RCTs) begin the analysis as high-certainty evidence, and observational studies begin the analysis as low-certainty evidence. Certainty of evidence can be downgraded for risk of bias, inconsistency, indirectness, imprecision, or publication bias; it can be upgraded for a large effect, for a dose-response effect, or if any residual confounding would be thought to decrease the detected effect.
The format for outcome data reporting varies by the data available but ideally includes both relative risk (RR) and the absolute risk difference (ARD), both with 95% CI. The ARD enables a more clinically useful assessment of the magnitude of the effect of an intervention and enables calculation of the number needed to treat (NNT=1/ARD). When the data do not enable absolute effect estimates, alternative measures of effect such as odds ratios (ORs) are reported.
Treatment recommendations are generated by the task forces after evaluating the evidence and after discussion. The strength of a recommendation does not depend solely on the certainty of evidence but also on the likely clinical impact as determined by task force members.
ILCOR’s goal is to review at least 20% of all PICO questions each year so that the CoSTRs reflect current and emerging science. Acknowledging that many PICO topics will not have sufficient new evidence to warrant a SysRev, ILCOR implemented 2 additional levels of evidence review in 2020. ScopRevs are undertaken when the amount and type of evidence on a broader topic is unclear. Search strategies are similar in rigor to those of SysRevs, but ScopRevs do not include bias assessments or meta-analyses. Although ILCOR does not create or alter treatment recommendations without a SysRev, if the topic of a ScopRev is thought to be of particular interest to the resuscitation community, good practice statements are often made. Good practice statements are not evidence-based recommendations but represent expert opinion in light of very limited data.
The third and least rigorous form of evidence evaluation is the EvUp, in which a minimum of a PubMed search is carried out to screen for significant new data and assess whether there has been sufficient new science to warrant a more extensive review and updated CoSTR. EvUps can inform a decision about whether a SysRev should be undertaken but are not used to generate new or updated treatment recommendations because they do not include bias assessment, GRADE evidence evaluation, or meta-analysis. In this document, ScopRevs are summarized in the relevant task force section, with references to the more complete online review. EvUps are listed at the end of each task force section in table form, with information including the prior treatment recommendation(s) related to the PICO question, how many new studies were identified, key findings, and whether an updated SysRev is recommended. Complete EvUps are provided in Appendix B.
The following topics are addressed in this CoSTR summary:
Basic Life Support
•
Optimal surface for performing cardiopulmonary resuscitation (CPR; Basic Life Support [BLS] 2510: SysRev)
•
Optimization of dispatcher-assisted recognition of out-of-hospital cardiac arrest (OHCA; BLS 2102: ScopRev)
•
Optimization of dispatcher-assisted CPR (BLS 2113: ScopRev)
•
Optimization of dispatcher-assisted automated external defibrillation (AED) retrieval and use (BLS 2120: ScopRev)
•
Feedback for CPR quality (BLS 2511: ScopRev)
•
Ultraportable or pocket AEDs (BLS 2603: ScopRev)
•
Compression-ventilation ratio (BLS 2202: EvUp)
•
Hand positioning (BLS 2502: EvUp)
•
CPR before defibrillation (BLS 2203: EvUp)
•
Rhythm check during compressions (BLS 2211: EvUp)
•
Head-up CPR (BLS 2503: EvUp)
•
Public access defibrillation programs (BLS 2121: EvUp)
Advanced Life Support
•
Post–cardiac arrest oxygenation and ventilation (Advanced Life Support [ALS] 3506 and 3516: SysRev)
•
Post–cardiac arrest hemodynamics (ALS 3515: SysRev Adolopment)
•
Post–cardiac arrest temperature control (ALS 3523, 3524, 3525: SysRev)
•
Post–cardiac arrest seizure prophylaxis and management (ALS 3502 and 3503: SysRev)
•
Extracorporeal CPR (ALS 3001: SysRev)
•
Cardiac arrest during pregnancy (ALS 3401: ScopRev)
•
Front of neck airway access (ALS 3606: ScopRev)
•
Cardiac arrest related to asthma (ALS 3408: EvUp)
•
Atropine for cardiac arrest (ALS 3206: EvUp)
•
Use of advanced airway during cardiac arrest (ALS 3300, 3301, 3302, 3303, 3304: EvUp)
•
Mechanical CPR devices (ALS 3002: EvUp)
•
CPR-induced consciousness (ALS 3004: EvUp)
•
Antiarrhythmics during and after cardiac arrest (ALS 3201, 3514: EvUp)
•
Cardiac arrest associated with pulmonary embolism (ALS 3400: EvUp)
Pediatric Life Support
•
Blood pressure targets following return of circulation after cardiac arrest (Pediatric Life Support [PLS] 4190-01: SysRev)
•
Effect of prophylactic antiseizure medication and treatment of seizures on outcome of pediatric patients after cardiac arrest (PLS 4210-02: SysRev)
•
Advanced airway interventions in pediatric cardiac arrest (PLS 4060-01: SysRev)
•
Ventilation rate with advanced airway during pediatric cardiac arrest (PLS 4120-02: SysRev)
•
Management of pulmonary hypertension with cardiac arrest in infants and children in the hospital setting (PLS 4160-11: ScopRev)
•
Prearrest care of pediatric dilated cardiomyopathy or myocarditis (PLS 4030-19: EvUp)
•
Ventilation rate in pediatric respiratory arrest with a perfusing rhythm present (post–cardiac arrest; PLS 4120-01: EvUp)
Neonatal Life Support
•
Cord management at birth for preterm infants (Neonatal Life Support [NLS] 5051: SysRev)
•
Effect of rewarming rate on outcomes for newborns who are unintentionally hypothermic after delivery (NLS 5700: SysRev)
•
Therapeutic hypothermia in limited resource settings (NLS 5701: SysRev)
Education, Implementation, and Teams
•
Cardiac arrest centers (Education, Implementation, and Teams [EIT] 6301: SysRev)
•
Cognitive aids during resuscitation education (EIT 6400: SysRev)
•
Immersive technologies for resuscitation teaching (EIT 6405: SysRev)
•
Gamified learning compared with other forms of resuscitation learning (EIT 6412: SysRev)
•
Rapid cycle deliberate practice in resuscitation training (EIT 6414: SysRev)
•
Team competencies training for resuscitation (EIT 6415: SysRev)
•
CPR education tailored to specific populations (EIT 6108: ScopRev)
•
International facets of the Chain of Survival (EIT 6311: ScopRev)
•
Provider workload and stress during resuscitation (EIT 6401: ScopRev)
•
Scripted debriefing compared with nonscripted debriefing in resuscitation training (EIT 6413: ScopRev)
•
Emergency medical services (EMS) experience and exposure (EIT 6104: EvUp)
•
Patient outcomes of team members attending a CPR course (EIT 6106: EvUp)
•
Willingness to provide CPR (EIT 6304: EvUp)
•
Implementation of guidelines in communities (EIT 6306: EvUp)
•
Debriefing of resuscitation performance (EIT 6307: EvUp)
•
CPR feedback devices during training (EIT 6404: EvUp)
•
Blended-learning approach for life support education (EIT 6409: EvUp)
•
High-fidelity training for resuscitation (EIT 6410: EvUp)
First Aid
•
Use of supplemental oxygen in first aid (First Aid [FA] 1649: ScopRev)
•
Recognition of sepsis (FA 7180: ScopRev)
•
Stroke recognition (FA 7170: EvUp)
•
Oxygen in stroke (FA7031: EvUp)
•
Dental avulsion (FA 7361: EvUp)
•
Second dose of epinephrine for anaphylaxis (FA 7111: EvUp)
•
Naloxone for opioid emergencies (FA 7442: EvUp)
•
Exertion-related dehydration and rehydration (FA 7241: EvUp)
•
Counter-pressure maneuvers for prevention of syncope (FA 7550: EvUp)
•
Recovery position (FA 7040: EvUp)
Readers are encouraged to monitor the ILCOR website3 to provide feedback on planned SysRevs and to provide comments when additional draft reviews are posted.
BLS Task Force
Optimal Surface for Performing CPR (BLS 2510: SysRev)
Rationale for Review
This topic was prioritized for review by the BLS Task Force because it had not been reviewed since 2019.4,5 Since the last SysRev of this topic,6 the task force was concerned that the practice of moving patients from the bed to the floor to improve the quality of CPR could delay CPR; thus, it was considered timely to update the SysRev completed for the 2020 CoSTR.4,5 The SysRev was registered before initiation (International Prospective Register of Systematic Reviews [PROSPERO] CRD42017080475).7 The full online CoSTR can be found on the ILCOR website.8
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults or children in cardiac arrest (OHCA and in-hospital cardiac arrest [IHCA])
•
Intervention: The performance of CPR using a hard surface (eg, backboard, floor, or deflatable or specialist mattress)
•
Comparators: The performance of CPR on a regular mattress or other soft surface
•
Outcomes: Survival with a favorable neurological outcome at hospital discharge/30 days (critical), survival at hospital discharge/30 days (critical), event survival (important), return of spontaneous circulation (ROSC; important), CPR quality (eg, compression depth, compression rate, compression fraction; important)
•
Study designs: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols) were excluded. Randomized manikin simulation or cadaver studies were included only if insufficient human studies were identified. Studies were included regardless of language if an abstract in English was available.
•
Time frame: The dates searched were September 17, 2019 (date of the search for the previous SysRev), to February 5, 2024.
Consensus on Science
In addition to the 11 manikin simulation RCTs9–19 identified in the previous review,6 we identified 1 small observational study20 and 6 additional manikin RCTs21–26 addressing this population, intervention, comparator, outcome, study design, and time frame (PICOST) question. The overall certainty of evidence was rated as very low to low due to risk of bias and serious indirectness. No studies reported patient outcomes. The included studies were grouped by surfaces studied: backboard versus hospital mattress, floor versus hospital mattress, floor versus firm home mattress, and floor versus other surface types. The small observational study that compared a backboard with a hospital mattress used a single accelerometer for measurement, and the results were considered unreliable.20 Results of the meta-analysis of data from the manikin simulation studies are given in Table 1.
Backboard compared with hospital mattress | |
Compression depth | 7 manikin RCTs11,12,14–16,18,24 Mean difference=2.16 mm (95% CI, 0.52 to 3.81) |
Compression rate | 5 manikin RCTs11,12,14,18,24 Mean difference=–0.11 (95% CI, –3.8 to 3.59) |
Floor compared with hospital mattress | |
Compression depth | 2 manikin RCTs10,13 Mean difference=5.36 mm (95% CI, –1.59 to 12.32) |
Compression rate | 2 manikin RCTs10,13 No meta-analysis performed. No significant difference. |
Floor compared with firm home mattress | |
Compression depth | 2 manikin RCTs19,26 Mean difference=2.11 mm (95% CI, –3.23 to 7.45) |
Compression rate | 2 manikin RCTs19,26 No meta-analysis performed. No significant difference. |
CPR indicates cardiopulmonary resuscitation; and RCTs, randomized controlled trials.
Prior Treatment Recommendations (2020)
We suggest performing chest compressions on a firm surface when possible (weak recommendation, very low–certainty evidence).
During in-hospital cardiac arrest, we suggest, where a bed has a CPR mode which increases mattress stiffness, it should be activated (weak recommendation, very low–certainty of evidence).
During in-hospital cardiac arrest, we suggest against moving a patient from a bed to floor to improve chest compression depth (weak recommendation, very low–certainty of evidence).
2024 Treatment Recommendations
We suggest performing chest compressions on a firm surface when this is practical and does not significantly delay the start of chest compressions (weak recommendation, very low–certainty evidence).
We suggest activation of the CPR mode to increase mattress stiffness if available for in-hospital cardiac arrest (good practice statement).
For health care systems that have already incorporated backboards into routine use during resuscitations, the evidence was considered insufficient to suggest against their continued use (weak recommendation, very low–certainty of evidence).
For health care systems that have not introduced backboards, the limited improvement in compression depth and uncertainty about harms seemed insufficient to justify the costs of purchasing backboards and training staff in their use (weak recommendation, very low–certainty of evidence).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision framework is provided in Appendix A.
When performing chest compressions on a patient lying on a mattress, the force of the chest compressions is dissipated through the compression of the chest and compression of the surface beneath the patient. Mattress compression can be as high as 57% of total compression depth, with greater compression seen in softer mattresses.27–29 This can lead to reduced spinal-sternal displacement and a reduction in effective chest compression depth. It is known that effective compression depths can be achieved on soft surfaces if the CPR provider increases overall compression depth to compensate for mattress compression.30–33 CPR feedback devices that account for mattress compression (eg, the use of dual, and not single, accelerometers or increasing compression depth targets) can help CPR providers to ensure adequate compression depth when CPR is performed on a mattress.11,33–35
In making these recommendations, the task force considered the importance of high-quality chest compressions and minimizing delays to the initiation of CPR and the lack of human data, including patient outcomes. Within the limitations of manikin studies, the available evidence indicates that using a backboard on a hospital mattress provides only a marginal depth benefit that is unlikely to be clinically significant. In considering whether to transfer a patient to the floor to improve compression depth, the task force considered the risks of harm (eg, interruption in CPR, risk of losing vascular access) to the patient and resuscitation team outweighed any small improvement in chest compression depth. The addition of 2 studies simulating out-of-hospital settings (where beds may be softer) and one where the CPR provider may be a single untrained rescuer led the task force to broaden the recommendations to include OHCA. The task force felt the indirect evidence on backboards was not sufficient to have backboards removed where they are currently used. However, users should be aware that mattress stiffness and backboard size and orientation influence the backboard’s effectiveness.36–39
Knowledge Gaps
•
Studies reporting clinical outcomes
•
Studies examining the logistical aspects of backboard deployment or moving a patient from a bed to the floor
•
Studies in both high- and low-resource settings where hospital bed or prehospital stretcher configurations may vary
Optimization of Dispatcher-Assisted Recognition of OHCA (BLS 2102: ScopRev)
Rationale for Review
The 2020 CoSTR on dispatcher-assisted diagnosis of cardiac arrest recommended that dispatch centers look for ways to optimize sensitivity of recognition of cardiac arrest.4,5 These interventions have not been reviewed by ILCOR before. A ScopRev was conducted to understand factors related to DA recognition and to review the current state of evidence for interventions aiming to optimize timely recognition to inform the development of a PICOST for a SysRev.40 The full online CoSTR can be found on the ILCOR website.41
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults and children who are in cardiac arrest outside of a hospital.
•
Intervention: Factors and interventions that improve dispatcher-assisted recognition of cardiac arrest.
•
Outcomes: Dispatcher-assisted recognition of cardiac arrest defined as initiation of cardiac arrest–specific actions, such as instructions to perform CPR.
•
Study designs: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies, qualitative) were eligible for inclusion. All relevant studies with an abstract in English were included.
•
Time frame: The search of Medline was performed on June 2, 2023, from database inception to June 2, 2023.
Summary of Evidence
This ScopRev identified 60 relevant articles.42–101 The included articles described 4 major categories and 18 subcategories: 2 major categories and 11 subcategories relate to factors found to influence DA recognition, and 2 major categories and 7 subcategories were interventions aiming to improve DA recognition (Table 2). The detailed findings within each theme are summarized in the full CoSTR on the ILCOR website.41
Categories | Subcategories |
---|---|
Factors related to dispatcher-assisted recognition | |
Communication between caller and dispatcher (n=16) | 1. Caller’s emotional state 2. Caller’s proximity to OHCA patient 3. Effects of dispatcher behavior and communication with caller 4. Caller’s status (health care professional compared with non–health care professional) 5. Effects of language barriers 6. Linguistic format of qualified breathing questions 7. Influence of callers chief complaint and use of trigger words |
Symptoms and patient characteristics (n=19) | 8. Agonal breathing 9. Patient status 10. Seizures 11. Patient demographics |
Interventions to improve dispatcher-assisted recognition | |
New technology to improve dispatcher recognition of OHCA (n=7) | 12. CCTV 13. Machine learning 14. Smart devices to detect agonal breathing |
Quality improvement/implementation of new protocols to improve dispatcher recognition (n=26) | 15. MPDS 16. Criterion-based dispatch 17. Breathing 18. Other quality improvement |
CCTV indicates closed-circuit television; MPDS, medical priority dispatch system; and OHCA, out-of-hospital cardiac arrest.
Task Force Insights
•
Most of the studies identified were retrospective, observational studies assessing the proportion of OHCAs recognized by dispatchers and factors associated with OHCA recognition. Only 1 study reported dispatcher-assisted recognition in pediatric arrests. There were no studies testing 2 different protocols in a randomized trial.
•
The most pertinent challenge to dispatcher-assisted recognition of OHCA seems to be determining whether the patient is breathing normally. Several strategies were studied, including bypassing breathing in the initial assessment and asking the caller to put their hand on the patient’s stomach. No strategy showed better results than the commonly used 2-questions strategies. Although several strategies were tested, there were no RCTs comparing different strategies.
•
The only RCT in this review studied the effect of including an artificial intelligence model to improve recognition of OHCA. Although the model had a higher rate of recognition of OHCA, it did not improve dispatcher recognition of OHCA when implemented in practice. The main problem appeared to be high false positive rates.
•
Based on this ScopRev, there is insufficient evidence to pursue a new SysRev on this topic.
Knowledge Gaps
•
Sensitivity, specificity, and positive predictive values of different factors to improve dispatcher-assisted recognition of OHCA, as well as how studied variables affect time to recognition
•
How different protocols and strategies compare with each other in randomized trials
•
The impact of the characteristics of dispatchers (eg, experience, training) and their exposure to OHCA calls on OHCA recognition
•
When dispatchers should deviate from the script in the dispatch protocol. There is an expectation or necessity for dispatchers to follow and not deviate from a script. However, deviation may be necessary in certain cases, and continuation of the script in these cases could lead to worse communication, lower rates of recognition of OHCA, or longer time to recognition. Studies to identify which cases may benefit from deviation of script are warranted.
•
How to optimize dispatcher-assisted recognition of pediatric OHCA
Optimization of Dispatcher-Assisted CPR (BLS 2113: ScopRev)
Rationale for Review
The 2020 SysRev recommends CPR instructions be provided by dispatchers during the emergency call.4,5 Although the certainty of evidence was rated as very low at that time, dispatcher-assisted CPR (DA-CPR) has been implemented widely,102–105 and the task force was aware of new evidence examining interventions aiming to optimize DA-CPR. A ScopRev was conducted to map this evidence and determine if it was sufficient to warrant a new SysRev of interventions to improve DA-CPR.106 Studies comparing compression-only CPR with standard CPR were excluded as this topic is covered in a separate ILCOR PICOST.107,108 The full online CoSTR can be found on the ILCOR website.109
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults and children with out-of-hospital cardiac arrest where DA-CPR is implemented
•
Intervention: Interventions used in addition to DA-CPR
•
Comparators: Nonmodified DA-CPR
•
Outcomes: Any outcomes
•
Study designs: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols), editorials, commentaries, animal studies, and SysRevs were excluded. If there were insufficient studies from which to draw a conclusion, case series could be included in the initial search. All relevant studies with an abstract in English were included.
•
Time frame: The search of Embase, Medline, Cumulative Index to Nursing and Allied Health Literature Database, and Cochrane Database of Systematic Reviews was performed on May 17, 2023, for the period January 1, 2000, to May 17, 2023.
Summary of Evidence
Thirty-one studies were included in this ScopRev: One was a nonrandomized implementation trial,110 16 were simulation studies (15 RCTs,111–125 1 nonrandomized comparison126), and 12 were observational studies reviewing real-world OHCAs from registries or collected data80,83,126–135 or emergency call review.136 Two included studies used qualitative137 and mixed methods.138 Only 1 study focused on pediatric cardiac arrest.117 Complete details of the studies and findings are reported in the full CoSTR on the ILCOR website.
The interventions examined were advanced dispatcher training (n=3),127–129 centralization of the dispatch center (n=2),130,131 use of metronome or varied metronome rates (n=2),111,112 change in CPR sequence and compression ratio (n=1)132 an animated audiovisual recording (n=1),113 prerecorded instructions compared with conversational live instructions (n=1)114 implementation of novel DA-CPR protocols (n=4)80,83,110,115 changes in terminology about compressions (n=6; 1 pediatric), 116–118,126,133,136 inclusion of “undress patient” instructions (n=1),119 verbal encouragement (n=1),125 and use of video at the scene (n=9).120–124,134,135,137,138
The implementation of novel DA-CPR protocols, prerecorded instructions, centralized dispatch, advanced dispatcher training, use of metronomes and varying metronome rates and instructions to undress the patient all have <3 articles published, and therefore, we are unable to make any comment on their effectiveness at this point.
The studies that focus on simplifying the compression instruction language (ie, “Push as hard as you can” versus “Push ≈2 inches/5 cm”) suggest an improvement in the quality of CPR.117,118,126,133 The studies that examined adding video to the emergency call, compared with audio-only calls, suggest an improvement in CPR practice (eg, hand positioning) and quality (eg, compression depth and rate).120–124,135
Task Force Insights
The task force discussed the review findings and noted the following:
•
The lack of high-quality evidence, studies in humans, and the significant heterogeneity between studies of the various interventions.
•
Terminology changes in instructions may not be generalizable to other languages.
•
Almost half of the studies comparing video to audio were simulation studies.
Based on this ScopRev, there is insufficient evidence to pursue a new SysRev on this topic.
Knowledge Gaps
•
High-quality prospective research in humans, including assessment of patient outcomes
•
Data on optimizing DA-CPR in pediatric cases
Optimization of Dispatcher-Assisted AED Retrieval and Use (BLS 2120: ScopRev)
Rationale for Review
Bystander use of AEDs is associated with high survival rates from OHCA,139,140 but its use is currently infrequent.141 This topic was selected for review by the BLS Task Force because of the widespread use of dispatch instructions for the retrieval and use of an AED105,142 and the need to optimize systems to improve the public’s AED use.143,144 Although there is no existing ILCOR treatment recommendation related to dispatcher-assisted AED retrieval, the task force decided the current evidence required a ScopRev to fully explore the scope of the topic. Studies using drone delivery were excluded from this review because this evidence was examined in the 2023 CoSTR publication.146 The full online CoSTR can be found on the ILCOR website.147
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults and children with out-of-hospital cardiac arrest
•
Intervention: dispatcher-assisted AED retrieval and use
•
Outcomes: Any reported outcomes
•
Study designs: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies), simulation studies, case series (>5 patients), trial protocols, and conference abstracts were included. All relevant studies with an abstract in English were included.
•
Time frame: The search of Embase, Medline, and Cochrane Central was performed on April 14, 2023, from database inception to April 13, 2023.
Summary of Evidence
Sixteen studies were included in this ScopRev: 5 observational studies reviewing real-world OHCAs148–152 and 11 simulation studies (6 RCTs,153–158 1 nonrandomized trial,138 and 4 observational159–162).
There were no studies that examined patient outcomes. One observational study did report improvement in survival with favorable neurological outcome in 1132 (of 1606) OHCAs when a DA-CPR protocol included instructions to retrieve an AED, but the relative contribution of the dispatcher-assisted AED instruction could not be determined from the data provided.150
In systems using dispatcher-assisted AED retrieval and use, 5 observational studies reported low rates of AED retrieval (0.8%–5.8%),148,149,151 pad application (0.4%–1.7%),149,151,152 and shocks delivered (2.4%–11%).148,150 In one study, rates of bystander defibrillation were greater with dispatcher instructions to retrieve an AED, compared with cases where no instructions were given (11% versus 5%, unadjusted P<0.001).150 Another observational study reported confusion and delays in the emergency call after a 3-part instruction to retrieve an AED.148 Callers often had to ask the dispatcher to repeat the instruction, or they asked clarifying questions.
In simulation studies, time to first shock, when measured from the time the AED arrived, was longer when dispatcher assistance was provided than when there was no assistance.153,154 However, when time to retrieve an AED was factored in, time to first shock was shorter.156,157
AED competence scores were consistently higher with dispatcher assistance (or an analogous form of instruction).138,153,154,158,162 In a simulation study, the use of video instruction enabled the correction of pad placement, which initially was done incorrectly by most bystanders.162 In another study the use of mobile phone video resulted in better performance than verbal instruction alone,153 but a second study demonstrated no difference.138 The use of prerecorded video instruction was inferior to real-time (verbal) dispatcher instruction.158 In 1 study, dispatchers facilitated the application of an AED in 5 out of 6 cases when the AED had been brought to the (simulated) patient’s side, but the study participant did not attempt to use it unprompted.160
Task Force Insights
•
There is limited published research in this area, particularly on the impact on patient outcomes.
•
Given the majority of OHCAs occur in the home, public-access AEDs are likely to be in close proximity in only a minority of cases, and fewer still are likely able to be located, retrieved, and attached to a patient in a meaningful time frame.
•
If an AED is not available on-site, the optimal strategy to consider AED retrieval depends on the number of available rescuers, the arrest setting (ie, residential versus public), the proximity of AEDs, the fidelity (accuracy) of AED registry, and the timeliness of the community’s professional response.
•
There is a risk that by implementing dispatcher instructions to retrieve and use public-access AEDs, other aspects of the community response (eg, time to CPR, delay to dispatcher CPR instructions, reduced CPR efficacy due to distraction or interruptions) could be affected. These risks are likely to be greatest when there is a lone rescuer at the scene.
The studies reviewed in the present ScopRev suggest there is currently insufficient evidence to pursue a new SysRev on this topic. There were no previous treatment recommendations on this topic. Given the widespread adoption of this intervention and interest in this topic, the task force considered the available evidence and developed the following good practice statements.
2024 Good Practice Statements
EMS implementing dispatcher-assisted public-access AED systems should monitor and evaluate the effectiveness of their system (good practice statement).
Once a cardiac arrest is recognized during the emergency call and CPR has been started, dispatchers should ask if there is an AED (or defibrillator) immediately available at the scene and ask the caller to update them when one arrives (good practice statement).
If an AED is not immediately available and if there is more than 1 rescuer present, dispatchers should offer instructions to locate and retrieve an AED. Retrieval instructions should be supported, where resources allow, by up-to-date registries about public-access AED locations and accessibility (good practice statement).
Once an AED is available, dispatchers should offer instructions on its use (good practice statement).
Task Force Knowledge Gaps
•
High-quality evidence of the effect of dispatcher-assisted public-access AED use on critical and important clinical (patient) outcomes
•
The effect of dispatcher-assisted public-access AED use in pediatric cardiac arrest
•
The risks associated with dispatcher instructions for public-access AED retrieval and use during an emergency call
•
What contribution dispatcher instructions for public-access AED retrieval and use have in the overall community and EMS response to OHCA
•
The barriers and facilitators to dispatcher instruction for public-access AED retrieval and use
•
Which specific interventions will increase bystander retrieval and use of a public-access AED after dispatcher instructions
•
Optimization of current systems: What is the optimal way to introduce and implement dispatcher instructions for public-access AED retrieval and use? How and where should AED retrieval integrate into current dispatch protocols/algorithms? What is the optimum phrasing to use? Do the AED’s instructions complement or conflict with DA-CPR instructions? What is the potential role of using live-stream video or similar during dispatcher instruction on AED use? How best to use registries and associated technology so that dispatchers can best help bystanders locate and retrieve AEDs?
Feedback for CPR Quality (BLS 2511: ScopRev)
Rationale for Review
CPR feedback devices are intended to improve patient outcomes through improving the quality of CPR. The 2020 CoSTR on feedback for CPR quality recommended the use of real-time audiovisual feedback and prompt devices during CPR when used as part of a comprehensive quality improvement program.4,5 There were challenges with the 2020 ILCOR review due to the exclusion of many studies because they combined the evaluation of feedback with other quality improvement activities (eg, debriefing). The task force decided to perform a ScopRev to understand if the wider literature, including studies with other interventions, may provide further insights into the effectiveness of feedback and improve the existing PICOST question.165 Additionally, the task force concluded that this review should focus on the provision of CPR by health professionals responding in a professional capacity, rather than by bystanders or lay responders. The detailed results are provided on the ILCOR website.166
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults and children (excluding neonates) who are in cardiac arrest in any setting who are resuscitated by health professionals responding in a professional capacity
•
Intervention: Real-time feedback and prompt devices concerning the mechanics of CPR quality (eg, rate and depth of compressions or ventilations)
•
Comparators: No feedback or prompt devices, or alternative devices
•
Outcomes: Any outcome or measure of CPR quality
•
Study designs: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) are eligible for inclusion
•
Time frame: PubMed, Embase, Cochrane, and Cumulative Index to Nursing and Allied Health Literature were searched from database inception to July 18, 2023. A gray literature search was performed in the Google search engine (July 18, 2023). All relevant studies with an abstract in English were included.
Summary of Evidence
Of the 55 studies included, we identified 10 SysRevs,167–176 5 RCTs,177–181 37 observational studies,20,182–216 2 case series,217,218 and 1 commentary.219 The patients included varied widely between studies. Only 3 studies included children,210,212,220 and most of the evidence consisted of before-and-after studies.
The use of metronomes was examined in 1 SysRev from 2014176 and 6 observational studies (3 OHCA and 3 IHCA).182–187 This evidence suggests an associated improvement in CPR quality, but there are few data on patient outcomes and what outcome data are reported are not adjusted for confounding (Table 3).
Studies | Design issues | Results with use of feedback |
---|---|---|
Survival to discharge/30 days | ||
Fletcher et al, 2008186 Bolstridge et al, 2016182 | Before/after study182,186 Small sample size182 Conference abstract182 Unadjusted outcome182,186 | Significant increase: 1 before/after OHCA study186 No change: 1 before/after IHCA study182 |
ROSC | ||
Bolstridge et al, 2016182 Chiang et al, 2005185 | Before/after study182,185 Small sample size182,185 Conference abstract182 Unadjusted outcome182,185 | No change: 1 before/after IHCA study182; 1 before/after OHCA study185 |
CPR quality: compression rate | ||
Bolstridge et al, 2016182 Rainey and Birkhoff, 2021184 Fletcher et al, 2008186 Kennedy et al, 2023187 | Before/after study182–184,186,187 Small sample size182,184 | Significant increase: 3 before/after IHCA studies182–184; 2 before/after OHCA study186,187 |
CPR quality: compression depth | ||
Bolstridge et al, 2016182 Khorasani-Zadeh et al, 2020183 | Before/after study182,183 Small sample size182 | Significant increase: 2 before/after IHCA studies182,183 |
CPR quality: chest compression fraction | ||
Chiang et al, 2005185 | Before/after study185 Small sample size185 | No change: 1 before/after OHCA study185 |
CPR indicates cardiopulmonary resuscitation; IHCA, in-hospital cardiac arrest; OHCA, out-of-hospital cardiac arrest; and ROSC, return of spontaneous circulation.
By including a wider range of published studies and studies examining audiovisual feedback with other system improvements, we identified 9 SysRevs,167–175 5 RCTs,177–181 31 observational studies,20,188–216,220 and 2 case series.217,218 Evidence examining key outcomes with a non-feedback comparator group suggests improved CPR quality, but most studies reporting improved patient outcomes beyond ROSC included other interventions, such as high-performance CPR and postevent debriefing (Table 4). This evidence aligns with ILCOR’s current treatment recommendation that feedback devices should be used as part of a comprehensive quality improvement program.4,5
Studies | Design issues | Results with use of feedback |
---|---|---|
Favorable neurological outcome | ||
Bobrow et al, 2013193 Sainio et al, 2013195 Freese et al, 2014196 Couper et al, 2015189 Davis et al, 2015190* Hopkins et al, 2016198† Pearson et al, 2016205‡ Riyapan et al, 2019199 Chandra et al, 2022192§ | Before/after or observational189,190,192,193,195,196,198,199,205 Abstract only192,196 Small sample size199 Unadjusted outcomes192,195,196,199 | Significant increase: 1 before/after IHCA study190; 2 before/after OHCA studies193,198 Significant decrease: 1 observational OHCA study205 No change: 4 before/after OHCA studies189,192,196,199; 1 observational195 |
Survival to discharge/30 d | ||
Kramer-Johansen et al, 2006191 Abella et al, 2007188 Bobrow et al, 2013193 Freese et al, 2014196 Couper et al, 2015189 Davis et al, 2015190* Hopkins et al, 2016198† Goharani et al, 2019180 Riyapan et al, 2019199 Vahedian-Azimi et al, 2020179 Nehme et al, 2021201† Alqudah et al, 2022202† Chandra et al, 2022192§ | Before/after188–193,196,198,199,201,202 Small sample size179,188,199 Unadjusted outcomes179,192,196,199 Patients excluded postrandomization180 | Significant increase: 1 IHCA RCT180; 1 before/after IHCA study190; 3 before/after OHCA studies193,201,202 No change: 1 cluster OHCA RCT178; 1 pilot RCT179; 2 before/after IHCA studies188,189; 4 before after OHCA studies191,196,198,199; 1 observational195 |
Event survival | ||
Hostler et al, 2011178 Sainio et al, 2013195 Freese et al, 2014196 Riyapan et al, 2019199 Lakomek et al, 2020200 Nehme et al, 2021201† Alqudah et al, 2022202† | Before/after or observational195,196,199–202 Small sample size199 Abstract only196 Unadjusted outcomes195,196,198–200 | Significant increase: 1 before/after OHCA study201; 1 observational study195 No change: 1 cluster OHCA RCT178; 4 before/after OHCA studies196,199,200,202 |
ROSC | ||
Abella et al, 2007188 Hostler et al, 2011178 Leis et al, 2013194 Sainio et al, 2013195 Freese et al, 2014196 Couper et al, 2015189 Hopkins et al, 2016198† Vahedian-Azimi et al, 2016181 Goharani et al, 2019180 Lakomek et al, 2020200 Vahedian-Azimi et al, 2020179 Nehme et al, 2021201† Alqudah et al, 2022202† Chandra et al, 2022192§ | Before/after or observational188,189,192,194,196,200,201 Small sample size179,188,192,194 Abstract only192,196 Unadjusted outcomes179,192,194–196,200 | Significant increase: 2 IHCA RCT180,181; 3 before after OHCA studies196,198,201; 1 observational195 No change: 1 cluster OHCA RCT178; 1 pilot RCT179; 2 before/after IHCA studies188,189; 3 before/after OHCA studies192,200,202; 1 observational194 |
CPR quality: compression rate | ||
Kramer-Johansen et al, 2006191 Abella et al, 2007188 Hostler et al, 2011178 Bobrow et al, 2013193 Crowe et al, 2015197§ Riyapan et al, 2019199 Nehme et al, 2021201† Chandra et al, 2022192§ Lyngby et al, 2022203 | Before/after study188,191–193,197,199–201,203 Abstract only192,203 Small sample size197,199 Significant missing data178,192 | Significant increase: 5 before/after OHCA studies191,193,199,200,203 No change: 1 cluster OHCA RCT178; 1 before/after IHCA study188,195; 3 before/after OHCA studies180,192,201 |
CPR quality: compression depth | ||
Kramer-Johansen et al, 2006191 Abella et al, 2007188 Hostler et al, 2011178 Bobrow et al, 2013193 Crowe et al, 2015197§ Riyapan et al, 2019199 Nehme et al, 2021201† Chandra et al, 2022192§ Lyngby et al, 2022203 | Before/after study188,191–193,197,199–201,203 Abstract only192,203 Small sample size197,199 Significant missing data178,192 | Significant increase: 1 cluster OHCA RCT178; 7 before/after OHCA studies191–193,197,199,200,203 No change: 1 before/after IHCA study188 |
CPR quality: chest compression fraction | ||
Kramer-Johansen et al, 2006191 Hostler et al, 2011178 Crowe et al, 2015197§ Riyapan et al, 2019199 Lakomek et al, 2020200 Nehme et al, 2021201† Chandra et al, 2022192§ Lyngby et al, 2022203 | Before/after study191,192,197,199–201,203 Abstract only192,203 Small sample size197,199 Significant missing data178,192 | Significant increase: 1 cluster OHCA RCT178; 3 before/after OHCA studies192,201,203 No change: 4 before/after OHCA studies191,197,199,200 |
CPR indicates cardiopulmonary resuscitation; IHCA, in-hospital cardiac arrest; OHCA, out-of-hospital cardiac arrest; and RCT, randomized controlled trials.
*
High-performance CPR education, audiovisual feedback, and debriefing.
†
High-performance training (audiovisual feedback, scenario-based training, checklist, team leader, and debriefing).
‡
High-performance CPR education and audiovisual feedback.
§
Audiovisual feedback and debriefing.
Task Force Insights
•
As this was a ScopRev, no formal assessment of the quality of the literature was performed. However, the lack of RCTs was noted and many of the studies published since the last review continue to have methodological issues (eg, lack of adjustment for confounders, small sample sizes, no patient outcomes reported).
•
EMS systems and hospitals in well-resourced settings have, or are implementing, quality improvement programs, including the use of feedback devices, to improve the quality of CPR. This implementation makes the study of isolated interventions, such as feedback devices, difficult to evaluate in observational research.
•
While 55 studies were included in the narrative synthesis, there was insufficient new evidence to recommend a SysRev using the expanded PICOST question. An update of the SysRev using the existing PICOST question is recommended, with subgroups based on the different devices and separate review for health care professionals and lay people.
•
This ScopRev has revealed a substantial adjacent literature studying the implementation of high-performance CPR and quality improvement programs, but it was not possible to extract a specific association with real-time CPR feedback from these studies. It is suggested that a new PICOST question is developed that examines the impact of these programs on clinical outcomes for both OHCA and IHCA patients.
2024 Treatment Recommendations (Unchanged from 2020)
We suggest the use of real-time audiovisual feedback and prompt devices during CPR in clinical practice as part of a comprehensive quality improvement program for cardiac arrest designed to ensure high-quality CPR delivery and resuscitation care across resuscitation systems (weak recommendation, very low–certainty evidence).
We suggest against the use of real-time audiovisual feedback and prompt devices in isolation (ie, not part of a comprehensive quality improvement program, weak recommendation, very low–certainty evidence).
Knowledge Gaps
•
High-quality evidence adequately powered to examine patient outcomes
•
The lack of implementation science research guiding the implementation of feedback devices and quality improvement programs
•
Studies examining the impact of ultrasound
Effectiveness of Ultraportable or Pocket AEDs (BLS 2603: ScopRev)
Rationale for Review
Early defibrillation is associated with a large increase in survival from OHCA.221–224 If defibrillation occurs within 3 to 5 minutes of collapse, survival rates as high as 50% to 70% have been reported.223,224 EMS response times rarely enable delivery of defibrillation in such a short time.225 Recently, several companies have started advertising “ultraportable” or “pocket” AEDs for personal use or equipping community volunteer responders to improve AED availability. These devices may be limited in the number and the energy of the shocks they deliver (eg, restricted to up to 20 shocks and a maximum of 85 J). This topic has not been reviewed before, and given the interest in these devices, the task force thought a review of their effectiveness in practice was timely.225a The detailed results are provided on the ILCOR website.226
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults and children in OHCA
•
Intervention: The use of an ultraportable or pocket AED
•
Outcomes: All outcomes were accepted
•
Study designs: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies, conference abstracts, and trial protocols) were eligible for inclusion. Studies that describe the use of mobile AEDs associated with drone technology were excluded. All studies with an abstract in English were included.
•
Time frame: The search of Embase and Medline was performed on November 1, 2023, for the period January 1, 2012, to October 31, 2023.
Summary of Evidence
This review included 3 studies: a medico-economic simulation study,227 a study protocol of a cluster RCT,228 and an abstract with preliminary results of that cluster RCT.229 Key findings from these studies are summarized in Table 5.
First author and year, study design | Population | Intervention/comparator(s) | Findings |
---|---|---|---|
Shaker et al, 2022227; economic analysis | 600 000 simulated patients at low, moderate, and high risk for SCA | Small AED for rapid treatment of SCA (SMART)/No SMART strategy | At a 1.6% SCA annual risk, SMART strategy was associated with $95 251/QALY (societal perspective) and $100 797/QALY (health care perspective). At a 3.5% SCA annual risk, SMART strategy was associated with $53 925/QALY (societal perspective) and $59 672/QALY (health care perspective). SMART prevented 1762 fatalities across risk strata (1.59% fatality relative risk reduction across groups). |
Todd et al, 2023228; cluster RCT study protocol | Sample size calculation of 714 (357 per arm) | Community responder dispatched with GoodSAM app equipped with an ultraportable AED (CellAED)/community responder not equipped with AED | Primary outcome: Survival to 30 days Aim to detect a 7% increase in survival (9%–16%) |
Todd et al, 2023229; cluster RCT preliminary results (abstract) | 1805 community responders recruited; 903 allocated to CellAED | Community responder dispatched with GoodSAM app equipped with an ultraportable AED (CellAED)/community responder not equipped with AED | Unfinished study; 1788 alerts to CellAED participants, 104 arriving before EMS |
AED indicates automatic external defibrillator; EMS, emergency medical services; QALY, quality-adjusted life years; RCT, randomized controlled trial; SCA, sudden cardiac arrest; and SMART, small AED for rapid treatment of SCA.
Task Force Insights
•
Ultraportable or pocket AEDs are a new generation of defibrillators characterized by small size, being lightweight and easy to carry on one’s person, and affordable for personal and home use.
•
We acknowledge that the development of ultraportable or pocket and more affordable AEDs offers the unique opportunity to develop more efficient public access defibrillation or community volunteer responder programs, increase home AED availability, and therefore potentially improve outcomes.
•
Device registration with regulatory authorities alone does not provide evidence of device performance in real-world settings. Because the success of defibrillation is related to several factors, including shock energy, transthoracic impedance, defibrillator pad size and anatomical location, diagnostic accuracy for shockable rhythms, and the duration the person has been in cardiac arrest, further research is required to demonstrate the clinical efficacy of pocket/ultraportable AEDs.
•
There is a lack of research in this area.
There is currently insufficient evidence to recommend progression to a formal SysRev. Given the proliferation of these devices, the task force issues a good practice statement requesting research.
2024 Treatment Recommendations (New)
There is currently insufficient evidence on the clinical effectiveness of ultraportable or pocket AEDs to make a treatment recommendation.
Knowledge Gaps
•
The effect of ultraportable or pocket AED use on critical and important clinical outcomes
•
A consensus on the definition of ultraportable AED
•
The clinical efficacy (ie, whether the devices work in optimal settings) or clinical effectiveness (real-world settings) of ultraportable AEDs
•
The performance of ultraportable AEDs compared with standard AEDs: Such research should address process measures (eg, time to defibrillation), evidence of efficacy (eg, termination of fibrillation, return of organized rhythm, ROSC) and clinical effectiveness (eg, survival with a favorable neurological outcome, survival to discharge).
•
The cost-effectiveness of ultraportable defibrillators in different contexts (eg, at home, by community volunteer responder programs, and in public locations)
•
How to best organize and maintain ultraportable defibrillators
BLS Topics Reviewed by EvUps
Topics evaluated with EvUps are summarized in Table 6. The complete EvUps are provided in Appendix B.
Topic/PICO | Year last updated | Existing treatment recommendation | RCTs since last review | Observational studies since last review | Key findings | Sufficient data to warrant SysRev? |
---|---|---|---|---|---|---|
PAD programs (BLS 2121) | 2020 | We recommend the implementation of public-access defibrillation programs for patients with OHCAs (strong recommendation, low-certainty evidence). | 0 | 4 | Four studies reported improved outcomes overall. Subgroup analysis in two studies showed benefits varied by age, sex and pathogenesis. | Yes (include subgroup analysis) |
CPR ratios (BLS 2202) | 2017 | We suggest a compression–ventilation ratio of 30:2 compared with any other compression–ventilation ratio in patients with cardiac arrest (weak recommendation, very low-quality evidence). | 0 | 2 | One study reported increased ventilation associated with improved outcomes. One study reported no association with ventilation rates and outcomes. | Yes (further studies identified in 2 SysRevs) |
CPR before defibrillation (BLS 2203) | 2019 | We suggest a short period of CPR until the defibrillator is ready for analysis and/or defibrillation in unmonitored cardiac arrest (weak recommendation, low-certainty evidence). | 0 | 0 | No new studies | No |
Timing of rhythm check: during compressions (BLS 2211) | 2019 | We suggest against the routine use of artifact-filtering algorithms for analysis of electrocardiographic rhythm during CPR (weak recommendation, very-low-certainty evidence). We suggest that the usefulness of artifact-filtering algorithms for analysis of electrocardiographic rhythm during CPR be assessed in clinical trials or research initiatives (weak recommendation, very-low-certainty evidence). | 0 | 4 | None of the studies report on critical outcomes and only one considers the important outcome of CPR quality (chest compression fraction). | No |
Hand positioning (BLS 2502) | 2020 | We suggest performing chest compressions on the lower half of the sternum on adults in cardiac arrest (weak recommendation, very low certainty evidence). | 0 | 0 | No new studies. | No |
Head-Up CPR (BLS 2503) | 2021 | We suggest against the routine use of head-up CPR during CPR (weak recommendation, very-low-certainty evidence). We suggest that the usefulness of head-up CPR during CPR be assessed in clinical trials or research initiatives (weak recommendation, very-low-certainty evidence). | 0 | 2 | High risk of bias. No difference in outcomes in propensity-matched cohort. | No |
BLS indicates basic life support; CPR, cardiopulmonary resuscitation; OHCA, out-of-hospital cardiac arrest; PAD, public access defibrillation; PICO, population, intervention, comparator, outcome; and RCT, randomized controlled trial.
Advanced Life Support
Post–Cardiac Arrest Oxygenation and Ventilation (ALS 3506 and 3516: SysRev)
Rationale for Review
This review was conducted by the ALS Task Force in collaboration with the BLS Task Force. Oxygenation and ventilation are important components of post–cardiac arrest management. This topic was last updated with a SysRev for the 2020 CoSTR (PROSPERO registration CRD42022371007).230–232 Since the last review of this topic, the task forces were aware of new clinical trials, prompting an update of the SysRev. The complete CoSTR can be found online.233
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Unresponsive adults with sustained ROSC after cardiac arrest in any setting (in-hospital or out-of-hospital)
•
Intervention: An oxygenation or ventilation strategy targeting a specific Spo2, Pao2, or Paco2
•
Comparators: Treatment without specific targets or with an alternate target to the intervention
•
Outcomes:
–
Critical: Survival or survival with a favorable neurological outcome at hospital discharge/30 days or longer
–
Other outcomes will depend on the available data and subsequent outcome prioritization by the ILCOR ALS Task Force
•
Study designs: Controlled trials, including RCTs, and nonrandomized trials (eg, pseudorandomized trials) were included. Observational studies, animal studies, ecological studies, case series, case reports, reviews, abstracts, editorials, comments, letters to the editor, and unpublished studies were excluded. All languages were included if there was an English abstract or full-text article.
•
Time frame: From August 22, 2019 (date of search of the prior review), to June 30, 2023
Consensus on Science
Five new RCTs including adult patients were identified.234–238 These studies add to the previous SysRev, which included 7 RCTs.231,239–245 Studies used various specific oxygen and carbon dioxide strategies or targets, as defined in Table 7.
Key results for both oxygen and carbon dioxide comparisons are presented in Table 8 and Table 9. Overall, there was no consistent evidence of benefit or harm from the different oxygen and carbon dioxide strategies investigated.
Study author, year | Intervention | Comparator |
---|---|---|
Kuisma et al, 2006244 | 2–4 L/min O2 | >10 L/min O2 |
Bray et al, 2018243 | O2 saturation goal 90%–94% | O2 saturation goal 98%–100% |
Thomas et al, 2019240 | O2 saturation goal 94%–98% | 100% Fio2 |
Bernard et al, 2022234 | O2 saturation goal 90%–94% | O2 saturation goal 98%–100% |
Jakkula et al, 2018239 | Pao2 10–15 kPa (75–113 mm Hg) | Pao2 20–25 kPa (150–188 mm Hg) |
Young et al, 2020242 | O2 saturation goal 90%–97% | Standard care |
Schmidt et al, 2022237 | Pao2 9–10 kPa (68–75 mm Hg) | Pao2 13–15 kPa (98–105 mm Hg) |
Semler et al, 2022236 | O2 saturation goal 88%–96% | O2 saturation goal 96%–100% |
Crescioli et al, 2023238 | Pao2 8 kPa (60 mm Hg) | Pao2 12 kPa (90 mm Hg) |
Jakkula et al, 2018239 | Paco2 5.8–6.0 kPa (44–45 mm Hg) | Pao2 90 mm Hg (12 kPa) |
Eastwood et al, 2016241 Eastwood et al, 2023235 | Paco2 6.7–7.3 kPa (50–55 mm Hg) | Paco2 4.7–6.0 kPa (35–45 mm Hg) |
Outcome (importance) | Participants, n (studies) | Certainty of evidence, GRADE | RR (95% CI) | ARD (95% CI) |
---|---|---|---|---|
Higher compared with lower oxygen in the prehospital setting | ||||
Survival to hospital discharge (critical) | 549 (4 RCTs)234,240,243,244 | Moderate | 0.98 (0.70, 1.37) | 34 fewer per 1000 patients (126 fewer to 88 more) |
Survival to 3 mo (critical) | 35 (1 RCT)240 | Very low | 3.15 (1.04, 9.52) | 379 more per 1000 patients (7 more to 1000 more) |
Survival to 12 mo (critical) | 401 (1 RCT)234 | Moderate | 0.82 (0.64, 1.06) | 76 fewer per 1000 patients (151 fewer to 25 more) |
Survival with favorable neurological outcome at 12 mo (critical) | 389 (1 RCT)234 | Moderate | 0.85 (0.62, 1.17) | 47 fewer per 1000 patients (118 fewer to 53 more) |
Higher compared with lower oxygen in the ICU | ||||
Survival to hospital discharge, 28 d, or 30 d (critical) | 1409 (2 RCTs, 2 RCT subgroups)236,237,239,242 | Low | 1.10 (0.95, 1.27) | 60 more per 1000 patients (30 fewer to 163 more) |
Survival with favorable neurological outcome at discharge (critical) | 789 (1 RCT)237 | Moderate | 1.03 (0.93, 1.14) | 20 more per 1000 patients (46 fewer to 93 more) |
Survival to 3 mo or 6 mo (critical) | 1405 (2 RCTs, 2 RCT subgroups)237–239,242 | Moderate | 1.05 (0.92, 1.20) | 29 more per 1000 patients (47 fewer to 116 more) |
Survival with favorable neurological outcome at 3 or 6 mo (critical) | 1059 (2 RCTs, 1 RCT subgroup)237,239,242 | Low | 1.07 (0.96, 1.20) | 43 more per 1000 patients (24 fewer to 122 more) |
ARD indicates absolute risk difference; GRADE, Grading of Recommendations Assessment, Development, and Evaluation; ICU, intensive care unit; RCT, randomized controlled trial; and RR, relative risk.
Outcome (importance) | Participants, n (studies) | Certainty of evidence, GRADE | RR (95% CI) | ARD (95% CI) |
---|---|---|---|---|
Moderate hypercapnia compared with normocapnia or low-normal Paco2 after ROSC | ||||
Survival to hospital discharge (critical) | 1866 (3 RCTs)235,239,241 | Moderate | 0.95 (0.82, 1.10) | 30 fewer per 1000 patients (108 fewer to 60 more) |
Survival to 6 mo (critical) | 1648 (1 RCT)235 | Moderate | 0.96 (0.88, 1.05) | 22 fewer per 1000 patients (65 fewer to 27 more) |
Survival with favorable neurological outcome at 6 mo (critical) | 1751 (3 RCTs)235,239,241 | Moderate | 0.96 (0.85, 1.10) | 19 fewer per 1000 patients (70 fewer to 46 more) |
ARD indicates absolute risk difference; GRADE, Grading of Recommendations Assessment, Development, and Evaluation; RCT, randomized controlled trial; ROSC, return of spontaneous circulation; and RR, relative risk.
Prior Treatment Recommendations (2020)
We suggest the use of 100% inspired oxygen until the arterial oxygen saturation or the partial pressure of arterial oxygen can be measured reliably in adults with ROSC after cardiac arrest in any setting (weak recommendation, very low–certainty evidence).
We recommend avoiding hypoxemia in adults with ROSC after cardiac arrest in any setting (strong recommendation, very low–certainty evidence).
We suggest avoiding hyperoxemia in adults with ROSC after cardiac arrest in any setting (weak recommendation, low-certainty evidence).
There is insufficient evidence to suggest for or against targeting mild hypercapnia compared with normocapnia in adults with ROSC after cardiac arrest.
2024 Treatment Recommendations
Oxygen Targets
We recommend the use of 100% inspired oxygen until the arterial oxygen saturation or the partial pressure of arterial oxygen can be measured reliably in adults with ROSC after cardiac arrest in the prehospital setting (strong recommendation, moderate-certainty evidence) and in-hospital setting (strong recommendation, low-certainty evidence).
We recommend avoiding hypoxemia in adults with ROSC after cardiac arrest in any setting (strong recommendation, very low–certainty evidence).
We suggest avoiding hyperoxemia in adults with ROSC after cardiac arrest in any setting (weak recommendation, low-certainty evidence).
Following reliable measurement of arterial oxygen values, we suggest targeting an oxygen saturation of 94% to 98% or a partial pressure of arterial oxygen of 75 to 100 mm Hg (≈10–13 kPa) in adults with ROSC after cardiac arrest in any setting (good practice statement).
When relying on pulse oximetry, health care professionals should be aware of the increased risk of inaccuracy that may conceal hypoxemia in patients with darker skin pigmentation (good practice statement).
Carbon Dioxide Targets
We suggest targeting normocapnia (a partial pressure of carbon dioxide of 35–45 mm Hg or ≈4.7–6.0 kPa) in adults with ROSC after cardiac arrest (weak recommendation, moderate-certainty evidence).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table is provided in Appendix A.
Oxygen Targets
•
The task forces discussed that avoiding oxygen titration until blood oxygen values are accurately measured is especially important in the prehospital setting, where arterial blood gas analysis is rarely available and peripheral blood oxygen saturation may be difficult to obtain consistently. The largest RCT in the prehospital setting suggested that early titration to a lower oxygen target is harmful.234 The task forces discussed whether the evidence favored avoiding any titration of oxygen in the out-of-hospital setting because most patients in the control arm of the EXACT trial (Reduction of Oxygen After Cardiac Arrest) received 100% oxygen without titration. However, most thought that once reliable measurement of oxygenation was available, the evidence only supported not titrating to a lower target range of 90% to 94%.
•
In making the recommendation to avoid hypoxemia, the task forces concluded that the physiologic basis for hypoxia being harmful justifies its avoidance and that detection of hypoxemia may be the best surrogate for true hypoxia.
•
The suggestion to avoid hyperoxemia is based on very low–certainty to moderate-certainty evidence that showed either harm (in observational studies included in the 2020 SysRev) or no benefit (in RCTs) from hyperoxemia. It is important to consider that the higher oxygen groups in RCTs generally did not reach the very high Pao2 values (300–400 mm Hg, or ≈40–53 kPa) associated with harm in some observational studies.
•
The variability in oxygenation targets across RCTs and observational studies makes it difficult to identify an evidence-based optimal range. However, the task forces recognized the need for more precise guidance than that provided previously and agreed that targeting an oxygen saturation of 94% to 98% or a Pao2 target of 75 to 100 mm Hg (10–13 kPa) is reasonable.
•
While studies evaluating the accuracy of pulse oximetry in people with different degrees of skin pigmentation were not part of this SysRev, the SysRev team and task forces were aware of and considered several such studies that have found a slightly higher risk of occult hypoxemia (pulse oximetry reading of >90% saturation, while arterial oxygen saturation by blood gas is <88%) in people with dark skin.246–248 While none of these studies were done in cardiac arrest patients, the task forces concluded that it was important to make medical professionals treating cardiac arrest patients aware of this issue because this knowledge could inform decision-making about whether to titrate supplemental oxygen. The task forces, therefore, provided a good practice statement to highlight this issue.
Carbon Dioxide Targets
•
The evidence from RCTs and observational studies is inconsistent. RCTs have failed to show any effect from different CO2 targets. Considering the lack of evidence for benefit or harm from targeting CO2 values above or below the normal range, the task forces deemed it reasonable to target normocapnia, generally defined as a Paco2 of 35 to 45 mm Hg (≈4.7–6.0 kPa), in both RCTs and observational studies. Notably, the task forces are aware of unpublished data from an included RCT234 as well as observational studies not included in this review,249–252 suggesting that ETco2 values may not accurately reflect Paco2 values, which may be an important consideration in the prehospital setting. As with all critically ill patients, there may be specific scenarios in which CO2 values may need to be higher or lower than normal to compensate for other illnesses (eg, severe lung injury or metabolic acidosis).
•
The task forces discussed whether cardiac arrest patients with baseline chronic lung disease and chronic CO2 retention might respond differently to different CO2 targets; however, no evidence addressing this subgroup was found.
Knowledge Gaps
•
The optimal oxygen target for post–cardiac arrest patients
•
Whether there is a threshold at which hypoxemia and hyperoxemia become harmful
•
The optimal duration for specific oxygen strategies
•
The optimal CO2 target for post–cardiac arrest patients
•
Whether there is a threshold at which hypocapnia and hypercapnia become harmful
•
The accurate correlation of ETco2 with Paco2 values
•
The effects of manipulating Paco2 on cerebral blood flow in post–cardiac arrest patients
•
How Paco2 targets should be adjusted in patients with chronic CO2 retention
•
Whether arterial blood gas analysis should be adjusted to 37 °C or to a patient’s current temperature
Post–Cardiac Arrest Hemodynamics (ALS 3515: SysRev Adolopment)
Rationale for Review
The topic of hemodynamic goals after cardiac arrest was previously reviewed by the ALS Task Force in 2015,253,254 and an EvUp was conducted in 2020.230,232 In the previous recommendation, consideration of hemodynamic goals was suggested, but there was insufficient evidence to recommend a specific target. New RCTs have been published on this topic, and the task force decided a SysRev was warranted. A recently published SysRev with individual patient data meta-analysis, which included a meta-analysis of the effect of targeting a mean arterial pressure (MAP) higher or lower than 70 mm Hg, was identified; this review was deemed of sufficient quality to be used for adolopment.255 The complete CoSTR can be found online.256
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults with sustained ROSC after cardiac arrest
•
Intervention: Targeting a MAP of 71 mm Hg or higher
•
Comparator: Targeting a MAP of 70 mm Hg or lower
•
Outcomes:
–
Critical: Survival or good functional outcome defined as a modified Rankin Scale score of 1 to 3 or a score of 1 to 2 on the Cerebral Performance Category scale at 90 to 180 days
–
Important: Intensive care unit mortality, new arrhythmia resulting in hemodynamic compromise or cardiac arrest while in the intensive care unit (ICU)
•
Study designs: RCTs were eligible for inclusion. All years and all languages were included as long as there was an English abstract. Observational studies and unpublished studies (eg, conference abstracts, trial protocols) were excluded.
•
Time frame: The literature search was conducted in October 2022 and updated in August 2023.
Consensus on Science
The SysRev identified 4 RCTs of 1065 patients comparing lower and higher MAP targets after ROSC.257–260 The included RCTs provided low-certainty evidence (downgraded for risk of bias and indirectness) of no benefit from a higher MAP compared with a lower MAP target for the critical outcomes of mortality at 180 days (RR, 1.08 [95% CI, 0.92–1.26]) and good functional outcome at 180 days (RR, 0.99 [95% CI, 0.84–1.16]). Similarly, there was no benefit for the outcomes of ICU mortality (RR, 1.09 [95% CI, 0.81–1.46]) or new arrhythmia resulting in hemodynamic compromise or cardiac arrest during ICU stay (RR, 1.04 [95% CI, 0.77–1.40]).
Prior Treatment Recommendations (2015)
We suggest hemodynamic goals (eg, MAP, systolic blood pressure) be considered during postresuscitation care and as part of any bundle of postresuscitation interventions (weak recommendation, low-certainty evidence).
2024 Treatment Recommendations
There is insufficient scientific evidence to recommend a specific blood pressure goal after cardiac arrest. Therefore, we suggest a mean arterial blood pressure of at least 60 to 65 mm Hg in patients after out-of-hospital (moderate-certainty to low-certainty evidence) and IHCA (low-certainty to very low–certainty evidence).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table is provided in Appendix A.
In making these updated recommendations, the ALS Task Force considered the following:
•
The 4 RCTs conducted since the prior review provide significant new evidence but have not yet identified an optimal BP strategy.
•
While no specific mean arterial BP strategy has been found to be beneficial in cardiac arrest trials, the task force thought it was important to provide more specific guidance than had been previously provided. The threshold of 65 mm Hg was agreed upon because this threshold is the accepted standard in other forms of critical illness, and there is no evidence to deviate from that practice in postarrest patients. Observational data suggest that the lowest MAP not associated with a worse outcome after cardiac arrest is about 60 to 70 mm Hg,261–263 and the “Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock” recommends targeting a MAP of >65 mm Hg in patients with septic shock.264
•
No statistically significant benefit or harm from targeting a higher MAP was found for any critical outcome.
•
All RCT studies conducted thus far focused on patients with a likely cardiac cause of the arrest and a high likelihood of a favorable outcome.
•
Whether a higher MAP target, such as 80 to 100 mm Hg, may be beneficial for some patients has not been determined by trials to date. The task force acknowledged that this is part of clinical practice at some cardiac arrest centers. The current treatment recommendation purposefully does not prescribe an upper limit for MAP targets because it is unknown.
Knowledge Gaps
•
Optimal BP management in patients with cardiac arrest of noncardiac pathogenesis or with IHCA and who have thus far not been included in trials
•
What MAP to target in the prehospital setting
•
The current evidence can exclude a relative positive or negative treatment effect of targeting a higher MAP of higher than 25% but not lower; this difference may be unrealistic, and there may be a need for larger trials.
•
Whether the effect of MAP on outcome is different in certain subgroups of patients, such as those with chronic hypertension
•
Whether targeting a higher BP could be beneficial in patients with deranged autoregulation
•
Whether increasing MAP influences cerebral or coronary blood flow
•
Whether MAP, as opposed to some other proxy for organ perfusion (lactate clearance, urinary output, capillary refill), is the optimal bedside therapeutic target
•
The optimal strategy to achieve a target MAP after cardiac arrest, which may include the use of intravenous fluids (fluid type and volume), specific vasopressors or combinations of vasopressors, and use of mechanical support
Post–Cardiac Arrest Temperature Control (ALS 3523, 3524, 3525: SysRev)
Rationale for Review
Since publication of the prior SysRev,265 the task force has been aware of new clinical trials examining temperature control in comatose post–cardiac arrest patients and, therefore, updated the SysRev (PROSPERO registration of original review CRD42020217954). The SysRev covered the following 6 different aspects of temperature management: (1) use of hypothermic temperature control, (2) timing, (3) specific temperature, (4) duration of temperature control, (5) method of temperature control, and (6) rate of rewarming. The full CoSTR can be found online.266
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults with cardiac arrest in any setting (in-hospital or out-of-hospital)
•
Interventions:
–
Intervention 1: Temperature control (temperature control studies targeting hypothermia at 32–34 °C in the SysRev)
–
Intervention 2: Temperature control induction before a specific time point (eg, prehospital or intracardiac arrest)
–
Intervention 3: Temperature control at a specific temperature (eg, 33 °C)
–
Intervention 4: Temperature control for a specific duration (eg, 48 hours)
–
Intervention 5: Temperature control with a specific method (eg, external)
–
Intervention 6: Temperature control with a specific rewarming rate
•
Comparators:
–
Comparator 1: No temperature control (temperature control studies targeting normothermia or fever prevention included in the SysRev)
–
Comparator 2: Temperature control induction after that specific time point
–
Comparator 3: Temperature control at a different specific temperature (eg, 36 °C)
–
Comparator 4: Temperature control at a different specific duration (eg, 24 hours)
–
Comparator 5: Temperature control with a different specific method (eg, internal)
–
Comparator 6: Temperature control with a different specific rewarming rate or no specific rewarming rate
•
Outcomes:
–
Critical: Survival and survival with a favorable neurological outcome at hospital discharge and 30 days and longer
•
Study designs: Controlled trials in humans, including RCTs and nonrandomized trials (eg, pseudorandomized trials), were included. Observational studies, ecological studies, case series, case reports, reviews, abstracts, editorials, comments, letters to the editor, and unpublished studies were excluded. Studies assessing cost-effectiveness were included for a descriptive summary. Unpublished studies (eg, conference abstracts, trial protocols) were excluded. All languages were included if there was an English abstract.
•
Time frame: The original literature search was performed on October 30, 2020, and updated for clinical trials on June 17, 2021. The literature search was conducted on May 31, 2023, for the updated SysRev and on June 3, 2023, for ongoing clinical trials.
Consensus on Science
Note on Terminology
The term targeted temperature management has been updated as below for clarity.
•
Hypothermic temperature control=active temperature control with the target temperature below the normal range
•
Normothermic temperature control=active temperature control with the target temperature in the normal range
•
Fever prevention temperature control=monitoring temperature and actively preventing and treating temperature above the normal range
•
No temperature control=no protocolized active temperature control strategy
This updated search yielded 6 new trials investigating different aspects of post–cardiac arrest temperature control, adding to the 32 trials identified in the previous review. Comparisons included temperature control versus no temperature control, timing of temperature control, specific temperature targets, durations of temperature control, methods of temperature control, and rates of rewarming. Key results are summarized in Table 10. Overall, there was no difference between hypothermic temperature control and normothermic temperature control or between other specific temperatures studied or different durations or methods of temperature control.
Outcome (importance) | Participants, n (studies) | Certainty of evidence, GRADE | RR (95% CI) | ARD (95% CI) |
---|---|---|---|---|
Hypothermia (32–34 °C) compared with normothermia or fever prevention | ||||
Survival to hospital discharge (critical) | 3074 (6 RCTs)267–272 | Low | 1.07 (0.91– 1.25) | 32 more per 1000 patients (41 fewer to 114 more) |
Survival with favorable neurological outcome at hospital discharge or 30 d (critical) | 2377 (4 RCTs)267,268,271,272 | Low | 1.16 (0.81– 1.66) | 59 more per 1000 patients (70 fewer to 243 more) |
Survival to 90 or 180 d (critical) | 3014 (6 RCTs)268–273 | Low | 1.06 (0.91, 1.23) | 25 more per 1000 patients (38 fewer to 97 more) |
Survival with favorable neurological outcome at 90 or 180 d (critical) | 2991 (6 RCTs)268–273 | Low | 1.16 (0.92, 1.47) | 57 more per 1000 patients (28 fewer to 166 more) |
33 °C compared with 36 °C | ||||
Survival with favorable neurological outcome at hospital discharge (critical) | 938 (1 RCT)274 | Low | 0.96 (0.83, 1.11) | 18 fewer per 1000 patients (78 fewer to 50 more) |
Survival with favorable neurological outcome at 180 d (critical) | 990 (2 RCTs)274,275 | Low | 1.01 (0.88, 1.15) | 4 more per 1000 patients (42 fewer to 53 more) |
Duration of cooling (12–24 h compared with 36 h of temperature control or 48 h compared with 24 h*) | ||||
Survival at 1 mo (critical) | 173 (1 RCT)276 | Very low | 1.03 (0.89, 1.18) | 24 more per 1000 patients (88 fewer to 145 more) |
Favorable neurological outcome at 1 mo (critical) | 173 (1 RCT)276 | Very low | 0.95 (0.75, 1.21) | 31 fewer per 1000 patients (156 fewer to 131 more) |
*Survival at 6 mo (critical) | 351 (1 RCT)277 | Low | 1.10 (0.96, 1.27) | 66 more per 1000 patients (26 fewer to 178 more) |
*Favorable neurological outcome at 6 mo (critical) | 351 (1 RCT)277 | Low | 1.08 (0.93, 1.25) | 51 more per 1000 patients (45 fewer to 159 more) |
Method of temperature control (endovascular compared with surface cooling) | ||||
Survival to hospital discharge or 28 d (critical) | 523 (3 RCTs)278–280 | Low | 1.14 (0.93, 1.38) | 56 more per 1000 patients (28 fewer to 152 more) |
Favorable neurological outcome at hospital discharge or 28 d (critical) | 523 (3 RCTs)278–280 | Low | 1.22 (0.95, 1.56) | 64 more per 1000 patients (15 fewer to 163 more) |
Rewarming rate (0.25 °C/h compared with 0.50 °C/h) | ||||
Survival at 90 d (critical) | 50 (1 RCT)281 | Low | 0.88 (0.56, 1.38) | 77 fewer per 1000 patients (282 fewer to 243 more) |
Favorable neurological outcome at 90 d | 50 (1 RCT)281 | Low | 1.00 (0.59, 1.70) | 0 fewer per 1000 patients (213 fewer to 364 more) |
Duration of fever prevention after initial temperature control | ||||
Survival at 90 d (critical) | 789 (1 RCT)282 | Low | 0.99 (0.90, 1.08) | 7 fewer per 1000 patients (80 fewer to 56 more) |
Favorable neurological outcome at 90 d (critical) | 789 (1 RCT)282 | Low | 0.98 (0.89, 1.08) | 14 fewer per 1000 patients (74 fewer to 54 more) |
ARD indicates absolute risk difference; GRADE, Grading of Recommendations Assessment, Development, and Evaluation; RCT, randomized controlled trial; and RR, relative risk.
*
Indicates outcomes for comparison of temperature control for 48 hours compared with 24 hours.
2024 Treatment Recommendations and Good Practice Statements (Unchanged from 2022)
We suggest actively preventing fever by targeting a temperature ≤37.5 °C for patients who remain comatose after ROSC from cardiac arrest (weak recommendation, low-certainty evidence).
Whether subpopulations of cardiac arrest patients may benefit from targeting hypothermia at 32 °C to 34 °C remains uncertain.
Comatose patients with mild hypothermia after ROSC should not be actively warmed to achieve normothermia (good practice statement).
We recommend against the routine use of prehospital cooling with rapid infusion of large volumes of cold intravenous fluid immediately after ROSC (strong recommendation, moderate-certainty evidence).
We suggest surface or endovascular temperature control techniques when temperature control is used in comatose patients after ROSC (weak recommendation, low-certainty evidence).
When a cooling device is used, we suggest using a temperature control device that includes a feedback system based on continuous temperature monitoring to maintain the target temperature (good practice statement).
Prior Good Practice Statement on Duration of Fever Prevention (2022)
2024 Good Practice Statement on Duration of Fever Prevention
We suggest active prevention of fever for 36 to 72 hours in post–cardiac arrest patients who remain comatose (good practice statement).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table is provided in Appendix A.
Hypothermia Compared With Normothermia or Prevention of Fever
•
All members of the task force agreed to continue to recommend active temperature control in post–cardiac arrest patients, although the evidence for this is limited.
•
The task force acknowledged that the SysRev found no difference in overall outcomes between patients treated with hypothermia and normothermia or fever prevention.
•
The majority of the task force favored fever prevention temperature control for comatose patients after ROSC as opposed to hypothermic temperature control, on the basis of the SysRevs and because this intervention requires fewer resources and had fewer side effects than hypothermic temperature control. Several members, however, wanted to leave open the option to use hypothermic temperature control (33 °C). Reasons for this include findings of a single trial suggesting benefit in those with a nonshockable initial rhythm270 and the relatively few data in patients with cardiac arrest of a noncardiac pathogenesis.
•
The task force discussed the possibility that earlier cooling and achieving the target temperature sooner might still be beneficial. Trials to date have largely not been able to achieve this.
•
Although there was no direct evidence in our SysRevs, the task force maintained the existing good practice statement supporting the avoidance of active warming of patients who have passively become mildly hypothermic after ROSC (eg, 32–36 °C) because there was concern that this may be a harmful intervention.
Prehospital Cooling
•
Our treatment recommendation for prehospital cooling is unchanged from our 2015 recommendation. No new studies were identified.
•
We found no evidence that any method of prehospital cooling improved outcomes, and the rapid infusion of large amounts of cold fluid immediately after achieving ROSC in the prehospital setting could be harmful. Any potential harm from this therapy may relate specifically to the prehospital setting, where there may be less control over the environment, fewer personnel, and reduced monitoring capabilities.
•
We have not made a treatment recommendation about intra-arrest cooling for OHCA.
Cooling Devices
•
There was consensus that temperature should be continually monitored by the cooling device, when such a device is used, so that a stable temperature is maintained.
Duration of Temperature Control
•
Our previous treatment recommendation was a good practice statement based on trials controlling temperature for at least 72 hours in those patients who remained sedated or comatose. One trial showed no difference between 24 and 48 hours of hypothermia,277 and another found no difference between 12 to 24 and 36 hours of hypothermia.276
•
This updated review includes an additional trial comparing temperature control for a total duration of 36 hours versus 72 hours that found no difference in outcomes.282 The same trial included temperature control with a surface cooling device at one site and an intravenous cooling device at the other site. Whether results are applicable to temperature control without a device or different cooling devices is unknown.
•
The task force was not able to reach consensus on a treatment recommendation on duration of temperature control or fever prevention. After discussion about the lack of consistency in the interventions and comparators across the available studies, the task force agreed that there was not enough trial evidence to support a recommendation specifically on how long to prevent fever. All task force members agreed on the good practice statement, which accommodates a range of duration that is supported by the limited data and by expert opinion.
Rewarming
•
The task force discussed that, although there is no evidence that active rewarming is harmful, expert opinion is that it is generally unwarranted and can be avoided.
Knowledge Gaps
•
Data on no temperature control versus fever prevention temperature control (little data available)
•
The effect of temperature control after extracorporeal cardiopulmonary resuscitation (ECPR)
•
The effect of temperature control after IHCA (only 1 small trial available)
•
Whether there is a therapeutic window within which hypothermic temperature control is effective in the clinical setting
•
If a therapeutic window exists, whether there are clinically feasible cooling strategies that can rapidly achieve therapeutic target temperatures within the therapeutic window
•
Whether the clinical effectiveness of hypothermia is dependent on providing the appropriate dose (target temperature and duration) based on the severity of brain injury
•
Whether there are unidentified subsets of post–cardiac arrest patients who would benefit from hypothermic temperature control as currently practiced
•
Whether temperature control using a cooling device with feedback is more effective than temperature control without a feedback-controlled cooling device
Post–Cardiac Arrest Seizure Prophylaxis and Treatment (ALS 3502 and 3503: SysRev)
Rationale for Review
This topic was last updated in 2020.230,232 This was a nodal SysRev between the ALS and Pediatric Life Support Task Forces based on the knowledge of new evidence examining the treatment of seizures after cardiac arrest. The nodal review included both adults and children. Readers should refer to the pediatric life support section for pediatric-specific recommendations on this topic. The SysRev was registered on PROSPERO (CRD42023460746 and CRD42023463581), and the full CoSTR can be found online.287
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults or children in any setting (in-hospital or out-of-hospital) with cardiac arrest and ROSC
•
Intervention: One strategy for prophylactic antiseizure medication or seizure treatment
•
Comparators: Another strategy or no prophylactic antiseizure medication or seizure treatment
•
Outcomes:
–
Critical: Survival or survival with favorable neurological/functional outcome at discharge, 30 days, 60 days, 180 days, or 1 year
•
Study designs: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols) were excluded. All relevant publications in any language were included if there was an English abstract.
•
Time frame: All years; search conducted on September 11, 2023
Consensus on Science
Prophylactic Antiseizure Medication
No new studies were identified since the prior review. For the critical outcome of survival with favorable neurological outcome at discharge, 30 days, or longer, 2 RCTs including 562 patients investigated prophylactic antiseizure medication and provided very low–certainty evidence of no benefit for survival or neurologic outcome.288,289 Agents used for prophylaxis included thiopentone,288 magnesium, diazepam, and the combination of magnesium and diazepam,289 all compared with placebo. A nonrandomized clinical trial of 107 patients provided very low–certainty evidence of no improvement in neurological outcome at hospital discharge or survival with thiopentone compared with historic controls.290
Treatment of Seizures
No RCTs or nonrandomized studies addressed the effect of treatment of clinical seizures in post–cardiac arrest patients compared with no seizure treatment. One RCT provided low-certainty evidence on the effect of treatment of rhythmic and periodic electroencephalogram (EEG) patterns in comatose patients after cardiac arrest, compared with no treatment, finding no difference in favorable neurological outcome (Cerebral Performance Category 1–2) at 3 months with administration of antiseizure medications compared with standard care (RR, 1.23 [95% CI, 0.48–3.15]; or 19 more per 1000 patients, [95% CI, from 43 fewer to 179 more]).291 There was also no difference in survival.
Prior Treatment Recommendations (2020)
We suggest against seizure prophylaxis in adult post–cardiac arrest survivors (weak recommendation, very low–certainty evidence).
2024 Treatment Recommendations
We suggest against the use of prophylactic antiseizure medication in post–cardiac arrest adults (weak recommendation, very low–certainty evidence).
We suggest treatment of clinically apparent and electrographic (EEG) seizures in post–cardiac arrest adults (good practice statement).
We suggest treatment of rhythmic and periodic EEG patterns that are on the ictal-interictal continuum in comatose post–cardiac arrest adults (weak recommendation, low-certainty evidence).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table is provided in Appendix A.
Prophylactic Antiseizure Medication
No new evidence has emerged on this topic since the prior review. The task force decided to clarify the language slightly but saw no reason for substantive change. The task force considered the evidence that the administration of prophylactic antiseizure medication in other forms of acute brain injury is not associated with improved outcomes and that most prophylactic antiseizure medications can have significant side effects. Finally, the task force acknowledged that most comatose post–cardiac arrest patients routinely receive sedatives like propofol or benzodiazepines, which are known to have antiseizure effects. However, the task force identified no controlled studies that examined whether different sedation strategies or choices of sedation drugs had an impact on the incidence of post–cardiac arrest seizures.
Seizure Treatment
The task force discussed the importance of consistent definitions when investigating this topic and creating treatment recommendations. Terms and definitions established by the American Clinical Neurophysiology Society are used in the discussion below and should be employed consistently in trials (Table 11).292
Category | Definition |
---|---|
Electrographic seizure | Epileptiform discharges averaging >2.5 Hz for ≥10 s (>25 discharges in 10 s) or Any pattern with definite evolution as defined above and lasting ≥10 s |
Electroclinical seizure | Any EEG pattern with either Definite clinical correlate time-locked to the pattern (of any duration) or EEG and clinical improvement with a parenteral (typically IV) antiseizure medication |
Electroclinical status epilepticus | An electroclinical seizure for ≥10 continuous min or A total duration of ≥20% of any 60-min period of recordingor ≥5 continuous min if the seizure is convulsive (ie, with bilateral tonic clonic motor activity; in any other clinical situation, the minimum duration to qualify as status epilepticus is >10 min Possible ECSE: A pattern on the ictal-interictal continuum that is present for ≥10 continuous min or for a total duration of >20% of any 60-min period of recording, which shows EEG improvement with a parenteral antiseizure medication but without clinical improvement |
Ictal-interictal continuum | Any PD or SW pattern that averages >1.0 Hz and <2.5 Hz over 10 s (>10 and <25 discharges in 10 s) or Any PD or SW pattern that averages >0.5 Hz and <1 Hz over 10 s (>5 and <10 discharges in 10 s) and has a plus modifier or fluctuation or Any lateralized RDA averaging >1 Hz for at least 10 s (at least 10 waves in 10 s) with a plus modifier or fluctuation and Does not qualify as an electrographic seizure or electroclinical status epilepticus |
ACNS indicates American Clinical Neurophysiology Society; ECSE, electroclinical status epilepticus; EEG, electroencephalogram; IV, intravenous; PD, periodic discharge; RDA, rhythmic delta activity; SE, status epilepticus; and SW, spike wave.
Other points of discussion included
•
Correct categorization of EEG findings requires the skilled interpretation of video EEG.
•
Untreated clinical seizure activity may cause additional brain injury, and, thus, treatment of clinical seizures is recommended despite the lack of high-certainty evidence.
•
Rhythmic and periodic EEG patterns that do not meet criteria for electrographic seizures are of unclear significance in patients who are comatose after cardiac arrest. It is not clear if they represent a marker of an injured brain or if treatment may improve outcomes.
•
In the TELSTAR trial (Treatment of Electroencephalographic Status Epilepticus After Cardiopulmonary Resuscitation), the majority (≈80%) of the EEG patterns were generalized periodic discharges of 0.5 to 2.5 Hz without evolution. Whether such EEG patterns deserve treatment is unknown, and no difference was seen in the trial. Post hoc subgroup analysis of TELSTAR suggested a possible beneficial effect in the small subgroup with electrographic seizures but not for treatment of periodic discharges.291
•
Indirect evidence from case series suggests sedatives such as propofol are effective in suppressing clinical seizures and electrographic seizures. A retrospective study provides some evidence that conventional antiseizure medications (specifically valproate and levetiracetam) also have an effect in suppressing epileptiform activity in the EEG.293
•
There is no direct evidence of undesirable effects of antiseizure medications in comatose post–cardiac arrest patients, although use of sedating agents may delay awakening.
•
The benefit of continuous EEG compared with intermittent EEG was not specifically reviewed. Continuous EEG monitoring is labor intensive and likely to add significant cost to patient care. The cost-effectiveness of this approach is controversial and may depend substantially on the setting. The CERTA study (Continuous EEG Randomized Trial in Adults) evaluated continuous versus intermittent EEG in critically ill adults with impaired consciousness, and approximately one third of the subjects had been resuscitated from cardiac arrest.294 No difference was found in outcome (6-month mortality), although more seizures were detected and more frequent changes to antiseizure medications were made in the continuous EEG group.
Knowledge Gaps
•
Whether antiseizure medications affect the outcome of post–cardiac arrest patients with either rhythmic and periodic EEG patterns or clinical seizures
•
The optimal timing, duration, dosing, and choice of antiseizure medications for seizure treatment in comatose post–cardiac arrest patients
•
The utility and cost-effectiveness of continuous EEG versus intermittent EEG monitoring in the diagnosis and treatment of seizures in comatose postarrest patients
•
The threshold for treating rhythmic and periodic EEG activity
•
The value of using volatile anesthetics to treat refractory status epilepticus in post–cardiac arrest patients
Extracorporeal Cardiopulmonary Resuscitation (ALS 3001: SysRev)
Rationale for Review
The task force was aware of new research published on the use of ECPR, and the decision was made to update our previous SysRev (PROSPERO registration CRD42022341077).295,296 For evidence related to pediatric cardiac arrest, refer to the Pediatric Life Support section of this summary. The full CoSTR can be found online.297
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults (>18 years) with cardiac arrest in any setting (out-of-hospital or in-hospital)
•
Intervention: ECPR, including extracorporeal membrane oxygenation or cardiopulmonary bypass during cardiac arrest
•
Comparators: Manual or mechanical cardiopulmonary resuscitation
•
Outcome: Any clinical outcome
•
Study designs: RCTs were included. Observational studies, animal studies, ecological studies, case series, case reports, reviews, abstracts, editorials, comments, letters to the editor, and unpublished studies were excluded. Studies assessing cost-effectiveness were included for a descriptive overview. Studies exclusively assessing the use of extracorporeal life support for cardiac or respiratory failure after sustained ROSC were excluded. Studies assessing extracorporeal circulation for deep hypothermia (or other conditions) were included only if cardiac arrest was documented. All languages were included if there was an English abstract or an English full-text article.
•
Time frame: From June 21, 2022 (date of the search for the previous review), to May 10, 2023
Consensus on Science
A single new RCT was identified.298 This adds to the 3 RCTs identified in the previous review.296,299–301 Given the existence of 4 RCTs and the critical risk of bias of the observational studies identified in prior reviews, only evidence from RCTs was considered.
The overall certainty of evidence was rated as low for OHCA and as very low for IHCA (downgraded further because all evidence was in OHCA) for all outcomes. Because of a high degree of heterogeneity between the randomized trials, no meta-analyses were performed. Key results are summarized in Table 12.
Author, year | n | Survival to discharge/30 d, n (%) | ARD (95% CI), % | Favorable functional outcome* at discharge/30 d, n (%) | ARD (95% CI), % | Favorable functional outcome* at 6 mo, n (%) | ARD (95% CI), % | |||
---|---|---|---|---|---|---|---|---|---|---|
ECPR strategy | Standard care | ECPR strategy | Standard care | ECPR strategy | Standard care | |||||
Yannopoulos et al, 2020299 | 30 | 6/14 (43) | 1/15 (7) | 36 (7.4 to 65) | 3/14 (21) | 0 | 21 (0 to 43) | 6/14 (43) | 0 | 43 (17 to 69) |
Hsu et al, 2021300 | 15 | 0 | 1/3 (33) | −33 (−87 to 20) | 0 | 0 | 0 | NA | NA | NA |
Belohlavek et al, 2022301 | 264 | 52/124 (42) | 43/132 (33) | 9.4 (−2.4 to 21) | 38/124 (31) | 24/132 (18) | 13 (2 to 23) | 39/124 (32) | 29/132 (22) | 10 (−1.3 to 20) |
Suverein et al, 2023298 | 134 | 14/70 (20) | 13/64 (20) | −0.3 (−14 to 13) | 14/70 (20) | 10/62 (16) | 3.9 (−9.2 to 17) | 14/70 (20) | 10/63 (16) | 4.1 (−8.9 to 17) |
ARD indicates absolute risk difference; CPC, Cerebral Performance Category; ECPR, extracorporeal cardiopulmonary resuscitation; mRS, modified Rankin Scale; and NA, not applicable.
*
Favorable functional outcome defined as mRS score of 0 to 3 or CPC score of 1 to 2.
2024 Treatment Recommendations (Unchanged from 2023)
We suggest that ECPR may be considered as a rescue therapy for selected adults with out-of-hospital cardiac arrest when conventional cardiopulmonary resuscitation is failing to restore spontaneous circulation in settings where this can be implemented (weak recommendation, low-certainty evidence).
We suggest ECPR may be considered as a rescue therapy for selected adults with in-hospital cardiac arrest when conventional cardiopulmonary resuscitation is failing to restore spontaneous circulation in settings where this can be implemented (weak recommendation, very low–certainty evidence).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table is provided in Appendix A.
•
In making this weak recommendation, we note that this patient population (ie, patients in whom conventional CPR is failing during cardiac arrest) has an extremely high mortality rate, particularly when refractory to standard advanced cardiac life support. Therefore, the potential for benefit and value of this intervention remains despite the overall low certainty of the evidence.
•
The published randomized trials use highly selected patients for ECPR and not the general population of all cardiac arrest cases. The trial by Yannopoulos et al299 enrolled OHCA patients with an initial shockable rhythm and randomized patients upon hospital arrival, whereas the trials by Hsu et al300 and Belohlavek et al301 enrolled OHCAs with any initial rhythm and randomized patients in the prehospital setting. The trial by Suverein et al298 enrolled OHCA patients with an initial shockable rhythm and randomized most patients in the prehospital setting (63% in the ECPR group and 66% in the conventional CPR group). Guidelines for clinical practice should ideally apply to similar populations, although the optimal population remains undefined. For this reason, the findings of individual trials should be interpreted cautiously in the context of the trial setting and population.
•
We acknowledge that ECPR is a complex intervention that requires considerable resources and training that are not universally available but also acknowledge the value of an intervention that may be successful in individuals for whom usual CPR techniques have failed. In addition, ECPR can sustain perfusion while another intervention, such as coronary angiography or percutaneous coronary intervention, can be performed.
Knowledge Gaps
•
There are few, and no large, randomized trials of ECPR versus standard care, and female patients are underrepresented in trials
•
The optimal patient population who may benefit from ECPR
•
The optimal time to initiate ECPR in cases of refractory cardiac arrest
•
Whether ECPR for OHCA should be initiated in the prehospital or in-hospital setting
•
The optimal techniques for providing safe and timely ECPR
•
The optimal post–cardiac arrest care strategy for patients resuscitated using ECPR
•
Whether there are population-specific differences in performing ECPR for in-hospital cardiac arrest and OHCA
•
Whether there are differences in quality of life between survivors of ECPR and standard CPR
•
The cost-effectiveness of ECPR
Cardiac Arrest During Pregnancy (ALS 3401: ScopRev)
Rationale for Review
Cardiac arrest during pregnancy is a rare but catastrophic event. Physiologic changes during pregnancy and concerns about both maternal and fetal survival bring additional considerations to resuscitation of a pregnant patient. The task force was aware that the evidence available was insufficient for a SysRev and meta-analysis to be possible but thought a review of this topic was a high priority, and this ScopRev was thus completed. The full report of this ScopRev, including detailed tables describing the individual studies, can be found online.302
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Pregnant or up to 1-year postpartum patients in cardiac arrest in any setting (in-hospital or out-of-hospital)
•
Intervention: Any specific intervention(s)
•
Comparators: Standard care or usual resuscitation practice
•
Outcomes:
–
Maternal
◦
Critical: Survival and favorable functional outcome at hospital discharge, 30 days, 60 days, 180 days, or 1 year
◦
Important: ROSC
–
Neonatal
◦
Critical: Survival and favorable functional outcome at hospital discharge, 30 days, 60 days, 180 days, or 1 year
◦
Important: ROSC
•
Study designs: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies, simulation/manikin and animal studies), case series with ≥20 patients, and descriptive studies without a comparator group were eligible for inclusion. Gray literature, social media, and non–peer-reviewed studies, unpublished studies, conference abstracts, and trial protocols were eligible for inclusion. All languages were included if there was an English abstract or an English full-text article.
•
Time frame: From August 2014 (date of prior review) to September 2023
Summary of Evidence
This ScopRev identified 8 heterogeneous studies describing several interventions for cardiac arrest during pregnancy.303–310 The studies are substantially limited by lack of granularity, small sample sizes, indirect measures of interventional effects, and high degrees of bias and confounding.
Studies are described in detail in the data tables in the online ScopRev.302 The studies identified concentrated on 3 interventions: (1) left-lateral uterine displacement with supine positioning for resuscitation, (2) perimortem or resuscitative delivery, and (3) extracorporeal life support.
Indirect data from a porcine model demonstrated significantly higher coronary perfusion pressures during resuscitation with supine positioning with left-lateral uterine displacement compared with left-lateral tilt positioning (perfusion pressure of 20 mm Hg compared with 5 mm Hg, P<0.05).305 Five observational studies reported data supporting performing perimortem cesarean or resuscitative delivery when ROSC does not occur early during resuscitation of cardiac arrest in a pregnant person with a uterine size ≥20 weeks’ gestation.306–310 The median time from collapse to cesarean delivery in survivors and nonsurvivors varied across studies, but shorter times from arrest to delivery were associated with improved maternal and neonatal outcomes. Two studies suggested that extracorporeal life support may improve pregnancy and peripartum outcomes for both the pregnant person and fetus in the setting of cardiac arrest, despite the potential of bleeding and clotting complications.303,304
Task Force Insights
The task force prioritized this topic because of the ongoing burden of mortality during pregnancy (estimated at 287 000 deaths globally in 2020, with mortality increasing in some countries, such as the United States).311,312 The prevalence of cardiac arrest during hospitalizations for delivery in the United States from 2017 to 2019 rose to 1/9000, previously reported as 1/12 000 in 2014 using the US National Inpatient Sample database.313 Cardiac arrest is the final common pathway of several pathophysiologic conditions leading to death during pregnancy, including hemorrhage, cardiomyopathy, hypertensive complications, embolic events, and sepsis. Management of cardiac arrest is complex because it requires accommodation of the physiological changes of pregnancy. Randomized trials are challenging to perform during pregnancy, and the evidence on this topic is limited. For these reasons, the task force decided to summarize the emerging research and identify specific knowledge gaps. The limited data did not support a full SysRev or making any changes to existing treatment recommendations, but 2 good practice statements were made.
2024 Treatment Recommendations (Unchanged from 2020) and Good Practice Statements (New)
We suggest delivery of the fetus by perimortem cesarean delivery for women in cardiac arrest in the second half of pregnancy (weak recommendation, very low–certainty evidence).
There is insufficient evidence to define a specific time interval by which delivery should begin.
High-quality usual resuscitation care and therapeutic interventions that target the most likely cause(s) of cardiac arrest remain important in this population.
There is insufficient evidence to make a recommendation about the use of left-lateral tilt or uterine displacement during CPR in the pregnant patient.
ECPR may be considered as a rescue therapy for selected cardiac arrest patients during pregnancy or in the postpartum period when conventional CPR fails and in settings in which it can be implemented (good practice statement).
This good practice statement does not replace the ALS treatment recommendation for use of ECPR in general.
Institution readiness and resuscitation education are required to accommodate the unique physiologic challenges of cardiac arrest during pregnancy (good practice statement).
Knowledge Gaps
•
How to improve outcomes of cardiac arrest during pregnancy
•
Optimal approach to airway management in cardiac arrest in pregnancy, including placement of an advanced airway, tracheal intubation, and use of videolaryngoscopy
•
Optimal management of OHCA during pregnancy, including issues of transport and consequent delays in perimortem or resuscitative delivery
•
How to select patients most likely to benefit from, and not be harmed by, ECPR
Emergency Front of Neck Airway Access During Cardiac Arrest (ALS 3606: ScopRev)
Rationale for Review
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adult patients in cardiac arrest in any setting in which adequate ventilation cannot be rapidly achieved by using basic or advanced airway management strategies
•
Intervention: Front-of-neck airway access attempt
•
Comparators: Ongoing attempts at basic or advanced airway management strategies
•
Outcome: Any clinical outcome
•
Study designs: RCTs, nonrandomized studies (eg, interrupted time series, controlled before-and-after studies and cohort studies), and case series with at least 5 patients were included. Animal studies, case series or reports with fewer than 5 patients, editorials, protocols, review articles, and letters were excluded.
•
Time frame: From inception to November 2, 2023
Summary of Evidence
Our search identified a single RCT316 and 68 observational studies from prehospital, in-hospital, and military settings.317–384 No studies specifically focused on cardiac arrest.
The RCT compared emergency cricothyrotomy and emergency percutaneous dilatational tracheostomy in 169 patients (9 with cardiac arrest) with failed airway management in the emergency department.316 The success rate of percutaneous cricothyrotomy (95.3%) was similar to that of percutaneous dilatational tracheostomy (97.6%; P=0.45).
The observational studies documented a median 11.4 front-of-neck access attempts per study (interquartile range [IQR], 2.9-31.5). Most studies were trauma specific or a mix of trauma and medical emergencies and occurred in a mix of prehospital, in-hospital, and military settings. The most common emergency front-of-neck airway intervention was surgical cricothyroidotomy.
Incidence of front-of-neck airway access attempts varied markedly across studies, from 0.06 to 436 attempts per 1000 patients. The variability was predominantly driven by the denominator chosen in each study (eg, all intubation attempts or all cases of failed intubation). Success rates were typically high, with most studies reporting success rates of >70%. Outcomes varied markedly across studies. In cardiac arrest patients, rates of ROSC ranged from 0% to 64%. The evidence on complications was challenging to interpret because reporting was inconsistent.
Task Force Insights
The task force discussed the review findings and noted the following:
•
None of the available evidence directly addressed the review question.
•
There were no studies that specifically examined patients in cardiac arrest, such that the incidence of front-of-neck airway access attempts in the cardiac arrest population is uncertain.
•
The success rate of emergency front-of-neck airway access attempts was generally high.
•
Clinical outcomes across studies varied markedly.
•
The available evidence does not enable the task force to make comparisons across different front-of-neck airway access strategies.
•
The context of cardiac arrest (eg, ongoing chest compressions, unreliability of pulse oximetry or other strategies to monitor oxygenation) may make it particularly challenging to rapidly identify a failure to achieve adequate ventilation and adequate oxygenation.
•
The task force recognized that the generation of high-quality data that directly address the review question would be challenging.
2024 Good Practice Statement (New)
In adults in cardiac arrest, when standard airway management strategies (eg, oropharyngeal airway and bag-mask, supraglottic airway, or tracheal tube) have failed, it is reasonable for appropriately trained rescuers to attempt front-of-neck airway access using a cricothyroidotomy technique (good practice statement).
Knowledge Gaps
•
The incidence or success rate of emergency front-of-neck airway access attempts in the adult cardiac arrest population
•
The optimal timing for emergency front-of-neck airway access in adults in cardiac arrest
•
Clinical outcomes of adults in cardiac arrest for whom emergency front-of-neck airway access is attempted
•
The optimal technique for achieving front-of-neck airway access
ALS Topics Reviewed by EvUps
ALS topics reviewed by EvUps are summarized in Table 13.
Topic/PICO | Year last updated | Existing treatment recommendation | RCTs since last review | Observational studies since last review | Key findings | Sufficient data to warrant SysRev? |
---|---|---|---|---|---|---|
Use of atropine in cardiac arrest (ALS 3206) | 2010 | There is insufficient evidence to support or refute the use of atropine in cardiac arrest to improve survival to hospital discharge. | 0 | 3 | Administration of atropine was not associated with improved survival to hospital discharge or longer-term survival/neurological outcomes. | No |
Airway management during cardiac arrest (ALS 3300–3304) | 2019 | We suggest using bag-mask ventilation or an advanced airway strategy during CPR for adult cardiac arrest in any setting (weak recommendation, low-certainty to moderate-certainty evidence). If an advanced airway is used, we suggest a supraglottic airway for adults with OHCA in settings with a low tracheal intubation success rate (weak recommendation, low-certainty evidence). If an advanced airway is used, we suggest a supraglottic airway or tracheal intubation for adults with out-of-hospital cardiac arrest in settings with a high tracheal intubation success rate (weak recommendation, very low–certainty evidence). If an advanced airway is used, we suggest a supraglottic airway or tracheal intubation for adults with in-hospital cardiac arrest (weak recommendation, very low–certainty evidence). | 2 and 9 RCT subanalyses | 50 | One cluster RCT found no significant difference between tracheal tube and iGel. Five observational studies compared video with direct laryngoscopy. In all 5 studies, video laryngoscopy was associated with either better or equivalent outcomes (outcomes ranging from glottic view to hospital survival). Two randomized trials compared proprietary laryngoscopy tools against direct laryngoscopy in small cohorts. In general, findings favored the proprietary tools over direct laryngoscopy. Seven observational studies, all limited by risk of bias, found an association between early advanced airway placement and better outcomes (patients who did not receive an advanced airway were excluded). | No |
CPR-induced consciousness (ALS 3004) | 2021 | In settings in which it is feasible, rescuers may consider using sedative or analgesic drugs (or both) in very small doses to prevent pain and distress to patients who are conscious during CPR (good practice statement). Neuromuscular-blocking drugs alone should not be given to conscious patients (good practice statement). The optimal drug regimen for sedation and analgesia during CPR is uncertain. Regimens can be based on those used in critically ill patients and according to local protocols (good practice statement). | 0 | 5 | Incidence of CPRIC appears to be high, with 57% of UK paramedics witnessing CPRIC. CPRIC is associated with memory and awareness of events and may have longer-lasting psychological sequelae (depression, anxiety, PTSD). It is unclear how to best treat CPRIC or whether treatment improves patient care and outcomes. | No |
Use of mCPR devices during cardiac arrest (ALS 3002) | 2015 | We suggest against the routine use of automated mechanical chest compression devices but suggest that they are a reasonable alternative to use in situations where sustained high-quality manual chest compressions are impractical or compromise provider safety. | 6 | 46 | One OHCA RCT found no difference in short-term survival with the LUCAS device compared with manual CPR. A subanalysis from a clinical trial of OHCA also found no difference in long-term outcomes with mechanical CPR compared with manual CPR. One feasibility trial of IHCA found use of the LUCAS was feasible and found no difference in outcomes, compared with manual CPR. One trial of OHCA in the emergency department found higher ROSC rate with the AutoPulse compared with manual CPR (45% with manual CPR compared with 23% with the AutoPulse, P=0.009). Survival was also higher in the AutoPulse group (39.1% compared with 21.9%, P=0.03). | Yes |
Cardiac arrest associated with asthma (ALS 3408) | 2010 | There is insufficient evidence to suggest any routine change to cardiac arrest resuscitation treatment algorithms for patients with cardiac arrest caused by asthma. | 0 | 1 guideline article | No | |
Antiarrhythmics during and after cardiac arrest (ALS 3201, 3514) | 2018 | We suggest the use of amiodarone or lidocaine in adults with shock refractory VF/pVT (weak recommendation, low-quality evidence). We suggest against the routine use of magnesium in adults with shock-refractory VF/pVT (weak recommendation, very low-quality evidence). The confidence in effect estimates is currently too low to support an ALS Task Force recommendation about the use of bretylium, nifekalant, or sotalol in the treatment of adults in cardiac arrest with shock-refractory VF/pVT. The confidence in effect estimates is currently too low to support an ALS Task Force recommendation about the use of prophylactic antiarrhythmic drugs immediately after ROSC in adults with VF/pVT cardiac arrest. | 0 6 secondary analyses of ROC-ALPS RCT | 20 | Observational studies and the secondary analyses of prior RCTs generally favor amiodarone or lidocaine over placebo, supporting the current treatment recommendations. Procainamide and β-blockers were included in the updated evidence review, for which there were insufficient data to support recommendations for their use in the treatment of adults in cardiac arrest with shock-refractory VF/pVT, as was also the case for bretylium, nifekalant, and sotalol. Studies supported early administration of antiarrhythmics during cardiac arrest as survival decreased with longer times to drug administration. | No |
Cardiac arrest associated with pulmonary embolism (ALS 3400) | 2020 | We suggest administering fibrinolytic drugs for cardiac arrest when PE is the suspected cause of cardiac arrest (weak recommendation, very low–certainty evidence). We suggest the use of fibrinolytic drugs or surgical embolectomy or percutaneous mechanical thrombectomy for cardiac arrest when PE is the known cause of cardiac arrest (weak recommendation, very low–certainty evidence). The role of ECPR techniques was addressed in the 2019 ILCOR CoSTR. We suggest that ECPR may be considered as a rescue therapy for selected patients with cardiac arrest when conventional CPR is failing in settings in which it can be implemented (weak recommendation, very low–certainty evidence). | 0 | 1 | Higher survival rate in patients treated with thrombolysis. Small number of patients, wide confidence intervals. Observational design, high risk of bias/confounding. | No |
ALS indicates advanced life support; CPR, cardiopulmonary resuscitation; CPRIC, CPR-induced consciousness; ECPR, extracorporeal cardiopulmonary resuscitation; EvUp, evidence update; IHCA, in-hospital cardiac arrest; LUCAS, Lund University Cardiopulmonary Assist System; mCPR, mechanical CPR; OHCA, out-of-hospital cardiac arrest; PE, pulmonary embolism; PICO, population, intervention, comparator, outcome; PTSD, posttraumatic stress disorder; RCT, randomized controlled trial; ROC-ALPS, Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo Study; ROSC, return of spontaneous circulation; SysRev, systematic review; and VF/pVT, ventricular fibrillation or pulseless ventricular tachycardia.
Pediatric Life Support
Blood Pressure Targets Following Return of Circulation After Pediatric Cardiac Arrest (PLS 4190-01: SysRev)
Rationale for Review
Determining the optimal BP targets in infants and children after cardiac arrest after ROSC, or after return of circulation (ROC) on mechanical support, poses a significant challenge due to lack of evidence. Clinical practice in this area is based on a few pediatric studies, extrapolation from studies conducted in adults, or expert consensus recommendations. While individual studies in infants and children suggest there is an association between hypotension post-ROSC or post-ROC and poor outcomes, these studies are small and it is unclear if the association is causal or a surrogate marker of more severe postresuscitation syndrome. To answer this knowledge gap, a systematic review aimed to evaluate the literature on the effects of BP targets on outcomes post-ROSC/ROC in infants and children (PROSPERO registration CRD42023483865). The full CoSTR can be found online.385
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Infants and children in any setting (in-hospital or out-of-hospital cardiac arrest) after ROC
•
Intervention: A specific BP target
•
Comparator: No BP target or a different BP target
•
Outcome
–
Critical: Survival/survival with favorable neurological outcome as per Pediatric Core Outcome Set for Cardiac Arrest386
•
Study design: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols) were excluded. All languages were included if there was an English abstract.
•
Time frame: All years were included. The initial search was done on January 25, 2023, and updated on November 3, 2023.
Consensus on Science
Six studies were identified.387–392 All 6 were nonrandomized observational cohort studies, with 5 being secondary analyses. We identified significant variation in BP target definitions (eg, systolic, mean, and diastolic BP and >5th, >10th, and >50th percentile for age) and time frames for measurement (<20 minutes, 0–6 hours, within 24 hours, and 0–72 hours). In our final analysis, we included 4 studies388,389,391,392 examining the BP targets of systolic BP >5th percentile for age compared with systolic BP ≤5th percentile within the first 6 hours after ROC. One study was not included in our analysis because only diastolic BP targets were reported.390 The pooled sample included 463/930 (49.8%) patients after IHCA and 467/930 (50.2%) after OHCA. We also included 1 study387 that enrolled 693 infants and children after IHCA (excluding patients who required extracorporeal life support [ECLS]). This study compared systolic BP >10th percentile with systolic BP ≤10th percentile within the first 6 hours after ROC. The systolic BP cutoff at the 10th percentile was generated from receiver operator characteristic curves and spline curves created from the study data.
Results from included pediatric studies are included in Table 14. A random effects model was chosen for meta-analysis to better account for study heterogeneity.
Outcomes (importance) | Study type, participants, n (studies, n) | Certainty of evidence (GRADE) | aRR (95% CI) | ARD with intervention |
---|---|---|---|---|
Exposure: ≤5th percentile vs >5th percentile for age systolic BP within 6 h post-ROC | ||||
Survival | Nonrandomized, 931 (4)388,389,391,392 | Very low | 1.34 (1.07–1.52) | 143 more patients per 1000 survived with the intervention (95% CI, 30 more patients per 1000 to 219 more patients per 1000 survived with the intervention) |
Survival with favorable neurologic outcome (critical) | Nonrandomized, 584 (2)388,389 | Very low | 1.30 (1.06–1.60) | 156 more patients per 1000 survived with the intervention (95% CI, 31 more patients per 1000 to 312 more patients per 1000 survived with the intervention) |
Exposure: ≤10th percentile vs >10th percentile for age systolic BP within 6 h post-ROC | ||||
Survival | Nonrandomized, 693 (1)387 | Very low | 1.21 (1.00–1.33); P<0.01 | 138 more patients per 1000 survived with the intervention (95% CI, 66 more patients per 1000 to 213 more patients per 1000 survived with the intervention) |
Survival with favorable neurologic outcome (critical) | Nonrandomized, 693 (1)387 | Very low | 1.22 (1.10–1.35); P<0.01 | 134 more patients per 1000 survived with the intervention (95% CI, 61 more patients per 1000 to 213 more patients per 1000 survived with the intervention) |
ARD indicates absolute risk difference; aRR, adjusted risk ratio; BP, blood pressure; GRADE, Grading of Recommendations Assessment, Development, and Evaluation; and ROC, return of circulation.
Prior Treatment Recommendation (2020)
We recommend that for infants and children after ROSC, parenteral fluids and/or inotropes or vasopressors should be used to maintain a systolic blood pressure of at least greater than the fifth percentile for age (strong recommendation, very low–certainty evidence).393
2024 Treatment Recommendations
We suggest in infants and children with return of circulation after an IHCA or OHCA that a systolic BP >10th percentile for age should be targeted (weak recommendation, very low–certainty evidence).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table is provided in Appendix A.
•
The PLS Task Force considered that the measurement and treatment of BP is a standard component of the postresuscitation bundle of care after cardiac arrest. However, current post–cardiac arrest BP targets and thresholds for treatment have been suggested through expert consensus and evidence extrapolated from individual studies.
•
Measurement of BP is a low-cost intervention and available in nearly all resource settings. However, the PLS Task Force did not compare the cost-effectiveness of intermittent noninvasive BP measurement with invasive arterial or continuous BP measurement.
•
There were no randomized controlled studies comparing 2 treatment approaches or 2 BP targets after cardiac arrest. The available evidence consisted of observational data demonstrating the impact of exposure to 2 different BP thresholds on clinically important outcomes. However, the BP thresholds were chosen either a priori by investigators as a clinically important threshold (eg, <5th percentile) or the cutoff value was derived statistically from the population data as the most significant inflection point (<10th percentile). The PLS Task Force focused on the impact of hypotension on clinical outcome and did not include studies assessing normotension or hypertension on outcomes. This will form part of future assessments.
•
The PLS Task Force considered the exposure overlap of the 2 thresholds, <5th percentile and <10th percentile. It was not statistically possible to perform meta-regression to compare the 2 treatment targets. The consensus of the task force was that the higher threshold target (<10th percentile) included the population included in the <5th percentile group. Acknowledging the low certainty of evidence, the target of >10th percentile systolic BP was the more acceptable systolic BP goal and ensured avoidance of the 5th to 10th BP percentiles that were associated with worse outcome in the larger study.387
•
The PLS Task Force concluded that although the effect size from the pooled studies is small, the value of the outcome is high and the potential impact on infant and child survivors globally is, therefore, large.
Knowledge Gaps
•
There are no interventional studies comparing benefit or harm of targeting specific BP targets
•
The impact of prehospital BP measurement or treatment for OHCA
•
Whether specific subgroups of pediatric patients after ROC require different BP targets. Observational data demonstrate an association between exposure to lower BP targets and worse outcome; however, more data are required to demonstrate a causal relationship between treatment interventions to achieve higher BP targets and improved outcomes. The task force was unable to assess the benefits or harm of exposure to hypertension in the period after cardiac arrest.
•
Whether patients receiving targeted temperature management (eg, 33 °C) require different BP targets
•
We encourage consistent reporting of BP monitoring definitions (eg, site, repeated measurement, component of BP [systolic, diastolic, mean BP]) and definitions of exposure to hypotension (eg, single episode versus percentage of time)
•
Most studies report exposure to BP thresholds within 6 hours; impact of BP interventions outside this time frame is important.
•
Which strategy is optimal to achieve a BP above the threshold level (eg, fluids, vasopressor support, mechanical support)
•
Whether a BP target or another marker of end organ perfusion (eg, lactate, urine output, or other) is the most appropriate target
•
Optimal BP targets during ECLS post–cardiac arrest. Some patients on ECLS may lack heart pulsatility, which also limits use of systolic BP targets in this patient group.
•
The optimal strategy to use when cerebral autoregulation is impaired
Effect of Prophylactic Antiseizure Medication or Treatment of Seizures on Outcome of Children After Cardiac Arrest (PLS 4210-02: SysRevs)
Rationale for Review
Cardiac arrest in children is relatively uncommon and has a very high mortality rate, with hypoxic-ischemic brain injury being a common cause of death. Seizures including suspected clinical, electroclinical, and electrographic seizures with EEG correlation are common manifestations of post–cardiac arrest brain injury in children, with an incidence of ≈10% to 40%.394–396 Seizures and abnormalities on EEG post–cardiac arrest are associated with poor neurologic outcome in children.396–399 It is unclear if prophylactic antiseizure medication to prevent seizures or treatment of seizures when they are identified improves outcome. There are no existing ILCOR recommendations for children, and this SysRev was thus undertaken (PROSPERO registrations CRD42023460746 and CRD42023463581). The full CoSTR can be found online.400
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults or pediatric patients in any setting (IHCA or OHCA) with ROC
•
Intervention: One strategy for prophylactic antiseizure medication or seizure treatment
•
Comparator: Another strategy or no prophylactic antiseizure medication or seizure treatment
•
Outcome
–
Critical: Survival or survival with favorable neurological outcome as per Pediatric Core Outcome Set for Cardiac Arrest386
•
Study design: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols) were excluded. All relevant publications in any language were included if there was an English abstract.
•
Time frame: Literature search includes all years up to September 11, 2023
Consensus on Science
Prophylactic Antiseizure Medication
For the critical outcome of survival with favorable neurological outcome at discharge/30 days or longer, no pediatric RCTs nor nonrandomized comparative studies were identified.
Indirect evidence from adult studies was identified and included (Table 15). We identified 2 randomized studies288,289 and a single nonrandomized study290 enrolling adult patients only. No studies reported improvement in survival with favorable neurological outcome or survival with prophylactic antiseizure medication.
Outcomes (importance) | Participants, n (studies, n/study type) | Investigation | Certainty of evidence (GRADE) | RR (95% CI) | ARD with intervention |
---|---|---|---|---|---|
Adult studies | |||||
Survival with favorable neurologic outcome (critical) | 262 (1 RCT)288 | Thiopentone vs standard care | Very low | 1.3 (0.76–2.21) | 46 more adult survivors per 1000 patients (95% CI, from 37 fewer to 185 more) |
300 (1 RCT)289 | IV magnesium vs placebo | Very low | 1.37 (0.83–2.25) | 94 more adult survivors per 1000 patients (95% CI, from 43 fewer to 317 more) | |
300 (1 RCT)289 | IV diazepam vs placebo | Very low | 0.68 (0.36–1.28) | 81 fewer adult survivors per 1000 patients (95% CI, from 162 fewer to 71 more) | |
300 (1 RCT)289 | IV magnesium and diazepam vs placebo | Very low | 0.68 (0.36–1.28) | 81 fewer adult survivors per 1000 patients (95% CI, from 162 fewer to 71 more) | |
107 (1 nonrandomized study)290 | Bolus and continuous infusion of thiopentone and phenobarbital compared with historic controls | Very low | 1.41 (0.88–2.27) | 137 more adult survivors per 1000 adults (95% CI, from 40 fewer to 423 more) | |
Survival to hospital discharge | 107 (1 nonrandomized study)290 | Bolus and continuous infusion of thiopentone and phenobarbital compared with historic controls | Very low | 1.40 (0.83–2.36) | 119 more adult survivors per 1000 patients (95% CI, from 50 fewer to 403 more) |
ARD indicates absolute risk difference; GRADE, Grading of Recommendations Assessment, Development, and Evaluation; RCT, randomized controlled trial; and RR, risk ratio.
Treatment of Seizures
For the critical outcome of survival with favorable neurological outcome at discharge/30 days or longer, no pediatric RCTs or nonrandomized comparative studies were identified.
Indirect evidence from adult studies was identified and included. We identified a single randomized study291 of 172 patients, assessing the effect of treatment of rhythmic and periodic discharges with antiseizure medication on the critical outcome of survival with favorable neurologic outcome at 3 months and finding no benefit (RR, 1.23 [95% CI, 0.48–3.15], or 19 more per 1000 patients [95% CI, from 43 fewer to 179 more]). There was also no difference in survival (RR, 1.14 [95% CI, 0.62–2.12], or 27 more survivors per 1000 patients [95% CI, from 68 fewer to 200 more]).
2024 Good Practice Statements: New
Prophylactic Antiseizure Medication
We suggest against the routine use of prophylactic antiseizure medication in children post–cardiac arrest (good practice statement).
Seizure Treatment
We suggest the treatment of seizures in children post–cardiac arrest (good practice statement).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table is provided in Appendix A.
Prophylactic Antiseizure Medication
•
Due to the lack of direct evidence in children post–cardiac arrest and very low certainty of indirect evidence from adults, the PLS Task Force was unable to make a treatment recommendation. The task force’s decision to provide a good practice statement suggesting against post–cardiac arrest prophylactic antiseizure medication was based on the absence of indirect evidence from adult comatose cardiac arrest survivors that prophylactic therapy with antiseizure medication prevents seizures or improves important outcomes. However, the PLS Task Force recognized the low certainty of the evidence from RCTs. The PLS Task Force also considered that the administration of prophylactic antiseizure medication in other forms of acute brain injury (eg, neonatal hypoxic-ischemic encephalopathy)401 is not associated with improved long-term outcomes. Although prophylactic antiseizure medication is recommended after traumatic brain injury in children,402 the evidence of benefit for early seizure prevention is of very low certainty and there is no evidence of improved long-term outcomes.403
•
The medications used for antiseizure prophylaxis in the included adult trials (eg, barbiturates) can have significant side effects, although the cardiac side effects seen in adults may be less common in children. The PLS Task Force acknowledged that newer antiseizure medications have not been evaluated and that their efficacy and side effect profile may differ. Further evaluation is encouraged.
Seizure Treatment
•
No direct pediatric evidence of the effects of treating seizures in children after cardiac arrest was identified, and the PLS Task Force could not make a treatment recommendation.
•
The PLS Task Force chose to make the good practice statement based on the knowledge that high seizure burden in children has been associated with poor neurological outcome.404,405 There are safe and effective antiseizure medications that can reduce seizure burden in children with status epilepticus, which, in turn, may benefit longer-term outcomes.406–408
•
The PLS Task Force acknowledges the challenge of seizure diagnosis and the important role of confirmatory EEG in addition to clinical signs of seizure to increase certainty of diagnosis. The potential risk of treating suspected seizures in settings without access to EEG confirmation needs to be balanced with potential harm of antiseizure medications. EEG confirmation remains the reference standard approach for seizure diagnosis; however, EEG may not be available in many clinical settings because it requires significant resources, including neurophysiology equipment, training, and expertise. Continuous EEG monitoring is labor intensive and likely to add significant cost to patient care. The cost-effectiveness of this approach is controversial and may depend on the setting. The relative benefit of continuous EEG compared with intermittent EEG monitoring was not reviewed.
•
There is insufficient evidence to suggest for or against the treatment of rhythmic and periodic EEG patterns in children post–cardiac arrest. One RCT in adults291 did not find a difference in the primary outcome with 1 therapeutic approach to treatment of rhythmic and periodic EEG patterns. However, no significant harm was noted in adults assigned to the treatment or control arm. Further research is required in children to evaluate the impact on treating specific EEG patterns and electrographic seizures.
•
Medication for sedation (eg, benzodiazepines and propofol) and use of hypothermic temperature control after cardiac arrest may also affect seizure burden, timing, and detection. Evaluation of the use of prophylactic antiseizure medication and seizure treatment in the context of these therapies is important.
Knowledge Gaps
•
Whether prophylactic antiseizure medication impacts outcomes in children post–cardiac arrest
•
Whether use of antiseizure medications to treat seizures impacts important clinical outcomes in children post–cardiac arrest
•
Indications for and cost-effectiveness of continuous EEG, quantitative EEG, and intermittent EEG post–cardiac arrest
•
Impact of prophylactic antiseizure medication and seizure treatment on seizure burden and timing and detection in the context of medication for sedation and hypothermic temperature control
Advanced Airway Interventions in Pediatric Cardiac Arrest (PLS 4060-01: SysRevs)
Rationale for Review
Airway management is vital in pediatric resuscitation, especially since respiratory conditions are frequently the primary cause of pediatric cardiac arrest. Maintaining an open airway and delivering sustained effective ventilations using a bag-mask device can be difficult, even in skilled hands. Placement of an advanced airway device, such as a supraglottic airway (SGA) or tracheal tube, may facilitate more effective oxygenation and ventilation than bag-mask ventilation (BMV). Both require skilled personnel, and the time taken to perform either procedure may interfere with other vital components of resuscitation (eg, chest compressions).
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Infants and children who received CPR after OHCA or IHCA (excluding newborn children)
•
Intervention: Placement of an advanced airway device
•
Comparator: BMV alone or non–advanced airway interventions (primary) or another advanced airway device (secondary)
•
Outcome
–
Critical: Survival to hospital discharge with favorable neurological outcome and survival to hospital discharge
–
Important: ROSC386
•
Study design: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols) were excluded. All relevant publications in any language were included if there was an English abstract.
•
Time frame: The previous SysRev included studies up to September 24, 2018. The updated search included studies from June 2018 through August 15, 2023.
Consensus on Science
The PLS Task Force reviewed the evidence for the following comparisons: tracheal intubation (TI) compared with BMV, SGA compared with BMV, and TI compared with SGA during pediatric cardiac arrest.
Nineteen studies were included. Only 1 study provided clinical trial data.411 Five studies provided propensity-adjusted cohort data.412–416 Nine other studies provided retrospective cohort data amenable to meta-analysis.417–425 Four studies provided retrospective cohort data in adjusted form only, not amenable to meta-analysis.426–429 One study430 that was included in the original SysRev409 was excluded from this updated SysRev because it overlapped with a newer study.416 Summative results from 15 of the studies are included in Table 16; the 4 cohort studies with results not amenable to meta-analysis were excluded.
Outcomes (importance) | Participants, n (studies, n/study type) | Certainty of evidence, GRADE | RR (95% CI) | Absolute risk with comparator | ARD with intervention |
---|---|---|---|---|---|
TI (I) compared with BMV (C) | |||||
Survival with favorable neurologic outcome (critical) | 591 (1 RCT)411 | Low | 0.69 (0.32–1.52) | 50/1000 | 15 fewer per 1000 (from 34 fewer to 26 more) |
4093 (5 propensity-matched observational studies)412–416 | Very low | 0.54 (0.29–1.00) | 146/1000 | 67 fewer per 1000 (from 104 fewer to 0 fewer) | |
372 (2 observational studies)420,425 | Very low | 0.76 (0.61–0.95) | 544/1000 | 131 fewer per 1000 (from 212 fewer to 27 fewer) | |
Survival to hospital discharge (critical) | 591 (1 RCT)411 | Low | 1.04 (0.60–1.79) | 80/1000 | 3 more per 1000 (from 32 fewer to 63 more) |
4393 (5 propensity-matched observational studies)412–416 | Very low | 0.72 (0.48–1.07) | 262/1000 | 73 fewer per 1000 (from 136 fewer to 18 more) | |
7392 (8 observational studies)417–419,421–425 | Very low | 0.85 (0.40–1.78) | 196/1000 | 29 fewer per 1000 (from 118 fewer to 153 more) | |
SGA (I) compared with BMV (C) | |||||
Survival with favorable neurologic outcome (critical) | 3123 (4 propensity-matched observational)413–416 | Very low | 0.57 (0.26–1.23) | 76/1000 | 33 fewer per 1000 (from 56 fewer to 18 more) |
Survival to hospital discharge (critical) | 3123 (4 propensity-matched observational studies)413–416 | Very low | 0.89 (0.54–1.46) | 126/1000 | 14 fewer per 1000 (from 58 fewer to 58 more) |
3085 (2 observational studies)417,423 | Very low | 0.53 (0.21–1.34) | 90/1000 | 43 fewer per 1000 (from 71 fewer to 31 more) | |
TI (I) compared with SGA (C) | |||||
Survival with favorable neurologic outcome (critical) | 1514 (3 propensity-matched observational studies)413,414,431 | Very low | 0.80 (0.44–1.43) | 40/1000 | 8 fewer per 1000 (from 23 fewer to 17 more) |
452 (1 observational studies)416 | Very low | 2.75 (0.67–11.27) | 13/1000 | 24 more per 1000 (from 4 fewer to 138 more) | |
Survival to hospital discharge (critical) | 1514 (3 propensity-matched observational studies)413,414,431 | Very low | 0.80 (0.55–1.15) | 126/1000 | 25 fewer per 1000 (from 57 fewer to 19 more) |
1007 (3 observational studies)416,417,423 | Very low | 1.35 (0.82–2.22) | 67/1000 | 24 more per 1000 (from 12 fewer to 82 more) |
ARD indicates absolute risk difference; BMV, bag-mask ventilation; C, comparator; GRADE, Grading of Recommendations Assessment, Development, and Evaluation; I, intervention; RCT, randomized controlled trial; RR, risk ratio; SGA, supraglottic airway; SysRev, systematic review; and TI, tracheal intubation.
A random effects model was chosen for meta-analysis to better account for study heterogeneity. The results suggest that resuscitation with TI is not superior to BMV-based resuscitation for cardiac arrest in children for the critically important outcomes of survival with favorable neurological outcome and survival to hospital discharge (with low to very low certainty). Some very low–certainty evidence suggests the use of TI may be associated with harm.
IHCA Versus OHCA
Separate analyses of studies of IHCA and OHCA produced similar results. However, the body of evidence for IHCA is particularly small (consisting of 1 propensity-matched cohort study and 3 other cohort studies) and provides very low–certainty evidence.412,420–422 The studies are very heterogeneous and showed inconsistent results.
Prior Treatment Recommendations (2019)
We suggest the use of BMV rather than TI or SGA in the management of children during cardiac arrest in the out-of-hospital setting (weak recommendation, very low–certainty evidence).
There is insufficient evidence to support any recommendation about the use of TI or SGA in the management of children with cardiac arrest in the in-hospital setting.409a
2024 Treatment Recommendations
We suggest the use of bag-mask ventilation rather than tracheal intubation or supraglottic airway in the management of children during cardiac arrest in the out-of-hospital setting (weak recommendation, very low–certainty evidence).
There is insufficient quality evidence to support any recommendation for or against the use of the bag-mask ventilation compared with tracheal intubation or supraglottic airway for in-hospital cardiac arrest.
The main goal of cardiopulmonary resuscitation is effective ventilation and oxygenation, by whatever means, without compromising the quality of chest compressions. We suggest that clinicians consider transitioning to an advanced airway intervention (supraglottic airway or tracheal intubation) when the team has sufficient expertise, resources, and equipment to enable placement to occur with minimal interruptions to chest compressions or when bag-valve-mask is not providing adequate oxygenation and ventilation (good practice statement).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table is provided in Appendix A.
•
Advanced airway interventions, particularly TI, are long-established components of the advanced life support bundle of care in children. As a result of inherent limitations in their design and data sources, the available studies, though individually well conducted, can provide only very low–certainty evidence about whether attempting advanced airway placement before ROSC improves resuscitation outcomes.
•
Most of the available data were obtained from registries, and an unknown proportion of events labeled as BMV resuscitation may have had failed intubation or SGA attempts (which would bias against BMV). Conversely, most of the included studies are susceptible to resuscitation-time bias, that is, the longer the child is in cardiac arrest, the more likely they will receive interventions but the less likely they will survive (which should bias against TI/SGA).
•
The best available data show no benefit from these advanced airway interventions, and some suggest association with harm, for the critical outcomes of survival with favorable neurological outcome and survival to hospital discharge.
•
Effective BMV, TI, and SGA are difficult skills that require initial training, retraining, and quality assurance to be done consistently, safely, and effectively. Pediatric advanced airway programs require a moderate investment in equipment and a significant investment in training, skills maintenance, and quality control programs to be successful.
•
The decision on choice of airway management technique in the setting of pediatric cardiac arrest is complex because the benefit or harm may differ depending on setting, age of the child, cause of arrest, and experience of the resuscitation team. Importantly, the available data do not inform the questions of whether better outcomes might be achieved by different airway strategies in long transport times or in prolonged resuscitation situations with highly experienced airway operators. The analyzed data are only relevant to advanced airway interventions during CPR and do not pertain to airway management in other critical situations or once ROSC is achieved.
Knowledge Gaps
•
Prehospital, emergency department-based, and in-hospital studies comparing TI, SGA, and BMV with planned subgroup analyses based on patient age and pathogenesis of arrest (trauma versus nontrauma)
•
The benefit of advanced airway interventions in particular settings (including in patients with poor pulmonary compliance and long transport times)
•
The efficacy and speed of placement of advanced airways using newer technologies, such as video-assisted laryngoscopy (compared with regular laryngoscopy)
•
Studies including measures of quality of ventilation (and cardiac metrics), timing of airway intervention, duration of CPR, and measures of the training and experience of the clinicians performing the interventions
Ventilation Rates in Pediatric CPR With an Advanced Airway (PLS 4120-02: SysRevs)
Rationale for Review
Ventilation is a major component of CPR for children and infants in cardiac arrest. During CPR, an adequate ventilation rate is an important element of ventilation.432,433 However, the appropriate ventilatory rate for children and infants during CPR remains a topic of ongoing debate and investigation.434 In 2010, the PLS Task Force reviewed the evidence about optimal minute ventilation (product of tidal volume and respiratory rate per minute) after the placement of an advanced airway during CPR in infants or children.432 The minute ventilation recommended in the 2010 CoSTR was based on expert consensus. In 2020, an EvUp was completed to identify any evidence published after 2010 that might indicate the need for a new SysRev. The EvUp identified a single-center observational article that reported an association between ventilatory rate during IHCA >12 to 20 breaths per minute and improved outcomes.435 Since this EvUp, the task force was aware of new evidence that led the task force to conduct a SysRev (PROSPERO registration CRD42023480925). The full CoSTR can be found online.436
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Infants and children (excluding newborn infants) with OHCA or IHCA and an advanced airway
•
Intervention: Use of any specific ventilatory rate
•
Comparator: Use of a ventilatory rate of 8 to 10 breaths per minute
•
Outcome:
–
Critical: Survival with favorable neurological outcome as per Pediatric Core Outcome Set for Cardiac Arrest386
•
Study design: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols) were excluded. All relevant publications in any language were included if there was an English abstract.
•
Time frame: Literature search includes all years up to June 1, 2023.
Consensus on Science
No studies were identified that compared the ventilatory rate of 8 to 10 breaths per minute with any other specific ventilatory rate.
Prior Treatment Recommendations (2020)
After placement of a secure airway, avoid hyperventilation of infants and children during resuscitation from cardiac arrest, whether asphyxial or arrhythmic in origin. A reduction in minute ventilation to less than baseline for age is reasonable to provide sufficient ventilation to maintain adequate ventilation-to-perfusion ratio during CPR while avoiding the harmful effects of hyperventilation. There are insufficient data to identify the optimal tidal volume or respiratory rate.435
2024 Treatment Recommendations
There is currently no supporting evidence to make a treatment recommendation on a specific ventilatory rate in pediatric cardiopulmonary resuscitation with an advanced airway.
For cardiac arrest that occurs with an advanced airway in place, the use of ventilatory rates >10 breaths per minute may be reasonable. The PLS Task Force suggests using ventilatory rates close to age-appropriate respiratory rates with avoidance of hypoventilation and hyperventilation (good practice statement).
Justification and Evidence-to-Decision Framework Highlights
•
The PLS Task Force discussed that no study met inclusion in this SysRev because none specifically addressed the ventilation rate comparison of 8 to 10 breaths per minute that had been defined in the PICOST.
•
The PLS Task Force discussed that the previous treatment recommendations of ventilation rates of 10 breaths per minute during cardiac arrest were derived from adult data. More recent adult studies suggest that ventilation rates of 10 breaths per minute during cardiac arrest were not associated with improved outcomes in adults. A ventilation rate of 10 breaths per minute could cause hypoventilation in infants and children, and no pediatric data to support this ventilation rate were identified.
Knowledge Gaps
•
The optimal ventilation rate during continuous chest compressions in children with an advanced airway
•
The optimal minute ventilation and other ventilation measurements, including peak pressure, positive end-expiratory pressure, capnography, and blood gas analysis and their impact on oxygenation and ventilation during CPR
•
The influence of hypocarbia and hypercarbia on outcomes
•
The optimal ventilation rate according to cardiac arrest pathogenesis
Management of Pulmonary Hypertension With Cardiac Arrest in Infants and Children in the Hospital Setting (PLS 4160-11: ScopRev)
Rationale for Review
This topic, with a new PICOST, was chosen by the PLS Task Force with input from the Neonatal Life Support Task Force because of the concern that children with pulmonary hypertension who are hospitalized are reported to be at higher risk of death after a cardiopulmonary arrest.437
In 2015, the American Heart Association and the American Thoracic Society published a guideline on the management of pediatric pulmonary hypertension.438 In 2018, the American Heart Association published a statement on the management of CPR in infants and children with cardiac disease that included a section on pulmonary hypertension.439 In 2018, the American Heart Association published a statement on right-sided heart failure and its management, but this statement focused on adults and did not include content for children.440 The 2019 ILCOR EvUps provided guidance on the acute treatment of pulmonary hypertension.
Faced with these children at high risk of cardiopulmonary arrest, we formulated the new PICOST and conducted a ScopRev to better understand if evidence for new specific therapies to treat cardiopulmonary arrest had been published. The full report of this ScopRev can be found online.441
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Infants and children with pulmonary hypertension at high risk of pulmonary hypertensive crises with a cardiac arrest in the in-hospital setting, including postoperatively
•
Intervention: Specific management strategies included (1) respiratory management and monitoring to avoid hypoxia and acidosis; (2) use of opioids, sedatives, and neuromuscular blocking agents; and (3) pulmonary arterial hypertension–specific targeted therapy, like (a) phosphodiesterase-5 inhibitors, endothelin receptor antagonists, inhaled pulmonary vasodilators (eg, inhaled nitric oxide or prostaglandin) or (b) drugs that enhance the nitric oxide–cyclic guanosine monophosphate biological pathway (eg, sildenafil, tadalafil, or riociguat), prostacyclin pathway agonists (eg, epoprostenol or treprostinil), or endothelin pathway antagonists (eg, bosentan or ambrisentan).
•
Comparator: Standard care without specific management strategies for pulmonary hypertensive crisis
•
Outcome
–
Critical: All, including survival to hospital discharge with favorable neurological outcome and survival to hospital discharge
•
Study design: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) and case series with >5 cases were included. Gray literature, social media, and non–peer-reviewed studies, unpublished studies, and conference abstracts were excluded. Trial protocols were eligible if they informed the question. All languages were included if there was an English abstract.
•
Time frame: The literature search was completed, and the selection focused on the most recent decade: from January 1, 2012, to December 22, 2023
Summary of Evidence
We included 19 studies in the ScopRev; 16 provided foundational background literature on the acute management of children with pulmonary hypertension,437–439,442–454 and 3 presented data on the management of cardiac arrest in children with pulmonary hypertension.455–457 Most did not report patient-level data in children with pulmonary hypertension and cardiac arrest. These articles collectively highlight the increased risk of death in children with pulmonary hypertension and the results of recent international efforts in establishing a pediatric pulmonary hypertension classification to support future international and multisite research and general therapeutic management.
Definition and Classification of Pediatric Pulmonary Hypertension
During the 6th World Symposium on Pulmonary Hypertension, the hemodynamic definition for pulmonary hypertension in children was aligned with the adult definition as a mean pulmonary artery pressure of >20 mm Hg458–460 from being previously ≥25 mm Hg.438 Five large clinical groups were updated: (1) pulmonary arterial hypertension, which includes pulmonary hypertension associated with congenital heart disease and persistent pulmonary hypertension of the newborn syndrome (the most frequent cause of transient pulmonary hypertension)459; (2) pulmonary hypertension due to left heart disease; (3) pulmonary hypertension owing to lung diseases and or hypoxia; (4) pulmonary hypertension due to pulmonary artery obstructions; and (5) pulmonary hypertension with unclear multifactorial mechanism.
Risk of Death and Intensive Care Hospitalizations
To promote the study of children with pulmonary hypertension, the term clinical worsening is emerging as a meaningful composite endpoint for interventional trials. In a recent multicenter study from the Pediatric Cardiac Critical Care Consortium from 2014 to 2019, the risk of death for children with pulmonary hypertension was higher compared with all other medical cardiac admissions (10% versus 3.9%). Importantly, 6.1% of these admissions with pulmonary hypertension experienced a CPR event. Among this cohort, the receipt of mechanical ventilation and vasoactive therapies within the first 2 days of ICU admission were associated with increased mortality.447
A study using the Virtual Pediatric Intensive Care Unit database included over 160 ICUs, focused on children with an IHCA, and compared patients with and without pulmonary hypertension. Using propensity matching, the study showed that patients with pulmonary hypertension were less likely to survive to hospital discharge (adjusted OR, 0.83 [95% CI, 0.72–0.95; P=0.01]). The pulmonary hypertension group with an IHCA had a predicted survival rate of 59.1% (56.5%–61.8%) compared with 61.6% (60.0%–63.2%) in the group without pulmonary hypertension with an IHCA.437
More recently, an analysis of 1129 pediatric IHCA events from the prospective multicenter ICU-RESUS study (Improving Outcomes from Pediatric Cardiac Arrest—the ICU-Resuscitation Project), where 16% of children had preexisting pulmonary hypertension, concluded that prearrest pulmonary hypertension was not associated with statistically significant differences in survival or intra-arrest physiologic measures.461
ECLS Technologies, Extracorporeal Membrane Oxygenation, and Pediatric Pulmonary Hypertension
Before a cardiac arrest, extracorporeal membrane oxygenation (ECMO) may be used to stabilize infants with persistent pulmonary hypertension of the newborn or congenital diaphragmatic hernia or in the postoperative period of congenital heart disease when inhaled nitric oxide and mechanical ventilation with general measures are insufficient.438
Pulmonary Hypertensive–Specific Therapies and Interventions for the Treatment of Cardiac Arrest
Only 3 articles presented data on the management of cardiac arrest in children with pulmonary hypertension (Table 17).455–457 Two of these studies included ECMO cannulation as intervention.455,457
Study, y | Country, study design | Population included | Age group | Exclusion criteria | Patients analyzed, n (events, N) | Total patients with PH and CA | Treatment exposure | Overall study sample survival (%) | Survival in patients with PH and CA (%) |
---|---|---|---|---|---|---|---|---|---|
Boudjemline et al, 2017455 | France, case series | Drug-resistant PAH who underwent Potts shunt | 5.9–17.9 y | Not described | 6 | 2 | ECMO provided to cardiac arrest events | 4/6 (67%) | 0/2 (0%) |
Morell et al, 2020457 | United States, retrospective multicenter registry study | Cannulated to ECMO with previous PH | 28 d to 18 y | <28 d | 605 (634 ECMO runs) | 106 (ECPR) | PH with ECMO | 48.70% | ECPR survival (27.4%) |
Li et al, 2022456 | China, retrospective single-center study | PAH who underwent RHC | <18 y | Cardiac shunts or other complex congenital heart disease patients with left heart disease, lung disease, and other types of PH | 147 (163 RHC) | 5 | PH with RHC | 146/147 (99.3%) | 4/5 (80%) |
CA indicates cardiac arrest; ECMO, extracorporeal membrane oxygenation; ECPR, extracorporeal cardiopulmonary resuscitation; PAH, pulmonary arterial hypertension; PH, pulmonary hypertension; and RHC, right heart catheterization.
Task Force Insights
General approaches to improving cardiopulmonary physiology in the context of a pulmonary hypertension crisis or cardiac arrest are important. Children hospitalized with pulmonary hypertension are at higher risk of cardiac arrest than other children. The next steps should focus on generating original evidence in pulmonary hypertension disease groups characterized using contemporary classification systems and definitions. This disease remains relatively rare, which suggests that future research will require multicenter studies or large registry-based comparative studies to better understand the value of one intervention over another for treatment of cardiac arrest.
Good Practice Statements
In children, including neonates, with pulmonary hypertension hospitalized for a clinical worsening event, we propose avoiding factors that may increase pulmonary vascular resistance while treating the aggravating condition to decrease the risk of cardiac arrest. Management strategies include avoiding hypoxia; hypercapnia; acidosis; stressors, such as pain, agitation, dehydration, or fluid overload; anemia; infection; or arrhythmias. Pulmonary hypertension–specific treatments (eg, inhaled nitric oxide, L-arginine, phosphodiesterase inhibitors [eg, milrinone, sildenafil], or endothelin-1 inhibitors [eg, bosentan]) may be considered (good practice statement).
In children who develop signs of pulmonary hypertensive crisis, low cardiac output, or right ventricular failure despite optimal medical therapy, ECMO may be considered before cardiac arrest or for refractory cardiac arrest (ie, ECPR) as a bridge to recovery or as a bridge to the evaluation for organ replacement and transplantation in very select cases (good practice statement).
Knowledge Gaps
•
Specific resuscitation management approaches for infants or children with pulmonary hypertension at high risk of cardiopulmonary arrest during cardiac arrest and after resuscitation
•
Optimal approaches to mechanical ventilation during the resuscitation of children with pulmonary hypertension (eg, timing of the advanced airway; the use of oxygen therapy in cyanotic and noncyanotic heart disease or in the context of an atrial septostomy; the use of positive end-expiratory pressure, of peak inspiratory pressure, of minute ventilation [normal ventilation or hyperventilation], or of inhaled nitric oxide; or modes of mechanical ventilation during the post–cardiac arrest care period to best support the right and left ventricles and minimize harmful cardiopulmonary interactions)
•
The dose or type of inotrope or vasopressor that could be delivered during a cardiopulmonary arrest event and the physiologic endpoints to target during the intra-arrest period, such as the optimal target in end-tidal capnography value
•
Whether children with pulmonary hypertension with known right heart catheterization data should receive personalized resuscitation measures instead of standard measures
•
The timing of transitioning from high-quality CPR to extracorporeal CPR in pediatric patients with severe pulmonary hypertension (eg, pulmonary hypertension listed for lung transplantation, pulmonary hypertension after atrial septostomy)463
•
Optimal diagnostic and severity classification systems to improve knowledge of pediatric pulmonary hypertension patients who suffer cardiopulmonary arrest462
•
Risk factors for cardiac arrest in children with pulmonary hypertension in the context of (1) anesthesia (for diagnostic catheterization or for other procedures), (2) postoperative period,447 (3) hospitalizations with deteriorations associated with clinical worsening events.464 We propose adding “cardiopulmonary arrest events” as a study variable among clinical worsening endpoints in longitudinal epidemiological registries; this would serve as a first step to measure the burden of this problem.
PLS Topics Reviewed by EvUps
Topics reviewed by EvUps are summarized in Table 18. Complete EvUps can be found in Appendix B.
Topic/PICO | Year last updated | Existing treatment recommendation | RCTs since last review | Observational studies since last review | Key findings | Sufficient data to warrant SysRev? |
---|---|---|---|---|---|---|
Prearrest care of the infant or child with dilated cardiomyopathy or myocarditis (PLS 4.030.19) | 2020 | 2020 unchanged from 2015: The confidence in effect estimates is so low that the panel decided a specific recommendation was too speculative. | 0 | 3 | 3 observational studies indirectly evaluated prearrest stabilization and intubation in patients with dilated cardiomyopathy or myocarditis.465–467 Key findings: (1) Use of ketamine was associated with fewer adverse events (aOR, 0.74; 95% CI, 0.58–0.95).465 (2) Given the high risk of cardiac arrest in children with acute myocarditis who demonstrate high-risk ECG changes (arrhythmias, heart block, ST segment changes) or low cardiac output, there should be early transfer to higher level of care for monitoring and therapy. (3) Where resources permit, prearrest use of ECLS may be beneficial. (4) Where resources permit, if cardiac arrest occurs, ECPR may be beneficial. | No |
Ventilation rate when a perfusing rhythm is present (PLS 4.120.01) | 2020 | None | 0 | 0 | There was a SysRev in 2020 including 6 pediatric observational studies that examined oxygenation and ventilation targets, but not ventilation rate, after cardiac arrest.231 For oxygenation, there was no association between hyperoxia and survival to hospital discharge or survival with favorable neurological outcome. For carbon dioxide levels, a single observational study rated as having less than critical risk of bias found both hypocapnia (OR, 2.71; 95% CI, 1.04–7.05) and hypercapnia (OR, 3.27; 95% CI, 1.62–6.61) to be associated with worse survival to hospital discharge compared with normocapnia. There remains insufficient evidence to make a recommendation on ventilation rates when a perfusing rhythm is present. | No |
aOR indicates adjusted odds ratio; ECG, electrocardiogram; ECLS, extracorporeal life support; ECPR, extracorporeal cardiopulmonary resuscitation; EvUps, evidence updates; PICO, population, intervention, comparator, outcome; RCTs, randomized controlled trials; SysRev, systematic review; and TR, treatment recommendation.
Neonatal Life Support
Cord Management at Birth for Preterm Infants (NLS 5051: SysRev)
Rationale for Review
Adaptation to air breathing immediately after birth requires that several critical interdependent physiologic events occur rapidly.468 Air breathing reduces pulmonary vascular resistance, which increases pulmonary blood flow. If the umbilical cord is clamped immediately, the increased pulmonary flow is initially from the aorta through the ductus arteriosus. If cord clamping occurs after the onset of breathing, the increased pulmonary blood flow can come from the placenta through the umbilical vein and ductus venosus, thereby maintaining left ventricular filling and output (vital for coronary and cerebral perfusion).469 Both milking the intact (not clamped or cut) umbilical cord and milking a long segment of clamped and cut cord have been proposed as alternatives to deferring clamping of the umbilical cord. Decisions about umbilical cord management can critically influence the cardiorespiratory adaptation after birth,470,471 how and when other resuscitation interventions are provided, and mortality during subsequent hospitalization, particularly among preterm infants.472
The topic was last reviewed in by ILCOR in 2021.473,474 Since then, additional RCTs have been completed and compiled into a very large pairwise individual patient data (IPD) meta-analysis and network meta-analysis (NMA), the iCOMP (Individual Participant Data on Cord Management at Preterm Birth) study,475 which provided higher-certainty evidence for various methods of umbilical cord management than could have been achieved with study-level meta-analysis alone.472,476 The Neonatal Life Support Task Force used the process of adolopment to appraise this evidence and develop updated treatment recommendations.477 Task force members and content experts overlapped with the iCOMP study team, but assessment of suitability of the iCOMP analyses for adolopment was assessed by task force members and content experts who had no conflict of interest. The IPD meta-analysis is presented first and then the NMA, because the PICOST structure differs. The pairwise IPD meta-analysis was used for subgroup analyses, and the NMA was used for multiple between-intervention comparisons.
The iCOMP SysRev was registered before initiation (PROSPERO registration CRD42019136640). The full online CoSTR can be found on the ILCOR website.477
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
Individual Patient Data Pairwise Meta-Analysis
•
Interventions:
–
Deferred (delayed/later) cord clamping (>15 seconds)
–
Umbilical cord milking (cord milking or stripping immediately after birth or after deferred cord clamping)
•
Comparators:
–
Immediate (early) cord clamping (≤15 seconds or as defined by the trialist) without cord milking and without initiation of respiratory support for any reason
–
Between-intervention comparisons
•
Outcomes:
–
Infant outcomes (importance assigned by task force consensus, in accordance with available guidelines478,479):
▪
Mortality before hospital discharge (critical)
▪
Major inpatient morbidities (including intraventricular hemorrhage), necrotizing enterocolitis, retinopathy of prematurity, bronchopulmonary dysplasia) for preterm infants <32 weeks’ gestation (critical)
▪
Neurodevelopmental outcomes (critical)
▪
Resuscitation and stabilization interventions (eg, receiving positive pressure ventilation, intubation, chest compressions, medications; important)
▪
Blood transfusion (important)
▪
Hematologic and cardiovascular status (in-hospital; important)
▪
Hematologic status (in infancy; important)
▪
Hyperbilirubinemia treated with phototherapy (important)
–
Maternal outcomes
▪
Mortality (critical)
▪
Maternal complications (postpartum hemorrhage and infection; critical)
•
Study designs: iCOMP included RCTs comparing umbilical cord management strategies but excluded trials with missing data, integrity issues, those not fitting intervention categories, and cluster- and quasi-randomized trials.475 ILCOR systematic reviews typically exclude unpublished studies (eg, conference abstracts, trial protocols), while the iCOMP analysis includes such studies. However, the iCOMP study “…conducted extensive data processing, quality, and integrity checks of all included data,”472 ensuring a level of integrity not usually available for unpublished data. Given these measures, the reduced publication bias from including unpublished studies was considered advantageous.480 All languages were included.
•
Time frame: All years were included. Medical databases, including MEDLINE, Embase, and CENTRAL, and clinical trial registries, including ClinicalTrials.gov, were originally searched up to February 2022 and WHO International Clinical Trials Registry Platform up to March 2022. The search was updated on June 6, 2023, and no additional eligible studies were identified.472
Consensus on Science
Comparison 1: Deferred Cord Clamping Compared With Immediate Cord Clamping
The pairwise IPD meta-analysis472 identified 21 eligible studies including 3292 infants.481–499 The median study sample size was 65 (IQR, 40–101). The median (IQR) gestational age at birth was 29 (27–33) weeks. Deferred cord clamping ranged from 30 to ≥180 seconds (some trials encouraging deferrals up to 5 minutes where feasible). For immediate cord clamping, most trials (14/21) specified clamping within 10 seconds. Of all infants, 61% were born by cesarean delivery 25% were multiples, and 56% were male. Trials were conducted in high-income (9/21), upper-middle-income (5/21), and lower-middle-income (7/21) countries as defined by World Bank country classification.500 For this review, we present odds ratios, aligning with the iCOMP statistical analysis plan.472,475,476 Key results are summarized in Table 19.
Outcomes (importance) | Participants (studies) | Certainty of the evidence (GRADE) | OR (95% CI) | Anticipated absolute effect | |
---|---|---|---|---|---|
Risk or mean concentration (±SD) with ICC | RD (CI) or MD (CI) with DCC; NNTB or NNTH, if applicable | ||||
Mortality before hospital discharge (critical) | 3263 (20 RCTs)481–499,501 | High | 0.68 (0.51–0.91) | 81/1000 | 25 fewer infants died per 1000 (38–7 fewer); NNTB, 40 (26–143) infants |
Hemoglobin concentration (g/dL) for infants <32 weeks’ gestation (important) | 523 (8 RCTs)482,485–488,495,498,499 | Moderate | NA | 16 (±2) g/dL | 0.88 (0.52–1.24) g/dL |
Red cell transfusion for infants <32 weeks’ gestation (important) | 1929 (13 RCTs)482,484–486,488,489,491,493,495,496,498,499,501 | Moderate | 0.59 (0.47–0.73) | 571/1000 | 131 fewer infants received red cell transfusion per 1000 (186 fewer–78 fewer); NNTB, 7 (6–13) infants |
Hypothermia on admission to NICU for infants <32 weeks’ gestation (adverse effect: important) | 1995 (8 RCTs)484–486,493,495,498,499,501 | Moderate | 1.28 (1.06–1.56) | 449/1000 | 62 more infants were hypothermic per 1000 (14 more–111 more); NNTH, 16 (9–71) infants |
DCC indicates deferred cord clamping; GRADE, Grading of Recommendations, Assessment, Development, and Evaluation; ICC, immediate cord clamping; MD, mean difference; NA, not applicable; NICU, neonatal intensive care unit; NNTB, number needed to treat to benefit; NNTH, number needed to treat to harm; OR, odds ratio; RCT, randomized controlled trial; and RD, risk difference.
For the subgroup of infants <32 weeks’ gestation allocated to deferred cord clamping, higher hematocrit values were also demonstrated (moderate-certainty evidence). For the subgroup of infants ≥32 weeks’ gestation allocated to deferred cord clamping, Hb and hematocrit values were also probably higher (low-certainty to moderate-certainty evidence). For other critical and important infant and maternal outcomes, clinical benefit or harm could not be determined.
Comparison 2: Umbilical Cord Milking Compared With Immediate Cord Clamping
The pairwise IPD meta-analysis472 identified 18 trials including 1565 infants.485,487,492,502–516 The median study sample size was 60 (IQR, 45–122). The median gestational age at birth was 29 (IQR, 27–31) weeks. The cord was milked intact 2 to 4 times in 12 trials (866 infants), whereas in 4 trials (340 infants) the cut cord was milked once, and in 2 trials (359 infants) there was a delay before intact-cord milking. Of all infants, 64% were born by cesarean delivery, 13% were multiples, and 56% were male. Trials were conducted in high-income (10/18), upper-middle-income (4/18), and lower-middle-income (4/18) countries. Key results are presented in Table 20.
Outcomes (importance) | Participants (studies) | Certainty of the evidence (GRADE) | OR (95% CI) | Anticipated absolute effect | |
---|---|---|---|---|---|
Risk or weighted mean concentration (±SD) with ICC | RD (CI) or MD (CI) with UCM; NNTB or NNTH, if applicable | ||||
Mortality before hospital discharge (critical) | 1565 (18 RCTs)485,487,492,502–516 | Low | 0.73 (0.44–1.20) | 56/1000 | 14 fewer infants died per 1000 (30 fewer–10 more) infants |
Hemoglobin concentration (g/dL) for infants <32 weeks’ gestation (important) | 944 (12 RCTs)502,504,506–508,510,512–515 | Low | NA | 15 (±2) g/dL | 0.45 (0.17–0.73) g/dL |
Red cell transfusion for infants <32 weeks’ gestation (important) | 1163 (15 RCTs)485,502–504,506–516 | Moderate | 0.69 (0.51–0.93) | 443/1000 | 92 fewer infants received red cell transfusion per 1000 (167 fewer–18 fewer); NNTB, 11 (6–56) infants |
DCC indicates deferred cord clamping; GRADE, Grading of Recommendations, Assessment, Development, and Evaluation; ICC, immediate cord clamping; NA, not applicable; NNTB, number needed to treat to benefit; OR, odds ratio; RCT, randomized controlled trial; RD, risk difference; and UCM, umbilical cord milking.
For the subgroup of infants <32 weeks’ gestation receiving umbilical cord milking, hematocrit values were also possibly higher (low-certainty evidence). For the subgroup of infants ≥32 weeks’ gestation receiving umbilical cord milking, hemoglobin and hematocrit values were possibly higher, and body temperatures on admission were possibly lower (very low–certainty evidence) while red cell transfusions were possibly reduced (low-certainty evidence). For all other critical and important infant and maternal outcomes (for all included infants or either subgroup), clinical benefit or harm could not be determined.
Comparison 3: Umbilical Cord Milking Compared With Deferred Cord Clamping
The pairwise IPD meta-analysis472 identified 15 trials including 1655 infants.485,487,492,517–528 The median study sample size was 44 (IQR, 36–171). The median gestational age at birth was 30 (IQR, 28–33) weeks. The intact cord was milked 2 to 4 times in 14 studies including 1649 infants and once in 1 study including 6 infants. Deferral times in the deferred cord clamping group ranged from 30 to 120 seconds. Of all infants, 64% were born by cesarean delivery, 15% were multiples, and 54% were male. Trials were conducted in high-income (8/15), upper-middle-income (3/15), and lower-middle-income (4/15) countries. Results are summarized in Table 21.
Outcomes (importance) | Participants (studies) | Certainty of the evidence (GRADE) | OR (95% CI) | Anticipated absolute effect | |
---|---|---|---|---|---|
Risk or mean concentration (±SD) with DCC | RD or change with UCM; NNTB or NNTH, if applicable | ||||
Mortality before hospital discharge (critical) | 1303 (12 RCTs)485,487,492,517,518,520,521,524–526,528,529 | Low | 0.95 (0.59–1.53) | 72/1000 | 3 fewer infants died per 1000 (28 fewer–34 more) |
Severe IVH in preterm infants <32 weeks’ gestation (critical) | 860 (7 RCTs)485,487,517,518,520,521,528 | Low | 2.20 (1.13–4.31) | 38/1000 | 42 more infants had severe IVH per 1000 (5 more–112 more); NNTH, 24 (9–200) infants |
Maternal postpartum blood transfusion (critical) | 653 (4 RCTs)485,517,518,521 | Low | 2.72 (1.11–6.65) | 25/1000 | 39 more mothers received blood transfusion per 1000 (3 more–118 more); NNTH, 25 (8–333) mothers |
DCC indicates deferred cord clamping; GRADE, Grading of Recommendations, Assessment, Development, and Evaluation; ICC, immediate cord clamping; IVH, intraventricular hemorrhage; NNTB, number needed to treat to benefit; NNTH, number needed to treat to harm; OR, odds ratio; RCT, randomized controlled trial; RD, risk difference; and UCM, umbilical cord milking.
For all other critical and important infant and maternal outcomes, clinical benefit or harm could not be determined.
Subgroup analyses.
For all 3 comparisons, subgroup analyses by gestational age at birth, multiple versus singleton birth, caesarean section versus vaginal birth, study start year, perinatal mortality rate of country where study was conducted, and sex of infant did not influence the effect on mortality (very low–certainty to low-certainty evidence).
Individual Patient Data Network Meta-Analysis
•
Population: Preterm infants born at <37+0 weeks’ gestation and their mothers.
•
Interventions:
–
Immediate (early) cord clamping at ≤15 seconds, without cord milking or initiation of respiratory support or as defined by the trialist
–
Short deferral of cord clamping for >15 seconds to <45 seconds without milking, with or without respiratory support
–
Medium deferral of cord clamping for ≥45 to <120 seconds without milking, with or without respiratory support
–
Long deferral of cord clamping for ≥120 seconds without milking, with or without respiratory support
–
Intact cord milking immediately after birth (with the umbilical cord attached to the placenta)
•
Comparisons: Between-intervention comparisons
•
Outcomes:
–
Mortality before hospital discharge (critical)
–
Intraventricular hemorrhage (critical)
–
Blood transfusion (important)
•
Certainty of evidence was assessed using the CINeMA framework (Confidence in Network Meta-Analysis), which is based on the GRADE framework but is adapted for network meta-analysis.530
Consensus on Science
The NMA476 and the IPD meta-analysis identified 47 eligible studies including 6094 in‑fants.481–485,487–499,501,502,504–506,508,510,511,516,518–525,528,531–540 The median study sample size was 60 infants (IQR, 40–127). The median gestational age at birth was 29.6 weeks (IQR, 27.6–33.3). Of all infants, 61% were born by cesarean delivery, 17% were multiples, and 54% were male. The primary outcome was missing for 4 (<0.1%) infants.
Sufficient data were found to include comparisons of the following 5 interventions in the NMA:
1.
Immediate (early) cord clamping (as soon as possible or within 15 seconds)
2.
Short deferral of cord clamping (≥15 seconds to <45 seconds)
3.
Medium deferral of cord clamping (≥45 seconds to <120 seconds)
4.
Long deferral of cord clamping (≥120 seconds)
5.
Intact cord milking immediately after birth (milking the umbilical cord before the cord was clamped)
For the outcomes of death before discharge, any intraventricular hemorrhage, and blood transfusion, the number of trials for each comparison ranged from 0 to 8 and the number of infants varied from 29 to 1993.476 The largest number of trials providing data for each outcome were for the cord milking compared with immediate cord clamping, for cord milking compared with medium deferral of cord clamping, and for immediate cord clamping compared with medium deferral of cord clamping. Note that in each case, the analysis was by intention to treat. Only 70% of the 47 trials reported treatment adherence.476 Key results are presented in Table 22.
Comparison | Participants (studies) | Certainty of the evidence (GRADE) | OR (95% CI) | NNTB |
---|---|---|---|---|
Mortality before hospital discharge (critical) | ||||
Long deferral (≥120 s) vs immediate cord clamping | 469 (3 RCTs)484,494,541 | Moderate | 0.31 (0.11–0.80) | 18 (4–143) |
Red cell transfusion (important) | ||||
Medium deferral vs immediate cord clamping | 1933 (6 RCTs)483,485,488,498,499,542 | Very low | 0.45 (0.48–1.39) | NA |
Short deferral vs immediate cord clamping | 383 (5 RCTs)481,482,489,491,501 | Moderate | 0.44 (0.17–0.90) | NA |
Intact cord milking vs immediate cord clamping | 786 (9 RCTs)502,504,506,508,511,516,535,543,544 | Very low | 0.56 (0.31–0.97) | NA |
GRADE indicates Grading of Recommendations, Assessment, Development, and Evaluation; NA, not applicable; NNTB, number needed to treat to benefit; and RCT, randomized controlled trial.
For comparisons and outcomes not included in Table 22, clinical benefit or harm could not be determined, and details are provided in the online CoSTR.477
When ranking probabilities were calculated, to prevent death before discharge, long deferred cord clamping had a 91% probability of being the highest ranked treatment; immediate cord clamping had <1% probability of being the best treatment and a 53% probability of being the worst treatment; and medium-length deferred cord clamping and intact umbilical cord milking had a high probability of being second or third best.476
Prior Treatment Recommendations (2021)
In infants born at <34 weeks’ gestational age who do not require immediate resuscitation after birth, we suggest deferring clamping the cord for at least 30 seconds (weak recommendation, moderate-certainty evidence).473,474
In infants born at 28+0 to 33+6 weeks’ gestational age who do not require immediate resuscitation after birth, we suggest intact-cord milking as a reasonable alternative to deferring cord clamping (weak recommendation, moderate-certainty evidence).473,474
We suggest against intact-cord milking for infants born at <28 weeks’ gestational age (weak recommendation, very low–certainty evidence).473,474
In infants born at <34 weeks’ gestational age who require immediate resuscitation, there is insufficient evidence to make a recommendation with respect to cord management.473,474
There is also insufficient evidence to make recommendations on cord management for maternal, fetal, or placental conditions that were considered exclusion criteria in many studies (in particular, multiple fetuses, congenital anomalies, placental abnormalities, alloimmunization, fetal anemia, fetal compromise, and maternal illness). In these situations, we suggest individualized decisions based on severity of the condition and assessment of maternal and neonatal risk (weak recommendation, very low–certainty evidence).473,474
2024 Treatment Recommendations
In preterm infants born at <37 weeks’ gestational age who are deemed not to require immediate resuscitation at birth, we recommend deferring clamping of the umbilical cord for at least 60 seconds (strong recommendation, moderate-certainty evidence).
In preterm infants born at 28+0 to 36+6 weeks’ gestational age who do not receive deferred cord clamping, we suggest umbilical cord milking as a reasonable alternative to immediate cord clamping to improve infant hematologic outcomes. Individual maternal and infant circumstances should be taken into account (conditional recommendation, low-certainty evidence).
We suggest against intact cord milking for infants born at <28 weeks’ gestation (weak recommendation, low-certainty evidence). There is insufficient evidence to make a recommendation concerning cut-cord milking in this gestational age group.
In preterm infants born at <37 weeks’ gestational age who are deemed to require immediate resuscitation at birth, there is insufficient evidence to make a recommendation with respect to cord management (weak recommendation, low-certainty evidence).
There is insufficient evidence to make recommendations on cord management for maternal, fetal, or placental conditions that were considered exclusion criteria in many studies (monochorionic multiple fetuses, congenital anomalies, placental abnormalities, alloimmunization or fetal anemia, fetal compromise, and maternal illness). In these situations, we suggest individualized decisions based on severity of the condition and assessment of maternal and neonatal risk (weak recommendation, very low–certainty evidence).
Whenever circumstances allow, the plan for umbilical cord management should be discussed between maternity and neonatal clinicians and parents before delivery and should take into account individual maternal and infant circumstances (good practice statement).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table can be found in Appendix A. A table summarizing key points of the treatment recommendations is presented in Table S1 in Appendix C.
The strong recommendation for deferring cord clamping for at least 60 seconds in preterm infants <37 weeks’ gestation reflects the following considerations:
•
Evidence for reduced mortality after deferred cord clamping compared with immediate cord clamping was rated high-certainty.472,477 The reduction in mortality was robust across several participant-level and trial-level subgroups (including gestational age at birth, mode of birth, multiple birth, sex, trial year, and perinatal mortality rate) and consistent in all prespecified sensitivity analyses.
•
We place high value on the outcome of mortality, and this has guided the strong treatment recommendation. The certainty of evidence for other outcomes varied from low to moderate, and, therefore, we concluded that the overall certainty of evidence is moderate.
•
There was moderate-certainty evidence in infants <32 weeks’ gestation for fewer red cell transfusions and in infants both < and ≥32 weeks’ gestation for higher hemoglobin concentrations within the first 24 hours after birth after deferred cord clamping compared with immediate cord clamping.
•
Sixty seconds or more was chosen as the recommended interval for deferred cord clamping because that threshold defined 80% of infants who received deferred clamping in the combined studies. The evidence for medium (60–119 seconds) or long (>120 seconds) deferral of cord clamping is based on fewer infants and trials. Moreover, the analysis was by intention to treat, many trials did not report actual interval from birth to cord clamping, and most trials allowed clinicians to clamp the cord when considered necessary to perform resuscitation. The reported adherence to long delay was lowest at 67% (compared with about 80% for medium deferral and 95% for immediate cord clamping, umbilical cord milking, and short deferred cord clamping), so the proportion and clinical characteristics of infants who benefited from medium or long delay are unclear. Furthermore, there were fewer than 121 extremely preterm infants in the trials of long delay.493,494
•
Medium or long delay may be justified for infants who are coping well without resuscitation or where appropriate newborn stabilization can be provided before umbilical cord clamping (skilled team, proper training, appropriate equipment, enough space, and ability to provide measures to maintain normal temperature).
•
The task force noted that there was moderate-certainty evidence for the adverse effect of an increase in the risk of hypothermia (body temperature <36.5 °C) on admission after deferred cord clamping compared with immediate cord clamping for infants <32 weeks’ gestation. Refer to ILCOR recommendations concerning maintaining normal temperature immediately after birth in preterm infants.146
•
Parents report that deferred cord clamping provides a positive experience, with the mothers feeling closer and more attached to their infants.545
In making the suggestion to consider umbilical cord milking as an alternative to immediate cord clamping in infants born at 28+0 to 36+6 weeks’ gestation, the task force considered the following:
•
Low-certainty evidence that umbilical cord milking may not reduce the critical outcome of death before discharge compared with immediate cord clamping
•
Moderate-certainty evidence for reduced red cell transfusion after umbilical cord milking compared with immediate cord clamping in infants both <32 weeks’ gestation and ≥32 weeks’ gestation
•
Low-certainty evidence for higher hemoglobin after umbilical cord milking compared with immediate cord clamping in infants, both <32 weeks’ gestation and ≥32 weeks’ gestation.
•
No evidence for adverse effects in preterm infants <37 weeks’ gestation or their mothers after umbilical cord milking compared with immediate cord clamping
•
No evidence for adverse effects after umbilical cord milking compared with deferred cord clamping in preterm infants born at 28+0 to 36+6 weeks’ gestation
•
The IPD meta-analyses did not distinguish between the 2 methods of cord milking (intact-cord and cut-cord). The intact cord was milked 2 to 4 times in most trials, while a few trials milked the cut cord once; therefore, no specific recommendations are made for either method.
In making the suggestion against intact umbilical cord milking in infants <28 weeks’ gestation, but not in infants of higher gestational age, the task force considered the following:
•
Low-certainty evidence for increased severe intraventricular hemorrhage after intact-cord milking compared with deferred cord clamping
•
One trial was stopped early because of increased rates of severe intraventricular hemorrhage in the prespecified subgroup of preterm infants born at <28 weeks’ gestation520
•
The same RCT has subsequently reported that for infants born at 28 to 32 weeks’ gestation there was no increase in severe intraventricular hemorrhage, mortality, or other adverse clinical outcomes after umbilical cord milking compared with deferred cord clamping.546 This study was not included in the analysis because it was published after the iCOMP meta-analysis was completed and the CoSTR development process was started.
There was insufficient evidence to make a recommendation concerning cord management of preterm infants who are deemed to require resuscitation at birth. This conclusion reflected the following:
•
Adherence to deferred cord clamping was low (<75% in those trials reporting adherence), in most cases because health care professionals chose immediate cord clamping or cord milking in preference to deferred cord clamping when they judged that the infant required assisted ventilation.472 Some studies did not report adherence. Taken together, these factors led to a conclusion that the benefits and risks of deferred cord clamping remain unclear for nonvigorous preterm infants and those who require resuscitation at birth.472
•
The evidence from animal studies and feasibility studies in human infants increasingly supports provision of some resuscitation measures while deferring cord clamping (variously described in studies as resuscitation with intact cord, physiologic cord clamping, or baby-directed cord clamping). Results of studies currently underway that evaluate these strategies may lead to changes in recommendations in the future, but there was insufficient evidence to make a recommendation now.
The suggestion for individualized decision-making in the context of maternal, fetal, or placental conditions that were exclusion criteria is unchanged from 2021 and took into account that similar constraints applied to the results of the iCOMP systematic reviews.
In suggesting discussion before birth (whenever possible) about the plan for umbilical cord management, the task force considered that this approach is most likely to lead to the best decisions about what plan of cord management to use and how to coordinate the steps in care of the infant among different care professionals and the parents.
Knowledge Gaps
•
Long-term neurodevelopment and health outcomes after different cord management strategies
•
Effectiveness of optimized cord management as a public health strategy to improve child health and development
•
Optimal cord management of preterm infants who are not breathing after initial steps of resuscitation
•
Optimal cord management for preterm infants born with specific maternal, fetal, and placental conditions that led to exclusion from RCTs
•
Optimal measures to prevent hypothermia during deferred cord clamping
•
Optimal duration of deferred cord clamping, and the criteria to determine that duration
•
Circumstances where cut-cord milking represents best-available management
•
Impact of cord management on vertical transmission of infectious diseases
•
Widely agreed-upon nomenclature and definition of different interventions, including delayed, deferred, later, optimal, and physiologic cord clamping as well as milking, stripping, intact-cord milking, and cut-cord milking
Effect of Rewarming Rate on Outcomes for Newborns Who are Unintentionally Hypothermic After Delivery (NLS 5700: SysRev)
Rationale for Review
Both term and preterm newborn infants are at high risk of hypothermia during and immediately after resuscitation in high-, middle-, and low-income countries.547–549 Previous large observational studies have found an association between hypothermia and neonatal mortality and morbidity.550–557 The optimal rate of rewarming for unintentionally hypothermic infants has not been defined. Slow rewarming could prolong metabolic demands and increase adverse outcomes of hypothermia such as apnea, respiratory distress, and hypoglycemia,550,558,559 but there is a suggestion from a few preclinical and clinical studies in other age groups and contexts (such as after therapeutic hypothermia) that rapid rewarming could be harmful.560 In 2020, the Neonatal Life Support Task Force undertook an evidence update which concluded that there were sufficient new studies to consider updating the systematic review.561 The SysRev was registered before initiation (PROSPERO registration CRD42022359005). The full online CoSTR can be found on the ILCOR website.562
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Newborn infants who are hypothermic (<36.0 ˚C) on admission
•
Intervention: Rapid rewarming (≥0.5 °C/hour)
•
Comparators: Slow rewarming (<0.5 °C/hour)
•
–
Mortality rate (critical)
–
Neurodevelopmental impairment (critical)
–
Need for respiratory support during the first 48 hours of life (important)
–
Hypoglycemia during the first week of life (important)
–
Convulsions/seizures during hospital stay (important)
–
Length of hospital stay (important)
–
In addition, for preterm infants born at <34 weeks:
▪
Intraventricular hemorrhage (all grades—important; severe [III or IV]—critical)
▪
Periventricular leukomalacia (critical)
▪
Necrotizing enterocolitis (important)
•
Study designs: RCTs and nonrandomized studies (nonrandomized controlled trials, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols), case series, case reports, and animal studies were excluded.
•
Time frame: All years and all languages were included if there was an English abstract. The search strategy designed for the 2020 evidence update was rerun in July 2022 and updated in July 2023.
Consensus on Science
The review identified 1 RCT of 42 infants comparing maximum temperature set points for the servo-controlled radiant warmers used for rewarming; rates of rewarming depended on these set points.563 The study enrolled only otherwise well, term newborn infants of normal birth weight. The review also identified 2 observational studies including a total of 280 infants, one of which included only infants born at ≤28 weeks’ gestation or birth weight ≤1000 g564 while the other enrolled only infants with birthweight <1500 grams.565 For the critical outcome of mortality, these 2 studies could not exclude benefit or harm from rapid rewarming compared with slow rewarming (RR, 1.09 [95% CI, 0.7–1.71]; absolute risk difference, 17 fewer deaths per 1000 infants [95% CI, from 58 fewer–138 more]; low-certainty evidence).564,565
For other critical and important outcomes, either data were inconclusive or there were no data.
Prior Treatment Recommendations (2015)
The confidence in effect estimates is so low that a recommendation for either rapid rewarming (0.5 °C/h or greater) or slow rewarming (0.5°C/h or less) of unintentionally hypothermic newborn infants (temperature <36 °C) at hospital admission would be speculative.566
2024 Treatment Recommendations
In newborn infants who are unintentionally hypothermic after birth, rewarming should be started, but there is insufficient evidence to recommend either rapid (≥0.5˚C/h) or slow (<0.5˚C/h) rates of rewarming.
Regardless of the rewarming rate chosen, a protocol for rewarming should be used. Frequent or continuous monitoring of temperature should be undertaken, particularly if using a supraphysiological set temperature point to accelerate the rewarming rate, because of the risk of causing hyperthermia. In any hypothermic infant, monitor blood glucose because there is a risk of hypoglycemia (good practice statement).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table can be found in Appendix A.
•
Although hypothermia after birth is associated with increased mortality and morbidity, the included studies were too small to determine the effect of rate of rewarming on mortality and other outcomes. One observational study showed an association of rapid rewarming with a reduced rate of respiratory distress syndrome in preterm infants.564 However, numbers were small, the absolute risk difference was not shown, and the authors did not report whether this resulted in a clinical difference in need for respiratory support for respiratory distress syndrome.
•
The task force considered that both the intervention and control treatment were acceptable and feasible. Two of the 3 included studies used servo-controlled devices to monitor and control the rate of rewarming. Regarding equity, servo-controlled devices (eg, servo-controlled radiant warmers, incubators, or thermal mattresses) have not yet been demonstrated to improve outcomes of rewarming. The cost of devices capable of operating in servo mode and disposable temperature probes may be unaffordable in resource-limited settings.
•
The rate of rewarming varied widely in the rapid rewarming groups in the included studies. The task force noted that a safe maximum rate of rewarming has not been identified. Furthermore, none of the included studies reported hyperthermia as an outcome. One observational study that did not meet inclusion criteria found that 43 (12.5%) of 344 included infants developed hyperthermia (>37.5 ˚C).567 In this study, a rapid rewarming rate, compared with a slow rewarming rate, was associated with hyperthermia. It is unclear whether this related to specific settings of the devices used for rewarming (which were radiant warmers and incubators in manual mode) in this study or to other characteristics of the included infants. These findings may be clinically important because recent observational studies have confirmed an association between hyperthermia on neonatal ICU admission and adverse outcomes.568,569 Future studies should consider this important outcome.
Knowledge Gaps
•
The optimal method and rate of rewarming, including equipment and settings
•
Effect of rewarming rate on short-term and long-term outcomes, for both preterm and term infants
•
Effect of rewarming rate on metabolic markers such as acidosis and glycemic status
•
Cost-effectiveness of rewarming strategies, including equipment and the need for and duration of neonatal ICU admission
•
The effects of protocols for rewarming on parental separation and the establishment of breastfeeding and on the safety and effectiveness of skin-to-skin care for rewarming
Therapeutic Hypothermia in Limited-Resource Settings (NLS 5701: SysRev)
Rationale for Review
Therapeutic hypothermia is now standard care in high-income countries for the treatment of moderate or severe hypoxic ischemic encephalopathy in term and near-term infants.570 However, uncertainty persists about the efficacy of therapeutic hypothermia in low-resource settings or in low- and middle-income countries. Because asphyxia is a leading cause of neonatal mortality and morbidity in low- and middle-income countries, it is critical to determine whether therapeutic hypothermia improves mortality and neurodevelopmental outcomes in this setting. The treatment shown to be effective in high-income countries generally consists of cooling to 33.5 °C commencing within 6 hours of birth and for a duration of 72 hours. Servo-controlled cooling devices are increasingly used in high-income countries because they achieve more consistent adherence to target temperatures,571 although effective cooling can be accomplished by removal of heat sources and clothing and by applying refrigerated gel packs, making the treatment feasible in low-resource settings.572 The topic was last reviewed by the task force in 2015, with an emphasis on the use of passive hypothermia or cold packs.468 An evidence update in 2020561 identified new studies and an ongoing large multicenter RCT that has since been published.573
The SysRev was registered before initiation (PROSPERO registration CRD42022360554). The full online CoSTR can be found on the ILCOR website.574
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Late preterm and term infants (34+0 or more weeks’ gestation) with moderate or severe hypoxic ischemic encephalopathy managed in low-resource settings
•
Intervention: Therapeutic hypothermia to a specified target temperature for a defined duration
•
Comparators: Standard care
•
–
Death or neurodevelopmental impairment at 18 months to 2 years: composite outcome (critical)
–
Death at hospital discharge (critical)
–
Neurodevelopmental impairments at 18 months to 2 years (critical)
–
Cerebral palsy (critical)
–
Blindness (critical)
–
Deafness (critical)
–
Persistent pulmonary hypertension of the newborn or other adverse outcome (as defined by the study authors)
Neurodevelopmental impairment was defined as abnormal motor, sensory, or cognitive function using an appropriate standardized test.
•
Study designs: RCTs and nonrandomized studies (nonrandomized controlled trials, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols) were excluded. All languages were included if there was an English abstract.
•
Time frame: Databases were searched from inception until September 2022, and the search was updated to July 2023.
Consensus on Science
The systematic review identified 21 RCTs involving 2145 infants with hypoxic ischemic encephalopathy.575–595 Most studies were single site, but 3 were multicenter.585,592,594 Key results are summarized in Table 23.
Outcomes (importance) | Participants (studies) | Certainty of the evidence (GRADE) | RR (95% CI) | Anticipated absolute effect | |
---|---|---|---|---|---|
Risk with standard care | RD with therapeutic hypothermia; NNTB, if applicable | ||||
Death or NDI at 18–24 mo (critical) | 813 (5 RCTs)576,585,592,594,595 | Moderate | 0.67 (0.45–0.99) | 458/1000 | 151 fewer infants died or had NDI per 1000 (5 fewer–252 fewer); NNTB, 7 (4–200) infants |
Death or NDI at any time of follow-up (critical) (post-hoc outcome) | 1168 (9 RCTs)576,578,581,582,585,590,592,594,595 | Low | 0.50 (0.35–0.71) | 474/1000 | 237 fewer infants died or had NDI per 1000 (138 fewer–308 fewer); NNTB, 5 (4–8) infants |
Death at hospital discharge (critical) | 1488 (15 RCTs)576–580,584,586–593,595 | Moderate | 0.70 (0.47–1.02) | 215/1000 | 64 fewer infants died per 1000 (114 fewer–4 more) |
Cerebral palsy (critical) | 919 (6 RCTs)576,583,585,590,592,594 | High | 0.52 (0.37–0.72) | 186/1000 | 89 fewer infants had cerebral palsy per 1000 (52 fewer–117 fewer); NNTB, 12 (9–20) infants |
Blindness (critical) | 718 (4 RCTs)581–583,592 | Moderate | 0.48 (0.22–1.03) | 53/1000 | 28 fewer infants were blind per 1000 (41 fewer–2 more) |
Deafness (critical) | 718 (4 RCTs)581–583,592 | Moderate | 0.42 (0.21–0.82) | 72/1000 | 42 fewer infants were deaf per 1000 (57 fewer–13 fewer); NNTB, 24 (18–77) infants |
PPHN (adverse effect: critical) | 564 (3 RCTs)575,591,592 | High | 1.31 (0.76–2.25) | 74/1000 | 23 more infants had PPHN per 1000 (18 fewer–92 more) |
GRADE indicates Grading of Recommendations, Assessment, Development, and Evaluation; NDI, neurodevelopmental impairment; NNTB, number needed to treat to benefit; PPHN, persistent pulmonary hypertension; RCT, randomized controlled trial; RD, risk difference; and RR, risk ratio.
Apart from persistent pulmonary hypertension, reporting of adverse events during therapeutic hypothermia was inconsistent between studies. Subgroup analysis suggested that non–servo-controlled methods were more efficacious, although the task force considered that these results were more likely due to other aspects of study design than to a benefit of non–servo-controlled methods.
Prior Treatment Recommendations (2015)
We suggest that newborn infants at term or near term with evolving moderate-to-severe hypoxic-ischemic encephalopathy in low-income countries and/or other settings with limited resources may be treated with therapeutic hypothermia (weak recommendation, low-quality evidence).566
Cooling should only be considered, initiated, and conducted under clearly defined protocols with treatment in neonatal care facilities with the capabilities for multidisciplinary care and availability of adequate resources to offer intravenous therapy, respiratory support, pulse oximetry, antibiotics, antiseizure medications, and pathology testing. Treatment should be consistent with the protocols used in the randomized clinical trials in developed countries, that is, cooling to start within 6 hours, strict temperature control at 33 °C to 34 °C for 72 hours, and rewarming over at least 4 hours.566
2024 Treatment Recommendations
We suggest the use of therapeutic hypothermia in comparison with standard care alone for term (≥37+0 weeks’ gestational age) newborn infants with evolving moderate-to-severe hypoxic-ischemic encephalopathy in low- and middle-income countries in settings where a suitable level of supportive neonatal care is available (weak recommendation, low-certainty evidence).
For late preterm infants, 34+0 to 36+6 weeks’ gestational age infants, a recommendation cannot be made due to insufficient evidence.
Therapeutic hypothermia should only be considered, initiated, and conducted under clearly defined protocols with treatment in neonatal care facilities with the capabilities for multidisciplinary care and availability of adequate resources to offer intravenous therapy, respiratory support, pulse oximetry, antibiotics, antiseizure medication, transfusion services, radiology (including ultrasound), and pathology testing, as required. Treatment should be consistent with the protocols used in RCTs. Most protocols included the starting of cooling within 6 hours after birth, strict temperature control to a specified range (typically 33 °C–34 °C) and most commonly for a duration of 72 hours with rewarming over at least 4 hours. Adoption of hypothermia techniques without close monitoring, without protocols, or without availability of comprehensive neonatal intensive care may lead to harm (good practice statement).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table can be found in Appendix A.
•
The largest included (multicenter) RCT found that therapeutic hypothermia significantly increased mortality and did not reduce the combined outcome of death or disability at 18 months.592
•
Nevertheless, the combined (moderate certainty) evidence from all RCTs that assessed death plus disability at 18 to 24 months or cerebral palsy found that therapeutic hypothermia reduced neurodevelopmental impairment without increasing mortality. For several of the critical outcomes, there was high heterogeneity, which together with the preponderance of smaller, single-center trials mostly reporting benefit, raised the possibility of publication bias. For some studies, concerns have been raised about study methodology underlying participant heterogeneity, including methods of patient selection, as well as consistency of diagnosis and pathogenesis.596 Therefore, the task force concluded that the overall certainty of evidence was low. Furthermore, for adverse effects of therapeutic hypothermia, there was heterogeneity and inconsistency of reporting among the included studies, precluding meta-analysis.
•
Although the PICOST intended to evaluate infants ≥34+0 weeks of gestational age, 15 of the 21 included studies specified ≥37 weeks of gestational age as an inclusion criterion, making the data for late preterm infants insufficient to support a treatment recommendation.
•
Distinction between low- and middle-income countries versus high-income countries, based on World Bank determinations, is straightforward.597 However, the hospitals in the included studies (all in low- and middle-income countries) could provide neonatal ICU care, including advanced respiratory support, indicating a high level of resources despite their location in low- and middle-income countries. Therefore, the recommendation is made in relation to low- and middle-income countries rather than to the low-resource settings intended by the PICOST.
•
In high-income countries, adequate follow-up assessment and care are also considered necessary to optimize neurodevelopmental outcomes and to monitor the effectiveness of treatment.
Knowledge Gaps
•
The minimum intensive care resources required for safe and effective provision of therapeutic hypothermia in low- and middle-income countries
•
Cost-effectiveness of therapeutic hypothermia in low- and middle-income countries
•
Resource implications for safe and effective care of infants during provision of therapeutic hypothermia in low- and middle-income countries
•
Strategies for optimal case selection of infants who may benefit from or may be harmed by therapeutic hypothermia in countries at all income levels
Education, Implementation, and Teams
Cardiac Arrest Centers (EIT 6301: SysRev)
Rationale for Review
Specialized post–cardiac arrest care at a cardiac arrest center (CAC) may improve long-term survival from OHCA. Previous studies have reported an association between survival to hospital discharge and transport to a CAC, but there is inconsistency in the hospital factors that are most related to patient outcome.598
In 2020, ILCOR reviewed the evidence on CACs despite a lack of high-quality data to support their implementation.232 Since then, new evidence on CACs has been published, triggering this update of the SysRev SysRev (PROSPERO number CRD42018093369). CACs are defined as specialized institutions offering treatment or services for patients with OHCA, including a coronary angiography laboratory with 24/7 percutaneous coronary intervention, post–cardiac arrest temperature control, extracorporeal membrane oxygenation, mechanical ventilation, and neurologic prognostication.599 For this review, we defined CAC as having the capability for 2 or more of the above interventions and explicitly referred to by study authors as CACs (or synonymous terms such as critical care medical center, tertiary heart center, or regional center).600 We excluded studies that used high volume (number of cases/patients) or percutaneous coronary intervention capability as the only distinguishing characteristics. The full CoSTR can be found online.601
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults and children with attempted resuscitation after nontraumatic IHCA or OHCA
•
Intervention: Care at a specialized CAC
•
Comparator: Care in an institute not designated as a specialized CAC
•
Outcome:
−
Critical: Survival at 30 days with favorable neurological outcome, survival at hospital discharge with favorable neurological outcome, survival at 30 days, and survival at hospital discharge
−
Important: ROSC after hospital admission for patients with ongoing CPR
•
Study design: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols) were excluded. All relevant publications in any language were included as long as there was an English abstract available.
•
Time frame: The literature search included all years to June 23, 2023.
Consensus on Science
Sixteen studies were included in our review.602–617 All studies had moderate to serious risk of bias from confounding, and the certainty of evidence was rated as low. Because of substantial heterogeneity, no meta-analyses could be performed.
Individual study details are provided in the published SysRev and online.601 Two studies showed improved outcomes associated with treatment at a CAC for survival to 30 days with favorable neurological outcomes (Figure 1),603,604,617a 11 for hospital discharge with favorable neurological outcomes (Figure 2),602,605–612,615,616 and 2 for survival to 30 days (Figure 3).602,608
The only RCT identified did not show any difference in outcomes, but its results were limited to non–ST-segment–elevation myocardial infarction patients with prehospital ROSC in an urban setting. Findings were not generalizable to other patient cohorts.602 Thirteen observational studies showed improved outcome of survival to hospital discharge associated with care at a CAC (Figure 4).603,605–614,616,617 Three observational studies showed improved outcome for ROSC associated with care at a CAC (Figure 5).604,606,613
Prior Treatment Recommendation (2019)
We suggest adult patients with nontraumatic OHCA be cared for in CACs rather than in non-CACs (weak recommendation, very low–certainty evidence).609a
2024 Treatment Recommendation
We suggest adults with OHCA should be cared for in cardiac arrest centers (weak recommendation, low-certainty evidence).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table is provided in Appendix A.
•
This topic was prioritized by the EIT Task Force on the basis of ongoing interest in improving patient outcomes after OHCA.
•
A trial of expedited transfer to a CAC for non–ST-segment elevation OHCA was published in 2023.602 The results did not show any benefits among patients transferred to a CAC. Based on these results, we are unable to recommend for or against transferring OHCA adults with presumed cardiac cause presenting with non–ST-segment elevation with prehospital ROSC to a CAC, because this RCT was in a very large urban city setting.
•
Given the lack of generalizability of the above trial, we included published data from nonrandomized studies in our review.
•
We considered the successful implementation of regionalized care for trauma, stroke, and STEMI with improved outcomes.
•
We reflected on the high level of resources required, particularly in regions with no regionalized emergency transport in place for other conditions (eg, trauma, stroke, STEMI) and concluded that the benefits potentially outweigh issues associated with implementation of CACs.
•
We recognized that implementing this recommendation may be resource and cost intensive, and although it has been successfully implemented in some countries, it may not be feasible in all regions.
•
There were insufficient data for subgroup analyses to make any recommendations about specific subgroups, including age group, presenting rhythm, and primary versus secondary transfer, except from 1 RCT in a very specific setting.
•
We did not identify any studies on children or in-hospital cardiac arrest in this review.
Knowledge Gaps
•
A universal definition of CAC
•
The effect of CACs for cardiac arrest in children or in the in-hospital setting
•
The effect of CACs on long-term neurological intact survival
•
The long-term benefits of CACs and the impact on patient-reported outcomes619
•
The effect of care at CACs in specific subgroups (eg, age, cardiac pathogenesis, shockable or nonshockable rhythm)
•
The cost-effectiveness of transferring or caring for patients at CACs
•
Whether there are any negative outcomes associated with bypassing the closest hospitals (eg, deskilling in postarrest management) and transferring patients to CACs
•
What defines a safe distance or time for transport to a CAC
•
The impact on families, particularly those from remote regions
•
The potential impact on organ donation
•
There are insufficient data from large RCTs, including a broad variety of populations and pathogenesis of cardiac arrest, because all but 1 study are observational trials
Cognitive Aids During Resuscitation (EIT 6400: SysRev)
Rationale for Review
The management of cardiac arrest and other medical emergencies can be complex. Cognitive aids have been widely adopted to enhance adherence to guidelines, improve performance, and reduce errors. These aids may provide a structured framework and clinical guidance through complex and dynamic processes. Resuscitation councils worldwide use cognitive aids during training and clinical practice in the form of algorithms, flow charts, checklists, posters, digital applications, and other formats. Whether use of such cognitive aids during resuscitation improves performance and patient outcomes is uncertain.
ILCOR reviewed the evidence in 2020 and did not recommend cognitive aids for laypeople during training and real CPR; however, they were suggested for training of health care professionals.620,621 Since then, new evidence has been published, triggering this update of the SysRev (PROSPERO registration CRD42020159162).622 The complete CoSTR can be found online.623
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults, children, and neonates in any setting (in-hospital or out-of-hospital) requiring resuscitation, or laypeople and health care professionals providing resuscitation or learning to provide resuscitation
•
Intervention: The use of cognitive aids or checklists during resuscitation
•
Comparator: No use of cognitive aids or checklists
•
Outcome:
−
Critical: Survival to hospital discharge with good neurological outcome, survival to hospital discharge
−
Important: Quality of performance in actual resuscitations, skill performance 1 year after course conclusion, skill performance between course conclusion and 1 year, skill performance at course conclusion, knowledge at course conclusion, adherence to resuscitation guidelines, CPR quality and test scores
•
Study design: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols) were excluded. All years and all languages were included as long as there was an English abstract available.
•
Time frame: Literature search was updated from January 1990 to October 28, 2023
Consensus on Science
All 29 studies included in this review were simulation studies that investigated the use of cognitive aids to facilitate clinical performance. No study investigated cognitive aids as an educational tool to improve knowledge acquisition. No meta-analyses could be performed because of a high degree of heterogeneity in the studies, and the overall certainty of evidence was very low for all outcomes. Details of individual studies are included in the published review and online.623
Four simulation studies624–627 investigated the effects of cognitive aids in neonatal resuscitation by health care professionals. Findings included improvement in performance score with a decision support tool using augmented reality (AR),627 fewer deviations from a resuscitation algorithm with a decision support tool with auditory and visual prompts,625 and improved adherence to a resuscitation algorithm and improved performance according to a guideline with audio voice guidance.626 A poster of an algorithm demonstrated no difference in performance.624
The use of cognitive aids during simulated pediatric resuscitation was assessed in 3 studies628–630 and showed no difference in CPR performance by using a noninteractive CPR checklist,630 and no difference in CPR quality metrics with a decision support app.629 However, improved adherence to protocols or processes was found in 2 RCTs.628,629 A computer-based resuscitation tool improved task completion,628 and a decision support app found significantly fewer deviations from guideline recommendations.629
Eight studies631–638 used interactive cognitive aids during adult ALS simulated resuscitation (smartphone apps,631,635,637 tablet apps,633,634,636 computer-based clinical decision display system632,638) with improved adherence to a protocol or process in all studies.
Five studies639–643 investigated the effects of cognitive aids (noninteractive checklists) used by health care professionals managing other emergencies in simulated events. In 4 RCTs: average performance scores increased,641 failure to adhere to critical steps was reduced,639 use of a medical emergency checklist improved adherence to critical process steps,642 and longer checklists seemed to be superior to shorter checklists or no checklist for overall CPR performance on procedural variables but not for CPR quality.643 Access to crisis checklists shortened time to adequate administration of glucose in a hypoglycemic coma scenario.640
Seven RCTs644–650 and 2 observational studies651,652 investigated the effects of cognitive aids used by lay rescuers during simulated resuscitation. Three RCTs645,646,648 of mobile phone applications found improved adherence to clinical processes, while another mobile phone application RCT650 found no improvement. Other RCTs found that using instruction cards improved adherence to AED sequences and time to shock,644 a voice-activated visual and auditory-assisted decision device improved adherence to a 30:2 CPR ratio,647 and use of a flowchart demonstrated reduced hands-off time during CPR.649
Prior Treatment Recommendations (2020)
•
We recommend against the use of cognitive aids for the purposes of lay providers initiating CPR (weak recommendation, low-certainty evidence).
•
We suggest the use of cognitive aids for health care providers during trauma resuscitation (weak recommendation, very low–certainty evidence). In the absence of studies on CPR, no evidence-based recommendation can be made.
•
There are insufficient data to suggest for or against the use of cognitive aids in lay provider training.
2024 Treatment Recommendations
•
We suggest the use of cognitive aids by health care professionals in resuscitation (weak recommendation, very low–certainty evidence).
•
We do not recommend the use of cognitive aids for lay providers initiating CPR (weak recommendation, low-certainty evidence).
•
We did not examine the use of cognitive aids in health professional or lay rescuer training in resuscitation so no recommendation for or against can be issued.
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision tables are provided in Appendix A.
•
The EIT Task Force continues to prioritize this topic because international resuscitation councils commonly provide cognitive aids to resuscitation course participants and health care organizations (algorithms, pocket cards). However, it has not been determined if they are effective in improving patient outcomes or rescuer performance during actual resuscitation, because no evidence was found for the use of cognitive aids by trained health care professionals during actual resuscitation events.
•
The 2021 EvUp focused on outcomes associated with CPR quality. In this review, the outcomes focused on improved team performance through adherence to clinical protocols and processes of care.
•
The task force’s recommendations differentiate between health care professionals and laypeople, as well as between use during resuscitation and during training, because the evidence for use of cognitive aids in these different groups and conditions differs substantially.
•
For lay providers, there is consistent evidence that there are potentially clinically important delays in initiating CPR when using a cognitive aid; however, the evidence for impact on CPR-quality metrics (eg, rate, depth, chest compression fraction) is less consistent. We found insufficient evidence to issue a recommendation for the use of cognitive aids in layperson training.
•
For health care professionals, sufficient new studies provided the evidence to issue a recommendation for the use of cognitive aids during resuscitation. Because no study reported the use of cognitive aids during patient resuscitation, results from simulation studies might be used as a surrogate to justify the use of cognitive aids, as these have been used over decades by all resuscitation councils.
•
Because no studies on resuscitation were found in the review in 2019, the task force previously considered the trauma resuscitation environment sufficiently similar to the CPR environment to extrapolate evidence that shows that trauma resuscitation teams generally adhere to resuscitation guidelines better, make fewer errors, and perform key clinical tasks more frequently if they use cognitive aids. In this review, sufficient new studies addressed the use of cognitive aids in resuscitation (however, only in a simulated environment) that the task force decided to exclude trauma studies from this review.
•
There were several studies that used composite scores as their primary outcome (eg, score calculated on the basis of completing several clinical tasks). We included these studies for this SysRev; however, given their heterogeneity, comparing and pooling the results were not possible.
•
Although all studies were simulation studies, none specifically investigated the use of cognitive aids as an educational tool to improve resuscitation learning. Therefore, we could not examine the use of cognitive aids for health care professionals or lay rescuer training in resuscitation. This needs to be examined in our next review.
Knowledge Gaps
•
The impact of cognitive aids in real-life cardiac arrests and on patient survival
•
Effective strategies for implementation of cognitive aids during training and real-life resuscitation for health care professionals
•
The most effective type of cognitive aid and how this will be influenced by the increasing use of artificial intelligence
•
Cost-effectiveness of the use of cognitive aids during resuscitation and training
•
The effect of cognitive aids for health care professional and layperson training
Immersive Technologies for Resuscitation Teaching (EIT 6405: SysRev)
Rationale for Review
Current methods for training laypeople and health care professionals often fall short, resulting in poor skill acquisition and long-term skill decay. Identification of alternative educational strategies with improved learning outcomes will help to enhance process of care and patient outcomes from cardiac arrest. Immersive technologies, such as virtual reality (VR; defined as real-time simulation and interactions through sensorial channels created by a computer and displayed on a head-mounted or smartphone device)653 and AR (defined as computer-generated holographic images overlaid into the real environment enabling users to interact with both the hologram and real objects),654 provide an alternative learning modality to traditional instructor-led training. These technologies can support training when combined with other instructional methodologies such as video, manikin-based training, or online learning. Implementation of immersive technology comes with a cost for both hardware and software components. VR and AR technology have been used in educational settings for both laypeople and health care professionals, but ILCOR has not previously reviewed the available evidence. A SysRev was initiated because the overall impact of VR and AR on learning and performance outcomes is unclear (PROSPERO registration CRD42023376751).655 The full CoSTR can be found online.656
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Laypeople and health care professionals in any educational setting
•
Intervention: Immersive technologies (VR, AR, mixed reality, extended reality) as part of instructional design to train neonatal, pediatric, and adult BLS and ALS
•
Comparator: Other methods of resuscitation training in BLS and ALS (eg, traditional manikin-based simulation training)
•
Outcome: Knowledge acquisition and retention, skills acquisition and retention, skill performance in real CPR, willingness to help, bystander CPR rate, patients’ survival
•
Study design: RCTs, nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies and case series where n>5, conference abstracts), and research letters were eligible for inclusion. All years and all languages were included as long as there was an English abstract available.
•
Time frame: Literature search from January 1, 1990, to April 3, 2023
Consensus on Science
No meta-analyses could be performed because of a high degree of heterogeneity in the studies, and the overall certainty of evidence was very low for all outcomes. Details of individual studies are included in tables in the published review and online.656
Out of 18 studies653,654,657–672 included in this review, 3 studies used AR in BLS training.653,654,658 Two of these used AR to provide real-time CPR feedback, with 1 study favoring AR and the other favoring the non-AR feedback.653,658 The third study used AR to provide clinical guidance during training, and results favored the AR intervention but were not significant.654
Of the 3 studies investigating AR, 2 demonstrated no difference in CPR depth performance with and without use of AR during training.653,654 One study reported better CPR depth compliance with the use of AR during training.658 Two studies showed no difference in CPR-quality parameters (compression depth and rate),653,654 while an additional study found no difference in compression rate but a difference in depth with the use of AR during training.658 Overall CPR performance was assessed in 2 studies653,658 and demonstrated mixed results.
VR for BLS was explored in 9 studies assessing laypeople 657,659–665,672 and 3 studies of health care professionals.666–668 All featured VR as the primary instructional methodology. An additional 3 studies described VR use for ALS training in health care professionals.669–671 Because of significant heterogeneity in the design of the interventions, control groups, participant types, and outcome measures, meta-analysis was not possible.
Six studies looked at VR for acquisition of BLS knowledge. Knowledge acquisition was significantly greater with VR in 3 studies compared with a serious game,666 e-learning with video,661 and video-based training.662 Two studies showed no difference compared with traditional training664 or video-based training.663 Knowledge retention with kindergarten teachers improved at 5 weeks after training with VR.662 Two other studies showed no difference at 6 months.660,664
Nine studies investigated the effects of VR on BLS skills outcomes. Adult laypeople achieved significantly greater chest compression fraction with instructor-led training compared with VR.657 Results for no-flow time were mixed. One study favored VR over web-based BLS training,668 and the other favored conventional BLS training over VR.667
Three studies in adult laypeople showed significantly better CPR depth in the control group compared with VR.657,659,672 Two other studies showed no difference in CPR depth between groups.664,665 Participants in instructor-led CPR training had significantly better CPR depth compliance compared with VR.657,672 One study demonstrated higher CPR rates with VR.657 Two other studies found no difference in CPR rate.659,665 CPR rate compliance was not better with VR; CPR rate compliance was either better for instructor-led training,657,672 or no difference was found.664 One study reported better chest recoil compliance with VR,657 but 3 studies demonstrated no difference.664,665,672 For overall CPR performance after training, 3 studies found no difference when comparing VR with instructor-led training665,672 or video-based training.663 Two studies measured retention of CPR skills at 6 months664 and 3 months672 after training and found no difference in CPR depth, rate, or chest recoil when comparing traditional training and VR.664,672
A study in adult laypeople found more willingness to perform CPR with instructor-led CPR training at 6 months after training than with VR-based CPR training (81% willing in the instructor-led control group compared with 71% in the VR intervention group, P=0.02).660
Three studies investigated VR for ALS training. A study in neonatal resuscitation compared high-fidelity simulation with VR and showed no difference in knowledge immediately after training.671 An advanced cardiovascular life support study found significantly improved adherence to guidelines with traditional training compared with VR training with limited feedback. No difference was found when comparing traditional training with VR training with comprehensive feedback.669 An additional study found no difference in objective structured clinical examination scores for clinical performance between standard Helping Babies Breathe training and VR-based Helping Babies Breathe immediately after training and 6 months later.670
2024 Treatment Recommendations (New)
We suggest the use of either AR or traditional methods for BLS training of laypeople and health care professionals (weak recommendation, very low–certainty evidence).
We suggest against the use of virtual reality only for BLS and ALS training of laypeople and health care professionals (weak recommendation, very low–certainty evidence).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table can be found in Appendix A.
Augmented Reality
•
The evidence was either equivocal or in support of AR.
•
Only a few studies were identified, with few participants.
Virtual Reality
•
The evidence was mixed but predominantly in favor of non–VR-based training or equivocal in nature.
•
Studies were very heterogeneous with respect to type of intervention, type of control, and outcome measures.
•
Although some studies reported improved knowledge acquisition with VR training, the results for more important outcomes (ie, skills outcomes, adherence to guidelines, clinical performance) were either in favor of non–VR-based training or equivocal in nature.
Knowledge Gaps
•
The relative and synergistic effect of immersive technologies when combined with other educational strategies (eg, video, gamification, feedback)
•
The effects of different applications of AR and VR, which can be used in many ways (eg, real-time feedback, gamification, knowledge delivery)
•
The impact of immersive technology on the acquisition and retention of knowledge and skills
•
The effect of immersive technology–based training on team-based skill performance and process measures (eg, time to epinephrine, time to defibrillation)
•
The role of the instructor when immersive technology is being used (eg, when it is beneficial for the instructor to provide feedback and the type of training the instructor requires when using immersive technology in resuscitation courses)
•
The costs associated with implementing and maintaining AR and VR devices as well as cost-effectiveness of these training modalities
Gamified Learning Compared With Other Forms of Resuscitation Learning (EIT 6412: SysRev)
Rationale for Review
Increased familiarity and ease with technology and digital media are features of younger generations. More effective teaching strategies for these learners may include a greater degree of stimulation and engagement with the use of active participation with and alongside peers. Gamification refers to the use of game-like elements (competition, point systems, scaffolded levels of difficulty, leaderboards), usually in a digital format, to encourage interactive and intuitive participation by learners. Some preliminary studies have found that gamified learning improves knowledge and skill during CPR training, either alone or used as pretraining to a standard life support course; other studies have found no significant difference. The task force undertook a SysRev because the impact of gamified learning on learning and performance outcomes is unclear (PROSPERO registration CRD42023483540).673 The full CoSTR can be found online.674
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Learners training in BLS or ALS
•
Intervention: Instruction using gamified learning (use of game-like elements in the context of training, eg, point systems, intergroup competition, leaderboards, scaffolded learning with increasing challenge, “medals” or “badges”)
•
Comparator: Traditional instruction or other forms of nongamified learning
•
Outcome:
−
Educational outcomes:
▪
Skill (eg, CPR performance, other procedural performance, scores in scenarios, time to task performance): Immediately after training (ie, end of course), at 3 months, 6 months, 1 year
▪
Knowledge (eg, test scores): Immediately after training (ie, end of course), at 3 months, 6 months, 1 year
▪
Attitudes: Participant satisfaction, learner preference, learner confidence
−
Clinical outcomes: Change in health care practitioner behavior at resuscitation in case of real cardiac arrest (CPR quality, time to task completion, teamwork/crisis resource management)
−
Patient outcomes: ROSC, survival to hospital discharge, neurologic intact survival
−
Process: Costs and resources utilization
•
Study design: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols) were excluded. All languages were included as long as there was an English abstract available.
•
Time frame: All years up to May 30, 2023
Consensus on Science
Six randomized trials and 7 observational studies were identified.675–687 Details of study design and key findings are presented in table form in the published review and online.674 No meta-analyses could be performed because of a high degree of heterogeneity in the studies, and the overall certainty of evidence was low to very low for all outcomes.
Eleven studies used digital platforms, including online or screen-based platforms,675,676,681,684,685,687 a digital leaderboard,677,680,681 and smartphone applications.683,686 One study used a board game, and another a card game.678,679 Eleven studies involved health care professionals,675–683,686,687 and 2 involved laypeople (high school students).684,685 Three studies examined performance of teams679,685,686; the remaining 10 examined individual performance. No study reported on outcomes of process, costs, and resources utilization, or on critical clinical and patient outcomes.
Overall CPR performance was addressed in 4 RCTs676,677,681,682 and 1 observational study.685 Three RCTs676,681,682 found better performance with gaming for health care professionals and laypeople. A multicenter RCT found no effect.677 The observational study in laypeople found improved performance 6 months after training with gaming.685 In an observational study of BLS training amongst high school students using a screen-based gamified learning interface, chest compression depth and rate was improved immediately after training and remained improved 3 months later.684
Two observational studies of health care professionals demonstrated improved knowledge scores after gamified learning during the Neonatal Resuscitation Program, a finding that persisted at 6 months in 1 of the studies.678,687 A card game to enhance Neonatal Resuscitation Program knowledge reported high levels of perceived usefulness.679 Another observational study found improved skills scores and faster time to positive pressure ventilation in a neonatal scenario that followed gamified learning.675
For ALS knowledge, 2 RCTs in health care professionals showed improvements with smartphone-based games.683,686 The latter study showed no difference for skills during ALS scenarios used in a smartphone-based game involving ALS scenarios but led to better self-reported confidence among users.
An observational study680 of nurses using a leaderboard showed decreased time to epinephrine dosing in children as well as increased proportion of learners knowing the correct concentration of epinephrine.
2024 Treatment Recommendation (New)
We suggest the use of gamified learning be considered as a component of resuscitation training for all types of BLS and ALS courses (weak recommendation, very low–certainty evidence).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table is provided in Appendix A.
•
All studies were very heterogeneous with respect to subjects, type of intervention, type of control, and outcome measure, and GRADE assessment showed that evidence was of very low certainty.
•
All studies reported at least 1 domain of learner outcome (skill, knowledge, attitude) with a positive result when gamified learning elements were included; no studies found a negative impact of gamified learning elements on any domain of learner outcomes.
•
Most studies involved an intervention requiring a digital platform (eg, video-based, smartphone-based); no studies reported any information about cost, implementation outside their study group, or wider dissemination to other settings or learners.
Knowledge Gaps
•
A more consistent definition of gamification across research studies (eg, use of video-based content delivery alone does not necessarily constitute a “game,” although this term is frequently used to describe such training elements)
•
Optimal approaches to dissemination of gamified learning elements as well as platforms to varied learner groups and settings
•
Costs, resources, and time requirements for implementation of gamified learning
•
The association between gamified learning elements and differences in stress or cognitive load
•
The impact of gamified learning on care delivery or patient outcomes
Rapid Cycle Deliberate Practice in Resuscitation Training (EIT 6414: SysRev)
Rationale for Review
Rapid cycle deliberate practice (RCDP) is a type of training in which feedback occurs immediately and frequently during the training. It should not be confused with repetitive practice. RCDP is characterized by a goal to be achieved, a stop-and-go practice with immediate feedback on the performance, ample time for repetition to improve performance aiming to improve clinical outcomes, and a safe environment that fosters an atmosphere where learners have no fear of making mistakes and receive feedback from a constructive perspective.688 ILCOR has not previously reviewed available evidence about RCDP in resuscitation training. Therefore, a SysRev was initiated (PROSPERO registration CRD42023468862).689 The full CoSTR can be found online.690
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Learners training in BLS or ALS
•
Intervention: Instruction that uses RCDP
•
Comparator: Traditional instruction or other forms of learning without RCDP
•
Outcome: Knowledge acquisition and retention, skills acquisition and retention, skill performance in real CPR, attitudes, willingness to help, and patients’ survival
•
Study design: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols) were excluded. All years and all languages were included as long as there was an English abstract available.
•
Time frame: All years up to November 1, 2023
Consensus on Science
Seven RCTs691–697 and 1 observational before-after study688 were identified, all in simulation settings.688,691–697 The studies included medical students,696 interns,693,694 residents,688,692,697 physicians,695 and a mix of fellows, nurses, and respiratory therapists691: all involved in adult,695,696 pediatric,688,691,692,694,697 and neonatal693 simulated scenarios. Seven of them referred directly to RCDP688,691–695,697; 1 used “in-simulation debriefing” during the clinical scenario, which contained the key components of RCDP.696
Details of the individual simulation studies are presented in the published review and online.690 Meta-analysis was only possible for time to chest compressions.
For time to chest compressions, 2 pediatric692,697 studies and 1 neonatal693 study provided very low–certainty evidence of no benefit from RCDP when compared with after-event debriefing (Figure 6). In an observational study, RCDP resulted in a significantly shorter time from cardiac arrest to initiation of chest compressions.688
A single RCT found no benefit in time to recognition of cardiac arrest with RCDP.695 An observational study found no benefit in time to bag-mask ventilation.688 In an RCT, time to positive-pressure ventilation within 1 minute was more frequent with RCDP than in the control.693 Three RCTs692,695,697 and 1 observational study688 assessed time to defibrillation, with shorter time from rhythm recognition to defibrillation in 2 RCTs692,695 and in the observational study.688 Two RCTs assessed time to administration of epinephrine,692,693 with 1 study describing a benefit with RCDP.693 RCDP also resulted in shorter pre-defibrillation pause durations in 2 studies.688,695 RCDP improved compression fraction/no-flow fraction in an RCT695 and in an observational study.688 Retention of skills at 4 months was analyzed in an RCT, and there was no difference with RCDP.693
2024 Treatment Recommendation (New)
We suggest that it may be reasonable to include RCDP as an instructional design feature of BLS and ALS training (weak recommendation, very low–certainty evidence).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table is provided in Appendix A.
•
We favored RCDP as a teaching modality because no side effects or harmful outcomes were reported and most outcomes showed a benefit from RCDP. Notably, shorter time to critical task performance (ventilation, defibrillation, administration of epinephrine) and shorter preshock pause durations were described in several of the simulation studies.
•
The only meta-analysis performed (for time to chest compressions) did not show a difference. This contributed to the weakness of the recommendation, despite other evidence being found in favor of RCDP.
•
Only 1 study (addressing teaching effectiveness) out of the 8 included in the review favored the control group.
•
As most of the RCDP studies included trainees, generalizability of the findings to other groups needs to be further explored.
Knowledge Gaps
•
The effect of RCDP in other populations (laypeople, first responders, and experienced health care professionals)
•
The medium or long-term follow-up effect of RCDP
•
Resources required and costs of implementation of RCDP in resuscitation training curriculum of health care professionals and other populations
•
The effect of RCDP on resuscitation training and clinical outcomes and patient survival
•
There is heterogeneity in the use of terms, and standardized definitions of deliberate practice and RCDP were not used across studies, making identification of relevant comparative studies difficult.
Team Competencies Training for Resuscitation (EIT 6415: SysRev)
Rationale for Review
Team competencies are defined as nontechnical skills, including team-related communication, task allocation, and leadership, that are known to be associated with patient outcomes in resuscitation. Investigating whether specific training of team competencies improves resuscitation performance could impact the organization of resuscitation services worldwide and potentially improve patient care. In 2020 we recommended the use of specific leadership training for resuscitation courses on the basis of very low–certainty evidence.620 This SysRev aimed to assess the effect of specific training on a broader range of team competencies as part of resuscitation training (PROSPERO registration CRD42023473154).698 The full CoSTR can be found online.699
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Learners undertaking life support training in any setting
•
Intervention: Life support training with a specific emphasis on team competencies
•
Comparator: Life support training without specific emphasis on team competencies
•
Outcome: Patient survival, CPR skill performance at course completion, CPR skill performance in actual resuscitation and simulation, CPR quality, confidence, and team competencies: all at course completion, <1 year and ≥1 year after course completion; resources (time, equipment, cost)
•
Study design: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Studies evaluating scoring systems (no relevant outcome), studies with self-assessment as the only outcome, reviews, and abstracts were excluded. All languages were included as long as there was an English abstract available.
•
Time frame: Literature search January 1, 1999, to August 30, 2023
Consensus on Science
Seventeen studies were included in this review, and individual study details are provided in the published review and online.699–716 No evidence was identified for CPR-skill quality and performance, confidence, and team competencies beyond 1 year. One RCT705 reported descriptive data on patient survival outcomes favoring team competencies, but this was not powered to make inferences.
For CPR skills and quality at course completion, 2 RCTs700,710 reported shorter time to at least 1 CPR-skills performance. One nonrandomized study for pediatric ALS706 reported higher checklist scores for CPR skills with team training, and 1 RCT704 found greater adherence to ALS guidelines. Nine studies (1 observational,706 8 RCTs702,705,709–711,713,715,716) reporting CPR performance found no effect from team competence training. One RCT701 reported shorter no-flow time, whereas another found no difference.704 Two studies found no difference in hands-on time or compression rate709 or chest compression quality.708
Two RCTs found no difference in CPR performance at 4 months716 and 6 months.711 Another RCT709 reported increased hands-on time and higher compression rates 4 months after course completion. Confidence at course completion and at a nonspecified follow-up interval showed was not different in 1 RCT.702
Team competencies were evaluated at course completion by 14 studies (12 RCTs,700–703,707–710,713–716 2 nonrandomized studies706,712). Three RCTs708,709,714 reported more leadership statements, 3 RCTs703,713,714 identified increased directed team communication, 1 RCT713 found increased closed-loop communication, and another RCT701 reported higher “teamwork verbalizations” (eg, directed orders, task assignments, planning).
Decision-making improved in 1 RCT.708 Leadership behavior was better in 2 RCTs,705,707 with 1 also reporting increased correction of improper chest compressions. A nonrandomized study712 reported no difference in leadership behavior.
Teamwork improved in 1 RCT702 with higher team-level efficacy, and 1 nonrandomized study706 reported more teamwork intervention events. Two RCTs715,716 and a nonrandomized study712 found no differences in teamwork measures. Nontechnical skills performance was found to be higher in 2 RCTs,700,710 and 2 RCTs714,715 reported improved workload management.
Prior Treatment Recommendation (2020)
We suggest that specific team and leadership training be included as part of ALS training for health care providers (weak recommendation, very low–certainty evidence).620
2024 Treatment Recommendation
We suggest that teaching team competencies be included in BLS and ALS training (weak recommendation, very low–certainty evidence).
Justification and Evidence-to-Decision Framework Highlights
The complete evidence-to-decision table is provided in Appendix A.
•
We identified no harmful effects of team competencies training in any course format.
•
Several studies reported that team competencies training improved CPR skill performance, which persisted beyond course completion.
•
The evidence relating to team competency outcomes varies but was mostly positive.
•
Previous clinical studies suggest that a lack of team competencies is a barrier to successful resuscitation, and team competencies have been associated with improved technical skill performance during clinical resuscitation attempts.
•
We valued the fact that team competencies training appears widely accepted.
Knowledge Gaps
•
Benefits of training team competencies on clinical resuscitation performance outcomes and patient outcomes
•
The optimal instructional design, duration, and mode of delivery for training of team competencies
•
Whether training in particular competencies is more important than others and whether this depends on the group of learners
•
Cost-effectiveness of team competencies training and effectiveness in low-resource settings
BLS Education Tailored to Specific Populations (EIT 6108: ScopRev)
Rationale for Review
The task force undertook this ScopRev because the individual backgrounds of specific populations (eg, working in a special environment, someone with special needs, impairments, or disabilities) who are not health care professionals may warrant specific BLS training that differs from standard courses.717–719 However, it is unclear which specific populations exactly could benefit from adapted tailored teaching. The complete report of this ScopRev can be found online.720
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Specific adult layperson populations or groups participating in BLS training
•
Intervention: Tailored BLS training
•
Comparator: Nontailored BLS training
•
Outcomes:
−
Patient outcomes:
◾
Critical: Survival to hospital discharge, 30-day survival, 12-month survival, neurological outcome
◾
Important: ROSC
−
BLS quality outcomes: Starting CPR in case of real cardiac arrest, performance during real CPR
−
Educational outcomes: Knowledge and skills acquisition, willingness to perform CPR, barriers toward performing CPR, participant satisfaction or knowledge and skills retention at the end of the respective course and later (eg, 3 months, 1 year), implementation success, resource implications, and cost-effectiveness
•
Study design: RCTs and nonrandomized studies (non-RCTs, controlled before-and-after studies, cohort studies, and case series n≥5), reviews, and surveys in respective population groups with at least an abstract in English were eligible for inclusion. Research aimed at teaching BLS to children and research on CPR training for health care professionals (both sufficiently covered elsewhere) were excluded.
•
Time frame: All years to July 10, 2023
Definitions
A.
Specific population/subgroup: A group with a specific feature (eg, job, age group)
B.
Layperson: An adult who is not a qualified, retired, or in-training health care professional. We defined 2 groups of laypeople:
1.
Duty to respond: Laypeople who have a duty to attend individuals of an emergency because of their profession (eg, law enforcement, firefighters, lifeguards, flight crews)
2.
No duty to respond: Community laypeople who have no duty (occupational expectation) to respond to a cardiac arrest
C.
Standard BLS training (nontailored BLS courses): BLS courses that follow current recommendations from the large course developers and organizers like the American Heart Association or the European Resuscitation Council
D.
Tailored training (tailored courses): Courses altered to serve the special needs of a population (eg, duration, frequency, content, assessment, feedback, materials and devices used, specific aids, contextualization of the environment, specially trained instructors)
Summary of Evidence
Details of the included studies and findings are presented in the published review and online.720 Most studies addressed training in those with disabilities, including Down syndrome,721,722 blindness,723,724 and deafness or hearing impairment.725–727 No studies comparing an approach tailored to specific populations with a standard course were identified. Only a small percentage of people with Down syndrome were able to perform high-quality chest compression–only CPR after a tailored course (shorter sessions and videos with comic elements).721,722 Two studies assessed CPR education for blind learners, which resulted in chest compression–only CPR similar to other BLS providers723; supervisors with special pedagogic training were able to teach rescue breaths.724 Tailored courses for trainees with hearing impairment725–727 incorporated sign language interpreters without altering the 30:2 approach. Activating emergency medical services and following automated external defibrillator voice prompts were the most challenging points. One tailored chest compression–only CPR course for refugees was deemed feasible but needed translators and a special focus on general health literacy.728
Task Force Insights
No studies were found comparing tailored courses with standard BLS courses, which was the intended aim of this review. Thus, whether tailoring BLS courses to specific populations yields better results than standard courses remains unknown. An overview of studies reporting tailored courses for specific populations was provided instead. Unfortunately, studies reported few details on the tailoring done or the development process. We acknowledge that educators will often make minor adaptations in courses to meet individual needs of students, but real tailoring has to address the needs of the special learners, include the specific populations in such developments, and undergo proper validation to ensure benefits to the learners.
The task force thought that tailored BLS education for specific populations is probably feasible and could expand the pool of potential bystander CPR providers to include groups that may otherwise have been left out (eg, individuals with disabilities). The importance of defining a structured way to tailor courses to those with specific needs and ways that members of specific groups might be involved in developing such courses were also discussed.
Knowledge Gaps
•
Which specific population groups may benefit from tailored BLS education
•
Whether tailored BLS education is cost-effective across different populations
•
What kind and amount of tailoring are optimal
•
Whether tailored courses would be effective for first responders with and without a duty to respond, including but not limited to police, firefighters, or lifeguards
•
How standard courses compare with tailored courses in specific populations
International Facets of the Chain of Survival (EIT 6311: ScopRev)
Rationale for Review
The term Chain of Survival is widely used in literature, scientific presentations, education, and awareness campaigns, with significant heterogeneity. This leads to confusion on which version should be used for which purpose, and the educational and clinical impacts of this heterogeneity are unclear. The American Heart Association issued various iterations of the Chain of Survival in their latest guidelines.718 The European Resuscitation Council switched to the concept of Systems Saving Lives, and, while still mentioning the Chain of Survival, no longer uses a depiction of the Chain of Survival.719 No review of this topic has been done by ILCOR previously. The full report of the ScopRev can be found online.729,730
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Literature using the term Chain of Survival or similar terms (eg, survival chain, chain of [other pathology])
•
Intervention and exposure: Adaptations of the original Chain of Survival
•
Comparator: The original Chain of Survival
•
Outcome:
−
Composition of the specific variations in adapted versions
−
Attitudes, rationale, and views concerning the adaptation
−
Incentives to develop novel versions
−
Way of implementation of adapted versions
−
Way of utilization of adapted versions in education
−
Variations in visualization
−
Effect of the use of the Chain of Survival or variants on teaching, implementation, and patient outcomes
•
Study design: All types of studies, including randomized trials or non-RCTs, narrative literature, letters, commentaries, or editorials in all languages
•
Time frame: All years to August 14, 2023
Summary of Evidence
The heterogeneity of works identified made a SysRev or meta-analysis impossible. Details of individual studies are summarized in the published review and online.729 We grouped the publications into novel concepts related to resuscitation (n=8),718,731–737 novel concepts not directly related to resuscitation (n=23),738–760 simple adaptations of the original Chain of Survival (n=9),761–769 and impact on outcomes (n=3).603,770,771
Novel Chains of Survival have been suggested for resuscitation for IHCA,718,732,735 pediatric resuscitation,718,736 and mass gatherings (including early planning).733 A chain mail of survival (with multiple rows of interlacing rings rather than a single row of linked rings)734 Adaptations of the existing chains (mostly expansions) included survival after ventricular fibrillation,769 rehabilitation,765 general prevention,766 family support,767 making the chain into a circle,761 STEMI,764 the chain mail of survival for low-resource settings,768 survival odds along the chain in contrast to research funding,762 and a visual adaptation of the rings according to their impact on outcome in ratios.763 Increased survival rates and better neurologic outcome after the introduction of the fifth link of the chain by the American Heart Association in 2010 was observed.603,770 After a public campaign about the Chain of Survival in France, bystander CPR rates increased.771 No educational or other outcomes were reported.
Several versions or adaptations not directly related to CPR were found,738–760 covering specific pathologies (trauma,738,752,759 severe hemorrhage,748 land mine incidents,743 stroke,744,751 STEMI,740,750 drowning,753,754 septic shock,745 complicated deliveries742) or occasions and situations (pandemics,755,760 events,749 terror attacks,758 chemical/biological/radiological/nuclear incidents,741 industrial incidents746). Others rethought the concept and proposed the survival ladder,757 or a Chain of Survival behaviors in first aid.756 Peculiarities were the animal Chain of Survival for veterinary patients,739 and 1 for anesthesia equipment.747
Task Force Insights
Chains of Survival range from classic versions used by resuscitation councils with minor adaptations to completely novel versions covering various pathologies or situations. Most health care workers know one or another version of the Chain of Survival because the concept has penetrated scientific literature and guiding documents, including gray literature. Also, the term is clinically and scientifically used as a synonym for whole systems of cardiac arrest care.
An educational aspect of the Chain of Survival does not really play a role in publications included in this review. Several adaptations of the classic chain lack essential links of the chain. Rehabilitation and prevention seem to be accepted as cornerstones of patient care. Special circumstances of cardiac arrest (eg, pediatric, out-of-hospital, in-hospital, drowning) may require consensus on more substantial modifications. Interestingly, only 3 publications assessed the impact of the Chain of Survival on outcomes,603,770,771 but the exact role the chain played in altering outcomes, if any, is unclear.
The EIT Task Force concluded that a version of the classic Chain of Survival with 6 links (as currently proposed by the American Heart Association;718 Figure 7) is a sensible choice as a cognitive aid for laypeople in education and awareness campaigns to convey the message of needed actions to save lives. If needed, modified versions of the chain for specific situations like drowning or trauma might also be acceptable. The task force also thought that ILCOR, as the international body on resuscitation, should provide the basic structure of this framework. National and regional resuscitation councils can provide regional applications for their implementation strategies.
Knowledge Gaps
•
Whether there is a need for revising the classic Chain of Survival
•
Who the Chain of Survival is targeted toward (clinicians, scientists, laypeople, stakeholders, or all of them), if laypeople need a simpler Chain of Survival than health care professionals do, and how it should be used optimally (a depiction of local systems to save lives, an educational framework, a cognitive aid)
•
Which of the various published Chains of Survival should be used by default; a comprehensive system could be evaluated for applicability in the future
•
The impact of various kinds of Chains of Survival on educational outcomes, clinical outcomes, and patient survival
Clinician Workload and Stress During Resuscitation (EIT 6401: ScopRev)
Rationale for Review
The workload and stress health care professionals might experience during resuscitation have the potential to affect the performance of individual rescuers or the resuscitation team.772,773 This ScopRev investigated what variables influence (ie, increase or decrease) health care professional workload and stress during cardiac arrest, in both real-world and simulated scenarios.774 The full report of the ScopRev can be found online.775
Population, Exposure, Comparator, Outcome, Study Design, and Time Frame
•
Population: Health care professionals performing resuscitation on patients in cardiac arrest in clinical settings or on manikins in a simulated setting
•
Exposure: Presence of any factors that would possibly impact the health care professional’s perceived workload or stress
•
Comparator: Absence of the specific factor
•
Outcome: Objective or subjective measures of workload or stress experienced by health care professionals during resuscitations
•
Study design: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies), unpublished studies (eg, conference abstracts, trial protocols), letters, editorials, comments, case reports, gray literature, and social media were eligible for inclusion. All relevant publications in any language were included as long as there was an English abstract available.
•
Timeframe: From inception to April 21, 2023
Summary of Evidence
We included 21 studies,634,642,776–794 including 17 RCTs,634,642,777,779–789,792–794 2 nonrandomized trials,778,791 and 2 observational studies.776,790 Because of heterogeneity in study design, SysRev with meta-analysis could not be performed. Study characteristics and key findings are provided in table form in the published review and online.775 All but 2 studies776,790 were simulation studies.
The NASA Task Load Index634,777,779–782,785–794 was used to measure subjective workload, and the State-Trait Anxiety Inventory784 and structured survey questions45 were used to measure stress. Physiologic stress markers included salivary cortisol, α-amylase levels, heart rate, and BP.778,789 Variables influencing perceived stress or workload were categorized into (1) team composition and roles, (2) telemedicine, (3) workflows, (4) tools like CPR-feedback devices, (5) cognitive aids, (6) presence of friends and families, and (7) clinician experience and exposure. Findings by category include the following:
•
Team composition and roles: A dedicated nursing team leader alleviated the medical team leader’s workload during resuscitation.794 CPR coaches decreased mental workload and increased physical workload among CPR providers788 but did not impact the team leader’s workload.782,788 In real pediatric resuscitations, the team leader reported higher mental load, whereas chest compressors had higher physical workload.776
•
•
•
Tools: The use of ventilation feedback devices or chest compression feedback devices increased workload for CPR providers.777 Real-time feedback devices had no effect on team leaders, while chest-compressing CPR providers reported higher workloads.785 Interestingly, equipment failure (defective defibrillator) in simulation did not increase stress for the team.789
•
Cognitive aids and smart apps: A smart app designed to help drug preparation reduced acute stress in paramedics in simulated pediatric cardiac arrest.784 A smart app with a resuscitation algorithm did not increase workload for team leaders.791 A tablet-based decision support tool’s effect on workload was inconclusive because the increase in workload disappeared later during simulation.786
•
Family presence and socioemotional stress: Presence of next of kin increased mental demands but did not change physical demands in simulation.781 An observational study of real pediatric resuscitations showed lower workload when at least 1 parent was present.790 This is in accordance with an ILCOR CoSTR on family presence during resuscitation in pediatric and neonatal cardiac arrest.795,796
•
Clinician experience: A quasi-experimental study found no association between level of clinical experience and subjective stress and physiologic parameters among nursing students during resuscitation simulation.778
Task Force Insights
In these studies, designated medical team leaders tended to experience increased workload, which was attenuated by assistance from senior nurse leaders. However, additional CPR coaches did not affect the team leader’s overall workload, and remote team leaders increased team workload. A goal-directed approach or use of task-focusing questions during resuscitations can reduce perceived workload or stress for the team. External support from cognitive aids reduced stress and workload, but workload was sometimes higher with first use. Therefore, introducing new equipment could potentially impose an additional cognitive burden if the users are not adequately familiarized with it.
The factors identified in this review (team composition and roles, workflows, tools, telemedicine, cognitive aids, smart apps, and socioemotional stress) represent potential modifiable elements. Adjusting these factors could alleviate or increase their impact on workloads or stress and, consequently, on resuscitation performance as well. However, there may be additional factors influencing the workload of resuscitation team members that were not covered in our review.797
Given the few studies specifically designed to manipulate workload and its impact on resuscitation performance, and that stress and workload may affect individuals’ performance differently, the task force did not include resuscitation performance in this review to avoid incorrect conjecture and to maintain the integrity of the results.
Knowledge Gaps
•
The association between workload/stress and resuscitation performance; more well-crafted experimental studies exploring the relationship between workload and performance of resuscitation teams are needed to gain more insight into this complex interaction
•
Health care professionals’ workload or stress during resuscitation on actual patients and how such workload and stress are associated with patient outcome
•
The influence of personal factors, contextual factors, and clinical experience in mitigating the impact of external stressors and perceived workload
Scripted Debriefing Compared With Nonscripted Debriefing in Resuscitation Training (EIT 6413: ScopRev)
Rationale for Review
Debriefing conducted during simulation-based training improves provider knowledge, clinical performance, and nontechnical skills performance.798–803 Studies assessing the impact of debriefing after cardiac arrest events demonstrate improved provider performance,804,805 while debriefings informed by clinical data have been associated with enhanced survival outcomes from cardiac arrest.806,807 Many different debriefing frameworks have been developed and implemented, leading to variability in how debriefing is conducted across programs and institutions.808
Debriefing scripts and tools have been developed to help standardize the approach to debriefing during resuscitation training. While their use has gained traction in both educational809,810 and clinical settings,811–813 the benefits of debriefing scripts in resuscitation education have not been clearly delineated, prompting this ScopRev.814 The full report of the ScopRev can be found online.815
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Health care professionals or laypeople receiving resuscitation training (primary) and instructors teaching resuscitation courses (secondary)
•
Intervention: Debriefing with a cognitive aid, checklist, script, or tool
•
Comparator: Debriefing without the use of a cognitive aid, checklist, script, or tool
•
Outcome: Patient outcome, improved resuscitation performance in clinical environments, improved learning outcomes (knowledge and skill acquisition and retention), satisfaction of learning, quality of teaching/debriefing, workload/cognitive load of debriefer
•
Study design: RCTs and nonrandomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Unpublished studies (eg, conference abstracts, trial protocols) and gray literature were excluded. All relevant publications in any language were included as long as there was an English abstract available.
•
Time frame: All years to April 18, 2023
Summary of Evidence
Six studies (5 RCTs809,816–819 and 1 quasi-experimental study820) were included in this review. Details of the included studies are summarized in the published review and online.814,815 No studies evaluated patient outcomes or provider performance on real patients.
Three studies used pediatric resuscitation scenarios809,817,818 and 3 others adult scenarios816,819,820 as the trigger for the debriefing. Five studies809,816–818,820 used a debriefing script, including debriefing framework, topics for discussion, and suggested phrasing; the other RCT819 did not use suggested phrases. Only 1 study incorporated CPR-quality parameters as objective data.818 Only 4 studies trained the debriefer in the use of the script.816–818,820 The PEARLS tool (Promoting Excellence and Reflective Learning in Simulation)816,818,820 was used most often, followed by advocacy-inquiry,809,817 and then the gather-analyze-summarize model.819 A multicenter trial reported that scripting led to debriefings of higher quality, with significant effects in novices,817 whereas another RCT found no difference when using a PEARLS script.816 The latter study found reduced cognitive load with script debriefing for novice debriefers (ie, simulation fellows).
Data-informed, PEARLS-scripted debriefing after a simulated pediatric cardiac arrest scenario improved learning outcomes (excellent CPR, guideline-compliant depth, chest compression fraction, perishock pause) in 1 RCT.818 A study including medical and nursing students showed no difference in teamwork performance comparing scripted with nonscripted debriefings.819 A multicenter RCT of health care professionals reported improved team leadership skills and improved knowledge acquisition but no difference in clinical performance scores with scripted debriefing by novice instructors.809
Task Force Insights
All studies had significant heterogeneity in design and implementation of scripted debriefing interventions (eg, blended method and framework of debriefing,816,818,820 single debriefing method like advocacy inquiry809,817). There were differences in the methods of familiarization of facilitators with scripts (from handing the debriefing script to facilitators before debriefing to comprehensive debriefing training). These variables may have contributed to the variability in results.
Our ScopRev did not identify any studies reporting patient or process outcomes in real resuscitations. Only 1 study integrated CPR performance metrics directly into the debriefing script,818 enabling a direct link between debriefing to clinically relevant performance metrics, which might enhance the overall impact of debriefing during resuscitation education.818
2024 Good Practice Statement
Consider using debriefing scripts to support instructors during debriefing in resuscitation programs because they may improve learning and performance. Instructors need to ensure they have a complete understanding of how the debriefing script should be used (good practice statement).
Knowledge Gaps
•
The relative and synergistic effect of scripted wording versus data-informed debriefing during resuscitation training
•
The impact of scripted debriefing on knowledge and skill retention
•
The impact of scripted debriefing during training on patient or process outcomes in real resuscitations
•
The importance of debriefer adherence to debriefing scripts and its influence on learning and performance outcomes
•
The influence of debriefer experience and learner characteristics on the impact of debriefing scripts
•
The impact of linking the content of debriefing scripts to clinically important metrics and clinically relevant outcomes
EIT Topics Reviewed by EvUps
Topics reviewed by EvUps are summarized in Table 24. Complete EvUps can be found in Appendix B.
Topic/PICO | Year last updated | Existing treatment recommendation | RCTs since last review | Observational studies since last review | Key findings | Sufficient data to warrant SysRev? |
---|---|---|---|---|---|---|
EMS experience and exposure (EIT 6104: EvUp) | 2021 | We suggest that EMS systems (1) monitor their clinical personnel’s exposure to resuscitation and (2) implement strategies, where possible, to address low exposure or ensure that treating teams have members with recent exposure (weak recommendation, very low–certainty evidence). | None | None | None | No |
Patient outcomes of team member attending a CPR course (EIT 6106: EvUp) | 2022 | We recommend the provision of accredited ALS training (ACLS, ALS) for health care providers who provide ALS care for adults (strong recommendation, very low–certainty evidence). We recommend the provision of accredited courses in NRT (NRT, NRP) and HBB for health care providers who provide ALS care for newborns and babies (strong recommendation, very low–certainty evidence). We have made a discordant recommendation (strong recommendation despite very low–certainty evidence) because we have placed a very high value on an uncertain but potentially life-preserving benefit, and the intervention is not associated with prohibitive adverse effects. | None | 2 pre-post studies; one on implementation of newborn resuscitation trainings in Nepal (HBB) and one on training of health care professionals on neonatal outcomes in the delivery room in Brazil. | Decreases in intrapartum stillbirths, neonatal deaths (within first 24 h), sick newborns transferred from maternity unit; for all P<0.001. No differences were observed in neonatal deaths after 24 h. Items required for neonatal resuscitation increased postintervention substantially. Delivery room mortality rate decreased by 73%. | No |
Willingness to provide CPR (EIT 6304: EvUp) | 2021 | To increase willingness to perform CPR, laypeople should receive training in CPR. This training should include the recognition of gasping or abnormal breathing as a sign of cardiac arrest when other signs of life are absent. Laypeople should be trained to start resuscitation with chest compressions in adult and pediatric individuals. If unwilling or unable to perform ventilation, rescuers should be instructed to continue compression-only CPR. EMS dispatchers should provide CPR instructions to callers who report cardiac arrest. When providing CPR instructions, EMS dispatchers should include recognition of gasping and abnormal breathing (ILCOR 2020, 2022 CoSTR, unchanged from 2010). | None | 37 observational studies: 23 studies explored factors linked to bystander CPR or AED use, and 14 studies focused on the COVID-19 pandemic. These studies included patients with OHCA who receive bystander CPR, with the thought that bystanders were less likely to perform CPR during the COVID-19 pandemic. | These factors had already been identified in the 2020 scoping review and the 2021 EvUp. | Yes. However, the PICOST needs to be refined. A separation is needed in a SysRev between factors associated with OHCA patients receiving CPR (eg, community level) and factors associated with bystanders performing CPR and AED use (eg, personal level). |
Implementation of guidelines in communities (EIT 6306: EvUp) | 2021 | This treatment recommendation remains unchanged since 2015: We recommend implementation of resuscitation guidelines within organizations that provide care for patients in cardiac arrest in any setting (strong recommendation, very low–quality evidence). | None | 2: 1 study in neonatal resuscitation in low-resource settings, and another reported on the World Restart a Heart campaign | No significant effect on survival rates; at least 302 million people received CPR training | No |
Debriefing of resuscitation performance (EIT 6307: EvUp) | 2021 | We suggest data-driven, performance-focused debriefing of rescuers after IHCA for both adults and children (weak recommendation, very low–certainty evidence). We suggest data-driven, performance-focused debriefing of rescuers after OHCA in both adults and children (weak recommendation, very low–certainty evidence). | None | None | NA | No |
CPR feedback devices during training (EIT 6404: EvUp) | 2022 | We suggest the use of feedback devices that provide directive feedback on compression rate, depth, release, and hand position during CPR training (weak recommendation, low-certainty evidence). If feedback devices are not available, we suggest the use of tonal guidance (eg, music or metronome) during training to improve compression rate only (weak recommendation, low-certainty evidence). | 4: 2 RCTs in BLS in health care professionals. 2 RCTs in simulation-based cardiac arrest training: 1 included augmented-reality CPR feedback devices, and the other assessed infant CPR performance | 1 pre-post cohort study | For RCTs: Feedback devices improve CPR-quality metrics, including long-term retention. Augmented reality–assisted feedback results in better performance in all CPR-quality metrics. Simulated infant CPR performance with a real-time feedback device was similar to CPR without such devices. For the observational study, defibrillator with CPR feedback features: Code teams achieve higher adherence to AHA guidelines for chest compression rate and chest compression fraction. | Yes |
Blended-learning approach for life support education (EIT 6409: EvUp) | 2021 | We recommend a blended-learning as opposed to nonblended approach for life support training when resources and accessibility permit its implementation (strong recommendation, very low–certainty evidence). | None | 1: cross-sectional cohort study on BLS blended learning in a classroom vs remote virtual attendance | Remote and classroom blended learning was not different in chest compression release, depth, or rate scores. Retakes of the final assessment were higher in remote blended learning. | No |
High-fidelity training for resuscitation (EIT 6410: EvUp) | 2021 | We suggest the use of high-fidelity manikins when training centers/organizations have the infrastructure, trained personnel, and resources to maintain the program (weak recommendations, very low–quality evidence). If high-fidelity manikins are not available, we suggest that the use of low-fidelity manikins is acceptable for standard ALS training in an educational setting (weak recommendations, low-quality evidence). | 2: 1 pilot study of manikins with slightly increased fidelity vs none in 15 nursing students. 50 ACLS-certified third-year medical students; high-fidelity simulator vs traditional manikin | None | No difference in CPR quality parameters (no statistics reported and no difference in self-report confidence questionnaire; higher scores for procedures with high-fidelity manikins, and in a pre- and postintervention confidence questionnaire. | No |
ACLS indicates advanced cardiovascular life support; AED, automated external defibrillator; AHA, American Heart Association; ALS, advanced life support; BLS, basic life support; CoSTR, Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations; CPR, cardiopulmonary resuscitation; EIT, Education, Implementation, and Teams; EMS, emergency medical services; EvUp, evidence update; HBB, Helping Babies Breathe; IHCA, in-hospital cardiac arrest; ILCOR, International Liaison Committee on Resuscitation; NRP, Neonatal Resuscitation Program; NRT, neonatal resuscitation training; OHCA, out-of-hospital cardiac arrest; PICO, population, intervention, comparator, outcome; PICOST, population, intervention, comparator, outcome, study design, time frame; RCT, randomized controlled trial; and SysRev, systematic review.
First Aid
Use of Supplemental Oxygen in First Aid (ScopRev FA1649)
Rationale for Review
Training in oxygen administration is typically not included in standard first aid courses but is sometimes offered in a separate first aid oxygen course. In the first aid setting, oxygen use has been described for loss of consciousness, diving emergencies, carbon monoxide poisoning, and during cardiac arrest. A 2015 CoSTR821,822 followed by a 2022 ScopRev146 identified evidence of potential harm with oxygen use in acute exacerbations of chronic obstructive pulmonary disease (COPD) but used limited search dates and broad exclusion criteria. The current ScopRev expands the search dates and inclusion criteria. Topics recently reviewed were once again excluded, such as the use of supplemental oxygen in acute coronary syndrome,823 suspected stroke,824 drowning,825 and after the return of spontaneous circulation after cardiac arrest.826 The full ScopRev can be found online.827
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults and children who exhibit symptoms or signs of shortness of breath, difficulty breathing, or hypoxia outside of a hospital
•
Intervention: Administration of oxygen by a first aid provider
•
Comparator: No administration of oxygen
•
Outcomes: Functional outcome at discharge, 30 days, 60 days, 180 days, or 1 year; survival only at discharge, 30 days, 60 days, 180 days, or 1 year; length of hospital stay; resolution of symptoms or signs; patient comfort; therapeutic endpoints (eg, oxygenation, ventilation)
•
Study designs: RCTs and non-randomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies), case series, and reports in English were eligible for inclusion. Non–peer-reviewed studies, unpublished studies, conference abstracts, evidence-based guidelines, trial registries, and protocols were eligible for inclusion.
•
Time frame: All dates to July 2023. The literature search was updated on December 1, 2023
Summary of Evidence
The search identified 3305 records, of which 31 underwent full-text review. No articles that directly addressed the PICOST were identified. The articles identified related to 3 main areas: supplemental oxygen for the treatment of carbon monoxide poisoning in the out-of-hospital setting (n=6), supplemental oxygen in the treatment of decompression injuries/illness in divers using compressed gas (n=11), and titrated oxygen in the treatment of people with an acute exacerbation of COPD (n=13). One article was identified that reviewed the supplemental use of oxygen in the out-of-hospital management of spinal cord injury.828
For the use of supplemental oxygen in acute exacerbations of COPD, we identified 2 SysRevs,829,830 1 cluster RCT,831 1 commentary on the same RCT,832 5 observational studies,833–837 1 literature review,838 3 evidence-based guidelines,839–841 and 1 registered with associated published study protocol for an ongoing trial.842,843 In the cluster RCT,831 405 patients with suspected acute exacerbations of COPD in the out-of-hospital setting were treated either with high-flow oxygen (defined as 8–10 L/min by nonrebreathing face mask and nebulized bronchodilators administered with oxygen at 6–8 L/min) or with titrated oxygen delivered by nasal cannula to achieve oxygen saturations between 88% and 92% and nebulized bronchodilators administered with compressed air and delivered with a face mask placed over the nasal cannula. In the intention-to-treat analysis for the subgroup of 214 patients with confirmed COPD, mortality rate was 9% (11/117) in the high-flow arm compared with 2% (2/97) in the titrated oxygen group (RR, 0.22; 95% CI, 0.05–0.91; P=0.04).
The remaining observational studies of oxygen administration for acute exacerbations of COPD in the out-of-hospital setting reported mixed results and were noted to have significant within-study confounders and heterogeneity between the studies.833–837
For the use of supplemental oxygen for carbon monoxide poisoning in the out-of-hospital setting, no clinical studies were identified. One older case series844 reported the prehospital and in-hospital management and clinical course of 206 patients with carbon monoxide poisoning, whereas 4 literature reviews845–848 and 1 guideline849 focused on in-hospital management. All articles commented on the need for immediate treatment with supplemental high-concentration oxygen.
For the use of supplemental oxygen for diving emergencies, 3 case series850–852 described use of oxygen in decompression sickness, with 1 case series852 specifically describing the use of first aid oxygen in 1045 cases in a sequential series of 2231 diving injury reports. The median time for oxygen administration was 2.2 hours after symptom onset and 4 hours after surfacing. First aid oxygen was reported to be associated with persistent complete relief in 14% and improvement of symptoms in 51%. The odds of multiple recompression treatments were reduced when oxygen was given at any time after surfacing (OR, 0.83; 95% CI, 0.70–0.98). The remaining articles identified in the search were literature reviews,853–858 a medical journal summarizing other articles,859 and 1 experimental study860 in healthy divers to compare tissue oxygenation levels while breathing oxygen by using different noninvasive delivery devices and oxygen flow rates.
A summary of all articles identified can be found in supplementary Tables 2 through 4 in Appendix C.
Task Force Insights
This ScopRev did not identify evidence to suggest for or against the first aid administration of oxygen for adults or children with signs or symptoms of difficulty breathing. However, we specifically excluded the use of supplemental oxygen in several settings because these indications have been covered in recent reviews. The studies included are from the out-of-hospital setting, and the evidence is considered indirect to the population of first aid providers trained in oxygen use.
The 1 RCT831 identified that evaluated the use of out-of-hospital titrated versus high-flow oxygen in acute exacerbations of COPD reported a 78% reduction in mortality rate with the use of titrated oxygen in the out-of-hospital setting. In task force discussions, there was concern about the potential for harm if high-flow oxygen was withheld from patients with acute exacerbations of COPD and life-threatening hypoxemia. Task force members emphasized the need for first aid providers trained in oxygen delivery to use pulse oximetry and to recognize that high-flow oxygen may be necessary if oxygen saturations are <88%. An update to the good practice statement on this topic reflects this concern.
There was insufficient evidence identified to pursue SysRevs related to oxygen use in the first aid setting for carbon monoxide poisoning, diving emergencies, general signs and symptoms of shortness of breath or difficulty breathing, or any other specific condition.
Prior Good Practice Statement (2023)
If first aid providers, trained to use oxygen, are administering supplemental oxygen to a person with known COPD, they should titrate the supplemental oxygen to maintain the oxygen saturation by pulse oximetry between 88% and 92% (good practice statement).146
2024 Good Practice Statement
When a first aid provider trained in oxygen use administers oxygen to a person with acute difficulty breathing who confirms that they have chronic obstructive pulmonary disease, it is suggested that pulse oximetry be used and that oxygen be titrated to maintain an oxygen saturation between 88% and 92% (good practice statement).
Although high-flow oxygen should in general be avoided in patients with chronic obstructive pulmonary disease with difficulty breathing in the out-of-hospital setting, high-flow oxygen should not be withheld in the presence of life-threatening hypoxemia (oxygen saturation <88%; good practice statement).
Recognition of Sepsis (ScopRev FA 7180)
Rationale for Review
A significant proportion of preventable deaths worldwide are caused by sepsis, and early detection and treatment is beneficial. No prior review has been undertaken, and in 2022, the task force elected by consensus to undertake a ScopRev on the recognition and awareness of sepsis by first aid providers evaluating adults with an acute illness.861 The full text of this ScopRev can be found online.862
Population, Intervention, Comparator, Outcome, Study Design, and Time Frame
•
Population: Adults who are being evaluated by a first aid provider for an acute illness
•
Intervention: The presence of any specific signs or symptoms (ie, pale, blue, or mottled skin, lips, tongue, gums, or nails; nonblanching rash; difficulty breathing or rapid respiratory rates; rigors/shivering; lack of urination in a day; muscle pain; confusion; or slurred speech)
•
Comparator: Fever (≥38 °C, 100.4 ° F) with signs of infection
•
Outcomes: Recognition of a seriously ill person requiring hospitalization or evaluation by a physician for sepsis and increased awareness of sepsis
•
Study designs: RCTs and non-randomized studies (non-RCTs, interrupted time series, controlled before-and-after studies, cohort studies) were eligible for inclusion. Gray literature, social media posts, non–peer-reviewed studies, unpublished studies, conference abstracts, and trial protocols were eligible for inclusion. All relevant publications in any language were included as long as there was an English abstract.
•
Time frame: From database inception through December 2, 2023
Summary of Evidence
There were insufficient studies to support a SysRev. Studies that were selected for inclusion evaluated physiologic variables that a lay provider could obtain in a first aid setting, such as temperature, heart rate, and respiratory rate, either in isolation or when assessing by using clinical scoring tools. It was noted that online resources that focused on educating the public on sepsis recognition listed presenting signs and symptoms of sepsis under 9 general categories: temperature (fever or hypothermia), neurologic (change in mental state, dizziness, slurred speech), musculoskeletal (severe muscle pain, extreme shivering), urologic (poor urine output), respiratory (rapid breathing or breathlessness), skin (clammy/sweaty, new rash, mottled or discolored), cardiac (elevated heart rate), gastrointestinal (nausea, vomiting, diarrhea), and subjective (feeling very unwell or impending sense of doom). However, there was variability as to which signs or symptoms were highlighted by each campaign or organization.
Task Force Insights
Given the lack of any direct studies, the task force agreed to include studies that were performed in either the prehospital setting by emergency medical service providers or the in-hospital setting, using extrapolated data to suggest relevance to the first aid setting. Despite the use of early warning scoring tools to assist in the detection of sepsis, sepsis recognition by trained clinicians in the health care setting remains challenging. Additionally, the definition of sepsis and the criteria defining sepsis continue to change. Therefore, it was felt by the task force that it was beyond the scope of a first aid provider to recognize and subsequently diagnose an acute illness as sepsis. Because sepsis cannot occur without an infection, a more reasonable expectation of a lay provider is to suspect an infection in a person presenting with an acute illness. Therefore, those providing first aid should consider an infection in any person who presents with an acute illness, and if the illness is associated with any abnormal signs or symptoms, they should urgently seek further medical evaluation.
2024 Good Practice Statement
Those providing first aid should consider an infection in any person who presents with an acute illness, and if the illness is associated with any abnormal signs or symptoms, they should urgently seek further medical evaluation (good practice statement).
Topics Reviewed by Evidence Updates
Topics reviewed by EvUps are summarized in Table 25. Complete EvUps can be found in Appendix B.
Topic/PICO | Year last updated | Existing treatment recommendation | RCTs since last review | Observational studies since last review | Key findings | Sufficient data to warrant SysRev? |
---|---|---|---|---|---|---|
Stroke recognition (FA 7170) | 2020 | We recommend that first aid providers use stroke assessment scales/tools for adults with suspected acute stroke (strong recommendation, low-certainty evidence). For first aid, we suggest the use of FAST, MASS, CPSS or LAPSS scales/tools for stroke assessment (weak recommendation, low-certainty evidence). For first aid, we suggest the use of stroke assessment scales/tools that include blood glucose measurement when available, such as MASS or LAPSS, to increase specificity of stroke recognition (weak recommendation, low-certainty evidence). For first aid, we suggest the use of FAST or CPSS stroke assessment scales/tools when blood glucose measurement is unavailable (weak recommendation, low-certainty evidence). | 0 | 4 | None of the new studies of established stroke scoring systems, or of new stroke scoring systems, offer any improvement in the public recognition of stroke by lay public or first aid provider. | No |
Oxygen in stroke (FA7031) | 2021 | For adults with suspected acute stroke, we suggest against the routine use of supplementary oxygen in the first aid setting compared with no use of supplementary oxygen (weak recommendation, low- to moderate-certainty evidence). | 2 | 1 | One RCT on high-flow oxygen compared with no oxygen found no significant difference in global disability scores. Another RCT found better outcomes with normobaric hyperoxia compared with room air. | Yes |
Dental avulsion (FA 7361) | 2020 | We suggest the use of HBSS, propolis (from 0.04 mg to 2.5 mg per mL 0.4% ethanol), oral rehydration salt solutions including Ricetral (oral rehydration salt solutions containing sodium chloride, glucose, potassium chloride, citrate [or extruded rice]), or cling film compared with any form of cow’s milk for temporary storage of an avulsed tooth that cannot be immediately replanted (weak recommendation, very low–certainty evidence). If none of the above choices are available, we suggest the use of cow’s milk, any percent fat or form, compared with tap water, buttermilk, castor oil, turmeric extract, or saline (sodium chloride) for temporary storage of an avulsed tooth (weak recommendation, very low–certainty evidence). There is insufficient evidence to recommend for or against temporary storage of an avulsed tooth in saliva compared with alternative solutions. There is insufficient evidence to recommend for or against temporary storage of an avulsed tooth in probiotic media, epigallocatechin-3-gallate, Dentosafe box, or egg white compared with cow’s milk. | 1 | 2 | One RCT found that, in general, PDL viability was better at the cooler temperature for all storage media, except HBSS. Milk was the most effective, followed by propolis and HBSS at 5 °C, but at 20 °C, HBSS was the most effective, followed by milk. Results from each of the observational studies suggested that propolis, as well as cow and almond milk, can be alternative storage mediums. | No |
Second dose of epinephrine for anaphylaxis (FA 7111) | 2021 | We suggest a second dose of epinephrine be administered by autoinjector to adults and children with severe anaphylaxis whose symptoms are not relieved by an initial dose (weak recommendation, very low–quality evidence). | 0 | 1 | Observational study identifying that 29% (n=11) needed 2 doses and 5% (n=2) needed 3 doses of epinephrine. | No |
Naloxone for opioid emergencies (FA7442) | 2020 | We suggest that CPR be started without delay in any unconscious person not breathing normally and that naloxone be used by lay rescuers in suspected opioid-related respiratory or circulatory arrest (weak recommendation based on expert consensus). | 0 | 0 | N/A | No |
Exertion-related dehydration and rehydration (FA7241) | 2022 | We recommend the use of any readily available rehydration drink or water for treating exertion-related dehydration in the first aid setting (good practice statement). We suggest rehydration for exertion-related dehydration with a 4% to 9% CED. Alternative rehydration options include 0% to 3.9% CEDs, water, coconut water, or skim or low-fat cow’s milk (weak recommendation, very low–certainty evidence). There is insufficient evidence to recommend for or against rehydration with beer (0%–5% alcohol). | 2 | 0 | One RCT found that the percentage of fluid retained at 3.5 h after ingestion of a sports drink was statistically significantly higher than after ingestion of water. In a second RCT that compared green tea with water, no differences in body fluid balance and cumulative urine output were observed. | No |
Counter-pressure maneuvers for prevention of syncope FA7550 | 2021 | We recommend the use of any type of physical counter-pressure maneuver by individuals with acute symptoms of presyncope due to vasovagal or orthostatic causes in the first aid setting (strong recommendation, low-certainty and very low–certainty evidence). We suggest that lower body physical counter-pressure maneuvers are preferable to upper body and abdominal physical counter-pressure maneuvers (weak recommendation, very low–certainty evidence). | 1 | 0 | 1 unblinded RCT; 0/15 using physical maneuvers had syncope compared with 5/15 in control arm. | No |
Recovery position (FA7040) | 2021 | When providing first aid to a person with a decreased level of responsiveness of nontraumatic pathogenesis and who does not require immediate resuscitative interventions, we suggest the use of the recovery position (weak recommendation, very low–certainty evidence). When the recovery position is used, monitoring should continue for signs of airway occlusion, inadequate or agonal breathing, and unresponsiveness (good practice statement). If body position, including the recovery position, is a factor impairing the first aid provider’s ability to determine the presence or absence of signs of life, the person should be immediately positioned supine and reassessed (good practice statement). People found in positions associated with aspiration and positional asphyxia, such as face down, prone, or in neck and torso flexion positions, should be repositioned supine for reassessment (good practice statement). | 0 | 0 | No |
CED indicates carbohydrate-electrolyte drink; CPR, cardiopulmonary resuscitation; CPSS, Cincinnati Prehospital Stroke Scale; FAST, Face, Arm, Speech, Time to call; HBSS, Hank’s Balanced Salt Solution; LAPSS, Los Angeles Prehospital Stroke Scale; MASS, Melbourne Ambulance Stroke Screen; PDL, periodontal ligament; and RCT, randomized controlled trial.
Article Information
Collaborators
Zehra Al-Hilali; Mohammed Aljanoubi; Abdulkarim A. Almazrua; Luke Andrea; Huba Atiq; Arna Banerjee; Adam Boulton; Maaret Castreen; Nino Fijačko; Alexandra R. Gosling; Anne Juul Grabmayr; Samantha Johnson; Kevin Kai-Wei Lin; Elina Koota; Sol Libesman; Joel Kian-Boon Lim; Kai-Wei Lin; Cheng-Heng Liu; Marco Neymayer; Justine Odakha; Leandra Rech; Josh Reynolds; Sarah Rudd; Eitan Schachna; Amir Shamshiraz; Erwin Snijders; Lucas Snow; James Sotiropoulos; Devita Stallings; Lorrel Toft; Rebecca L. West; Wolfgang Wetsch; James Whiting; Dyan Zhe-Wei Zhang
Acknowledgments
The writing group acknowledges Jack Billi, Eddy Lang, and Veronica Zamora.
Footnote
Abbreviations and Acronyms
- AED
- automated external defibrillation
- ALS
- advanced life support
- BLS
- basic life support
- BMV
- bag-mask ventilation
- BP
- blood pressure
- CAC
- cardiac arrest center
- CERTA
- Continuous EEG Randomized Trial in Adults
- COPD
- chronic obstructive pulmonary disease
- CPR
- cardiopulmonary resuscitation
- DA-CPR
- dispatcher-assisted cardiopulmonary resuscitation
- ECLS
- extracorporeal life support
- ECMO
- extracorporeal membrane oxygenation
- ECPR
- extracorporeal cardiopulmonary resuscitation
- EEG
- electroencephalogram
- EIT
- Education, Implementation, and Teams
- EMS
- emergency medical services
- FA
- first aid
- GRADE
- Grading of Recommendations Assessment, Development, and Evaluation
- ICU
- intensive care unit
- IHCA
- in-hospital cardiac arrest
- ILCOR
- International Liaison Committee on Resuscitation
- IPD
- individual patient data
- IQR
- interquartile range
- MAP
- mean arterial pressure
- NLS
- neonatal life support
- NMA
- network meta-analysis
- NNT
- number needed to treat
- OHCA
- out-of-hospital cardiac arrest
- PEARLS
- Promoting Excellence and Reflective Learning in Simulation
- PICO
- population, intervention, comparator, outcome
- PICOST
- population, intervention, comparator, outcome, study design, and time frame
- PLS
- pediatric life support
- PROSPERO
- Prospective Register of Systematic Reviews
- RCDP
- rapid cycle deliberate practice
- RCT
- randomized controlled trials
- ROC
- return of circulation
- ROSC
- return of spontaneous circulation
- SGA
- supraglottic airway
- STEMI
- ST-segment–elevation myocardial infarction
- TELSTAR
- Treatment of Electroencephalographic Status Epilepticus After Cardiopulmonary Resuscitation
- TI
- tracheal intubation
Supplemental Material
References
1.
International Liaison Committee on Resuscitation. Consensus on science with treatment recommendations (CoSTR). Accessed February 2, 2024. https://costr.ilcor.org/
2.
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, et al. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–394. doi: 10.1016/j.jclinepi.2010.04.026
3.
International Liaison Committee on Resuscitation. ILCOR website. Accessed February 2, 2024. https://www.ilcor.org/home
4.
Olasveengen TM, Mancini ME, Perkins GD, Avis S, Brooks S, Castren M, Chung SP, Considine J, Couper K, Escalante R, et al; Adult Basic Life Support Collaborators. Adult Basic Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2020;142:S41–S91. doi: 10.1161/CIR.0000000000000892
5.
Olasveengen TM, Mancini ME, Perkins GD, Avis S, Brooks S, Castren M, Chung SP, Considine J, Couper K, Escalante R, et al; Adult Basic Life Support Collaborators. International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Resuscitation. 2020;156:A35–A79. doi: 10.1016/j.resuscitation.2020.09.010
6.
Holt J, Ward A, Mohamed TY, Chukowry P, Grolmusova N, Couper K, Morley P, Perkins GD. The optimal surface for delivery of CPR: A systematic review and meta-analysis. Resuscitation. 2020;155:159–164. doi: 10.1016/j.resuscitation.2020.07.020
7.
Dewan M, Schachna E, Perkins G, Eastwood K, Bray J. The optimal surface for delivery of CPR: an updated systematic review and meta-analysis. Resusc Plus. 2024;19:100718. doi: 10.1016/j.resplu.2024.100718
8.
Dewan M, Perkins G, Schachna E, Eastwood K, Smyth M, Olasveengen TM, Bray J, on behalf of the International Liaison Committee on Resuscitation Basic Life Support Task Force. Optimal surface for CPR: an updated systematic review and meta-analysis. Consensus on science with treatment recommendations [Internet]. Brussels, Belgium: International Liaison Committee on Resuscitation (ILCOR) Basic Life Support Task Force, 2024. Accessed June 2024. https://costr.ilcor.org/document/firm-surface-for-cpr-an-updated-systematic-review-bls-2510
9.
Tweed M, Tweed C, Perkins GD. The effect of differing support surfaces on the efficacy of chest compressions using a resuscitation manikin model. Resuscitation. 2001;51:179–183. doi: 10.1016/s0300-9572(01)00404-x
10.
Perkins GD, Benny R, Giles S, Gao F, Tweed MJ. Do different mattresses affect the quality of cardiopulmonary resuscitation? Intensive Care Med. 2003;29:2330–2335. doi: 10.1007/s00134-003-2014-6
11.
Perkins GD, Smith CM, Augre C, Allan M, Rogers H, Stephenson B, Thickett DR. Effects of a backboard, bed height, and operator position on compression depth during simulated resuscitation. Intensive Care Med. 2006;32:1632–1635. doi: 10.1007/s00134-006-0273-8
12.
Andersen LO, Isbye DL, Rasmussen LS. Increasing compression depth during manikin CPR using a simple backboard. Acta Anaesthesiol Scand. 2007;51:747–750. doi: 10.1111/j.1399-6576.2007.01304.x
13.
Jantti H, Silfvast T, Turpeinen A, Kiviniemi V, Uusaro A. Quality of cardiopulmonary resuscitation on manikins: on the floor and in the bed. Acta Anaesthesiol Scand. 2009;53:1131–1137. doi: 10.1111/j.1399-6576.2009.01966.x
14.
Sato H, Komasawa N, Ueki R, Yamamoto N, Fujii A, Nishi S, Kaminoh Y. Backboard insertion in the operating table increases chest compression depth: a manikin study. J Anesth. 2011;25:770–772. doi: 10.1007/s00540-011-1196-2
15.
Oh J, Chee Y, Song Y, Lim T, Kang H, Cho Y. A novel method to decrease mattress compression during CPR using a mattress compression cover and a vacuum pump. Resuscitation. 2013;84:987–991. doi: 10.1016/j.resuscitation.2012.12.027
16.
Fischer EJ, Mayrand K, Ten Eyck RP. Effect of a backboard on compression depth during cardiac arrest in the ED: a simulation study. Am J Emerg Med. 2016;34:274–277. doi: 10.1016/j.ajem.2015.10.035
17.
Putzer G, Fiala A, Braun P, Neururer S, Biechl K, Keilig B, Ploner W, Fop E, Paal P. Manual versus mechanical chest compressions on surfaces of varying softness with or without backboards: a randomized, crossover manikin study. J Emerg Med. 2016;50:594–600.e1. doi: 10.1016/j.jemermed.2015.10.002
18.
Sanri E, Karacabey S. The impact of backboard placement on chest compression quality: a mannequin study. Prehosp Disaster Med. 2019;34:182–187. doi: 10.1017/S1049023X19000153
19.
Ahn HJ, Cho Y, You YH, Min JH, Jeong WJ, Ryu S, Lee JW, Cho SU, Oh SK, Park JS, et al. Effect of using a home-bed mattress on bystander chest compression during out-of-hospital cardiac arrest. Hong Kong J Emerg Med. 2021;28:37–42. doi: 10.1177/1024907919856485
20.
Picard C, Drew R, Norris CM, O’Dochartaigh D, Burnett C, Keddie C, Douma MJ. Cardiac arrest quality improvement: a single-center evaluation of resuscitations using defibrillator, feedback device, and survey data. J Emerg Nurs. 2022;48:224–232.e8. doi: 10.1016/j.jen.2021.11.005
21.
Hasegawa T, Okane R, Ichikawa Y, Inukai S, Saito S. Effect of chest compression with kneeling on the bed in clinical situations. Jpn J Nurs Sci. 2020;17:e12314. doi: 10.1111/jjns.12314
22.
Kingston T, Tiller NB, Partington E, Ahmed M, Jones G, Johnson MI, Callender NA. Sports safety matting diminishes cardiopulmonary resuscitation quality and increases rescuer perceived exertion. PLoS One. 2021;16:e0254800. doi: 10.1371/journal.pone.0254800
23.
Shimizu Y, Sadamori T, Saeki N, Mukai A, Doi M, Oue K, Yoshida M, Irifune M. Efficacy of chest compressions performed on patients in dental chairs versus on the floor. Anesth Prog. 2021;68:85–89. doi: 10.2344/anpr-68-01-07
24.
Cuvelier Z, Houthoofdt R, Serraes B, Haentjens C, Blot S, Mpotos N. Effect of a backboard on chest compression quality during in-hospital adult cardiopulmonary resuscitation: A randomised, single-blind, controlled trial using a manikin model. Intensive Crit Care Nurs. 2022;69:103164. doi: 10.1016/j.iccn.2021.103164
25.
Torsy T, Deswarte W, Karlberg Traav M, Beeckman D. Effect of a dynamic mattress on chest compression quality during cardiopulmonary resuscitation. Nurs Crit Care. 2022;27:275–281. doi: 10.1111/nicc.12631
26.
Missel AL, Donnelly JP, Tsutsui J, Wilson N, Friedman C, Rooney DM, Neumar RW, Cooke JM. Effectiveness of lay bystander hands-only cardiopulmonary resuscitation on a mattress versus the floor: a randomized cross-over trial. Ann Emerg Med. 2023;81:691–698. doi: 10.1016/j.annemergmed.2023.01.012
27.
Lin Y, Wan B, Belanger C, Hecker K, Gilfoyle E, Davidson J, Cheng A. Reducing the impact of intensive care unit mattress compressibility during CPR: a simulation-based study. Adv Simul (Lond). 2017;2:22. doi: 10.1186/s41077-017-0057-y
28.
Noordergraaf GJ, Paulussen IW, Venema A, van Berkom PF, Woerlee PH, Scheffer GJ, Noordergraaf A. The impact of compliant surfaces on in-hospital chest compressions: effects of common mattresses and a backboard. Resuscitation. 2009;80:546–552. doi: 10.1016/j.resuscitation.2009.03.023
29.
Song Y, Oh J, Lim T, Chee Y. A new method to increase the quality of cardiopulmonary resuscitation in hospital. Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:469–472. doi: 10.1109/EMBC.2013.6609538
30.
Beesems SG, Koster RW. Accurate feedback of chest compression depth on a manikin on a soft surface with correction for total body displacement. Resuscitation. 2014;85:1439–1443. doi: 10.1016/j.resuscitation.2014.08.005
31.
Nishisaki A, Maltese MR, Niles DE, Sutton RM, Urbano J, Berg RA, Nadkarni VM. Backboards are important when chest compressions are provided on a soft mattress. Resuscitation. 2012;83:1013–1020. doi: 10.1016/j.resuscitation.2012.01.016
32.
Lee S, Oh J, Kang H, Lim T, Kim W, Chee Y, Song Y, Ahn C, Cho JH. Proper target depth of an accelerometer-based feedback device during CPR performed on a hospital bed: a randomized simulation study. Am J Emerg Med. 2015;33:1425–1429. doi: 10.1016/j.ajem.2015.07.010
33.
Ruiz de Gauna S, Gonzalez-Otero DM, Ruiz J, Gutierrez JJ, Russell JK. A feasibility study for measuring accurate chest compression depth and rate on soft surfaces using two accelerometers and spectral analysis. Biomed Res Int. 2016;2016:6596040. doi: 10.1155/2016/6596040
34.
Hellevuo H, Sainio M, Huhtala H, Olkkola KT, Tenhunen J, Hoppu S. The quality of manual chest compressions during transport--effect of the mattress assessed by dual accelerometers. Acta Anaesthesiol Scand. 2014;58:323–328. doi: 10.1111/aas.12245
35.
Oh J, Song Y, Kang B, Kang H, Lim T, Suh Y, Chee Y. The use of dual accelerometers improves measurement of chest compression depth. Resuscitation. 2012;83:500–504. doi: 10.1016/j.resuscitation.2011.09.028
36.
Cheng A, Belanger C, Wan B, Davidson J, Lin Y. Effect of emergency department mattress compressibility on chest compression depth using a standardized cardiopulmonary resuscitation board, a slider transfer board, and a flat spine board: a simulation-based study. Simul Healthc. 2017;12:364–369. doi: 10.1097/SIH.0000000000000245
37.
Cloete G, Dellimore KH, Scheffer C. Comparison of experimental chest compression data to a theoretical model for the mechanics of constant peak displacement cardiopulmonary resuscitation. Acad Emerg Med. 2011;18:1167–1176. doi: 10.1111/j.1553-2712.2011.01213.x
38.
Cloete G, Dellimore KH, Scheffer C, Smuts MS, Wallis LA. The impact of backboard size and orientation on sternum-to-spine compression depth and compression stiffness in a manikin study of CPR using two mattress types. Resuscitation. 2011;82:1064–1070. doi: 10.1016/j.resuscitation.2011.04.003
39.
Perkins GD, Kocierz L, Smith SC, McCulloch RA, Davies RP. Compression feedback devices over estimate chest compression depth when performed on a bed. Resuscitation. 2009;80:79–82. doi: 10.1016/j.resuscitation.2008.08.011
40.
Grabmayr AJ, Dicker B, Dassanayake V, Bray J, Vaillancourt C, Dainty KN, Malta Hansen C; on behalf of the International Liaison Committee on Resuscitation Basic Life Support Task Force. Optimizing telecommunicator recognition of out-of-hospital cardiac arrest: a scoping review. Resusc Plus. 2024;20:100754. doi: 10.1016/j.resplu.2024.100754
41.
Malta Hansen C, Juul Grabmayr A, Dicker B, Dassanayake V, Vaillancourt C, Dainty K, Olasveengen T, Bray J; on behalf of the International Liaison Committee on Resuscitation Basic Life Support Task Force. Optimization of dispatcher-assisted recognition of out-of-hospital cardiac arrest: a BLS Task Force synthesis of a scoping review. Consensus on science with treatment recommendations [Internet]. Brussels, Belgium: International Liaison Committee on Resuscitation (ILCOR) Basic Life Support Task Force, January 8, 2024. Accessed June 2024. https://costr.ilcor.org/document/optimization-of-dispatcher-assisted-da-recognition-of-ohca-a-scoping-review-bls-2102-scr
42.
Alfsen D, Moller TP, Egerod I, Lippert FK. Barriers to recognition of out-of-hospital cardiac arrest during emergency medical calls: a qualitative inductive thematic analysis. Scand J Trauma Resusc Emerg Med. 2015;23:70. doi: 10.1186/s13049-015-0149-4
43.
Chien CY, Chien WC, Tsai LH, Tsai SL, Chen CB, Seak CJ, Chou YS, Ma M, Weng YM, Ng CJ, et al. Impact of the caller’s emotional state and cooperation on out-of-hospital cardiac arrest recognition and dispatcher-assisted cardiopulmonary resuscitation. Emerg Med J. 2019;36:595–600. doi: 10.1136/emermed-2018-208353
44.
Missel AL, Dowker SR, Chiola M, Platt J, Tsutsui J, Kasten K, Swor R, Neumar RW, Hunt N, Herbert L, et al. Barriers to the initiation of telecommunicator-CPR during 9-1-1 out-of-hospital cardiac arrest calls: a qualitative study. Prehosp Emerg Care. 2023;28:118–125. doi: 10.1080/10903127.2023.2183533
45.
Richards CT, McCarthy DM, Markul E, Rottman DR, Lindeman P, Prabhakaran S, Klabjan D, Holl JL, Cameron KA. A mixed methods analysis of caller-emergency medical dispatcher communication during 9-1-1 calls for out-of-hospital cardiac arrest. Patient Educ Couns. 2022;105:2130–2136. doi: 10.1016/j.pec.2022.03.004
46.
Garza AG, Gratton MC, Chen JJ, Carlson B. The accuracy of predicting cardiac arrest by emergency medical services dispatchers: the calling party effect. Acad Emerg Med. 2003;10:955–960. doi: 10.1111/j.1553-2712.2003.tb00651.x
47.
Bang A, Herlitz J, Holmberg S. Possibilities of implementing dispatcher-assisted cardiopulmonary resuscitation in the community. An evaluation of 99 consecutive out-of-hospital cardiac arrests. Resuscitation. 2000;44:19–26. doi: 10.1016/s0300-9572(99)00163-x
48.
Bang A, Ortgren PO, Herlitz J, Wahrborg P. Dispatcher-assisted telephone CPR: a qualitative study exploring how dispatchers perceive their experiences. Resuscitation. 2002;53:135–151. doi: 10.1016/s0300-9572(01)00508-1
49.
Castren M, Kuisma M, Serlachius J, Skrifvars M. Do health care professionals report sudden cardiac arrest better than laymen? Resuscitation. 2001;51:265–268. doi: 10.1016/s0300-9572(01)00422-1
50.
Bradley SM, Fahrenbruch CE, Meischke H, Allen J, Bloomingdale M, Rea TD. Bystander CPR in out-of-hospital cardiac arrest: the role of limited English proficiency. Resuscitation. 2011;82:680–684. doi: 10.1016/j.resuscitation.2011.02.006
51.
Perera N, Birnie T, Ngo H, Ball S, Whiteside A, Bray J, Bailey P, Finn J. “I’m sorry, my English not very good”: Tracking differences between language-barrier and non-language-barrier emergency ambulance calls for out-of-hospital cardiac arrest. Resuscitation. 2021;169:105–112. doi: 10.1016/j.resuscitation.2021.10.035
52.
Riou M, Ball S, Williams TA, Whiteside A, Cameron P, Fatovich DM, Perkins GD, Smith K, Bray J, Inoue M, et al. ‘She’s sort of breathing’: What linguistic factors determine call-taker recognition of agonal breathing in emergency calls for cardiac arrest? Resuscitation. 2018;122:92–98. doi: 10.1016/j.resuscitation.2017.11.058
53.
Stangenes SR, Painter IS, Rea TD, Meischke H. Delays in recognition of the need for telephone-assisted CPR due to caller descriptions of chief complaint. Resuscitation. 2020;149:82–86. doi: 10.1016/j.resuscitation.2020.02.013
54.
Tamminen J, Lyden E, Kurki J, Huhtala H, Kamarainen A, Hoppu S. Spontaneous trigger words associated with confirmed out-of-hospital cardiac arrest: a descriptive pilot study of emergency calls. Scand J Trauma Resusc Emerg Med. 2020;28:1. doi: 10.1186/s13049-019-0696-1
55.
Riou M, Ball S, Morgan A, Gallant S, Perera N, Whiteside A, Bray J, Bailey P, Finn J. ‘I think he’s dead’: A cohort study of the impact of caller declarations of death during the emergency call on bystander CPR. Resuscitation. 2021;160:1–6. doi: 10.1016/j.resuscitation.2021.01.001
56.
Linderoth G, Hallas P, Lippert FK, Wibrandt I, Loumann S, Moller TP, Ostergaard D. Challenges in out-of-hospital cardiac arrest - A study combining closed-circuit television (CCTV) and medical emergency calls. Resuscitation. 2015;96:317–322. doi: 10.1016/j.resuscitation.2015.06.003
57.
Linderoth G, Moller TP, Folke F, Lippert FK, Ostergaard D. Medical dispatchers’ perception of visual information in real out-of-hospital cardiac arrest: a qualitative interview study. Scand J Trauma Resusc Emerg Med. 2019;27:8. doi: 10.1186/s13049-018-0584-0
58.
Blomberg SN, Folke F, Ersboll AK, Christensen HC, Torp-Pedersen C, Sayre MR, Counts CR, Lippert FK. Machine learning as a supportive tool to recognize cardiac arrest in emergency calls. Resuscitation. 2019;138:322–329. doi: 10.1016/j.resuscitation.2019.01.015
59.
Byrsell F, Claesson A, Ringh M, Svensson L, Jonsson M, Nordberg P, Forsberg S, Hollenberg J, Nord A. Machine learning can support dispatchers to better and faster recognize out-of-hospital cardiac arrest during emergency calls: A retrospective study. Resuscitation. 2021;162:218–226. doi: 10.1016/j.resuscitation.2021.02.041
60.
Blomberg SN, Christensen HC, Lippert F, Ersboll AK, Torp-Petersen C, Sayre MR, Kudenchuk PJ, Folke F. Effect of machine learning on dispatcher recognition of out-of-hospital cardiac arrest during calls to emergency medical services: a randomized clinical trial. JAMA Netw Open. 2021;4:e2032320. doi: 10.1001/jamanetworkopen.2020.32320
61.
Nikolaj Blomberg S, Jensen TW, Porsborg Andersen M, Folke F, Kjaer Ersboll A, Torp-Petersen C, Lippert F, Collatz Christensen H. When the machine is wrong. Characteristics of true and false predictions of out-of-hospital cardiac arrests in emergency calls using a machine-learning model. Resuscitation. 2023;183:109689. doi: 10.1016/j.resuscitation.2023.109689
62.
Rafi S, Gangloff C, Paulhet E, Grimault O, Soulat L, Bouzille G, Cuggia M. Out-of-hospital cardiac arrest detection by machine learning based on the phonetic characteristics of the caller’s voice. Stud Health Technol Inform. 2022;294:445–449. doi: 10.3233/SHTI220498
63.
Chan J, Rea T, Gollakota S, Sunshine JE. Contactless cardiac arrest detection using smart devices. NPJ Digit Med. 2019;2:52. doi: 10.1038/s41746-019-0128-7
64.
Dami F, Rossetti AO, Fuchs V, Yersin B, Hugli O. Proportion of out-of-hospital adult non-traumatic cardiac or respiratory arrest among calls for seizure. Emerg Med J. 2012;29:758–760. doi: 10.1136/emermed-2011-200234
65.
Besnier E, Damm C, Jardel B, Veber B, Compere V, Dureuil B. Dispatcher-assisted cardiopulmonary resuscitation protocol improves diagnosis and resuscitation recommendations for out-of-hospital cardiac arrest. Emerg Med Australas. 2015;27:590–596. doi: 10.1111/1742-6723.12493
66.
Deakin CD, England S, Diffey D, Maconochie I. Can ambulance telephone triage using NHS pathways accurately identify paediatric cardiac arrest? Resuscitation. 2017;116:109–112. doi: 10.1016/j.resuscitation.2017.03.013
67.
Derkenne C, Jost D, Thabouillot O, Briche F, Travers S, Frattini B, Lesaffre X, Kedzierewicz R, Roquet F, de Charry F, et al; Paris Fire Brigade Cardiac Arrest Task Force. Improving emergency call detection of out-of-hospital cardiac arrests in the greater Paris area: efficiency of a global system with a new method of detection. Resuscitation. 2020;146:34–42. doi: 10.1016/j.resuscitation.2019.10.038
68.
Fukushima H, Imanishi M, Iwami T, Kitaoka H, Asai H, Seki T, Kawai Y, Norimoto K, Urisono Y, Nishio K, et al. Implementation of a dispatch-instruction protocol for cardiopulmonary resuscitation according to various abnormal breathing patterns: a population-based study. Scand J Trauma Resusc Emerg Med. 2015;23:64. doi: 10.1186/s13049-015-0145-8
69.
Gram KH, Praest M, Laulund O, Mikkelsen S. Assessment of a quality improvement programme to improve telephone dispatchers’ accuracy in identifying out-of-hospital cardiac arrest. Resusc Plus. 2021;6:100096. doi: 10.1016/j.resplu.2021.100096
70.
Hardeland C, Olasveengen TM, Lawrence R, Garrison D, Lorem T, Farstad G, Wik L. Comparison of medical priority dispatch (MPD) and criteria based dispatch (CBD) relating to cardiac arrest calls. Resuscitation. 2014;85:612–616. doi: 10.1016/j.resuscitation.2014.01.029
71.
Hardeland C, Sunde K, Ramsdal H, Hebbert SR, Soilammi L, Westmark F, Nordum F, Hansen AE, Steen-Hansen JE, Olasveengen TM. Factors impacting upon timely and adequate allocation of prehospital medical assistance and resources to cardiac arrest patients. Resuscitation. 2016;109:56–63. doi: 10.1016/j.resuscitation.2016.09.027
72.
Heward A, Damiani M, Hartley-Sharpe C. Does the use of the advanced medical priority dispatch system affect cardiac arrest detection? Emerg Med J. 2004;21:115–118. doi: 10.1136/emj.2003.006940
73.
Huang CH, Fan HJ, Chien CY, Seak CJ, Kuo CW, Ng CJ, Li WC, Weng YM. Validation of a dispatch protocol with continuous quality control for cardiac arrest: a before-and-after study at a city fire department-based dispatch center. J Emerg Med. 2017;53:697–707. doi: 10.1016/j.jemermed.2017.06.028
74.
Kuisma M, Boyd J, Vayrynen T, Repo J, Nousila-Wiik M, Holmstrom P. Emergency call processing and survival from out-of-hospital ventricular fibrillation. Resuscitation. 2005;67:89–93. doi: 10.1016/j.resuscitation.2005.04.008
75.
Mao DR, Ee AZQ, Leong PWK, Leong BS, Arulanandam S, Ng M, Ng YY, Siddiqui FJ, Ong MEH. Is your unconscious patient in cardiac arrest? A new protocol for telephonic diagnosis by emergency medical call-takers: a national study. Resuscitation. 2020;155:199–206. doi: 10.1016/j.resuscitation.2020.08.009
76.
Michiels C, Clinckaert C, Wauters L, Dewolf P. Phone CPR and barriers affecting life-saving seconds. Acta Clin Belg. 2021;76:427–432. doi: 10.1080/17843286.2020.1752454
77.
Moller TP, Andrell C, Viereck S, Todorova L, Friberg H, Lippert FK. Recognition of out-of-hospital cardiac arrest by medical dispatchers in emergency medical dispatch centres in two countries. Resuscitation. 2016;109:1–8. doi: 10.1016/j.resuscitation.2016.09.012
78.
Nurmi J, Pettila V, Biber B, Kuisma M, Komulainen R, Castren M. Effect of protocol compliance to cardiac arrest identification by emergency medical dispatchers. Resuscitation. 2006;70:463–469. doi: 10.1016/j.resuscitation.2006.01.016
79.
Orpet R, Riesenberg R, Shin J, Subido C, Markul E, Rea T. Increasing bystander CPR: potential of a one question telecommunicator identification algorithm. Scand J Trauma Resusc Emerg Med. 2015;23:39. doi: 10.1186/s13049-015-0115-1
80.
Plodr M, Truhlar A, Krencikova J, Praunova M, Svaba V, Masek J, Bejrova D, Paral J. Effect of introduction of a standardized protocol in dispatcher-assisted cardiopulmonary resuscitation. Resuscitation. 2016;106:18–23. doi: 10.1016/j.resuscitation.2016.05.031
81.
Sanko S, Kashani S, Lane C, Eckstein M. Implementation of the Los Angeles tiered dispatch system is associated with an increase in telecommunicator-assisted CPR. Resuscitation. 2020;155:74–81. doi: 10.1016/j.resuscitation.2020.06.039
82.
Sanko S, Feng S, Lane C, Eckstein M. Comparison of emergency medical dispatch systems for performance of telecommunicator-assisted cardiopulmonary resuscitation among 9-1-1 callers with limited english proficiency. JAMA Netw Open. 2021;4:e216827. doi: 10.1001/jamanetworkopen.2021.6827
83.
Stipulante S, Tubes R, El Fassi M, Donneau AF, Van Troyen B, Hartstein G, D’Orio V, Ghuysen A. Implementation of the ALERT algorithm, a new dispatcher-assisted telephone cardiopulmonary resuscitation protocol, in non-advanced medical priority dispatch system (AMPDS) emergency medical services centres. Resuscitation. 2014;85:177–181. doi: 10.1016/j.resuscitation.2013.10.005
84.
Travers S, Jost D, Gillard Y, Lanoe V, Bignand M, Domanski L, Tourtier JP; Paris Fire Brigade Cardiac Arrest Work Group. Out-of-hospital cardiac arrest phone detection: those who most need chest compressions are the most difficult to recognize. Resuscitation. 2014;85:1720–1725. doi: 10.1016/j.resuscitation.2014.09.020
85.
Vaillancourt C, Charette M, Kasaboski A, Hoad M, Larocque V, Crete D, Logan S, Lamoureux P, McBride J, Cheskes S, et al. Cardiac arrest diagnostic accuracy of 9-1-1 dispatchers: a prospective multi-center study. Resuscitation. 2015;90:116–120. doi: 10.1016/j.resuscitation.2015.02.027
86.
Vaillancourt C, Verma A, Trickett J, Crete D, Beaudoin T, Nesbitt L, Wells GA, Stiell IG. Evaluating the effectiveness of dispatch-assisted cardiopulmonary resuscitation instructions. Acad Emerg Med. 2007;14:877–883. doi: 10.1197/j.aem.2007.06.021
87.
Viereck S, Moller TP, Ersboll AK, Baekgaard JS, Claesson A, Hollenberg J, Folke F, Lippert FK. Recognising out-of-hospital cardiac arrest during emergency calls increases bystander cardiopulmonary resuscitation and survival. Resuscitation. 2017;115:141–147. doi: 10.1016/j.resuscitation.2017.04.006
88.
Watkins CL, Jones SP, Hurley MA, Benedetto V, Price CI, Sutton CJ, Quinn T, Bangee M, Chesworth B, Miller C, et al. Predictors of recognition of out of hospital cardiac arrest by emergency medical services call handlers in England: a mixed methods diagnostic accuracy study. Scand J Trauma Resusc Emerg Med. 2021;29:7. doi: 10.1186/s13049-020-00823-9
89.
Roppolo LP, Westfall A, Pepe PE, Nobel LL, Cowan J, Kay JJ, Idris AH. Dispatcher assessments for agonal breathing improve detection of cardiac arrest. Resuscitation. 2009;80:769–772. doi: 10.1016/j.resuscitation.2009.04.013
90.
Berdowski J, Beekhuis F, Zwinderman AH, Tijssen JG, Koster RW. Importance of the first link: description and recognition of an out-of-hospital cardiac arrest in an emergency call. Circulation. 2009;119:2096–2102. doi: 10.1161/CIRCULATIONAHA.108.768325
91.
Bang A, Herlitz J, Martinell S. Interaction between emergency medical dispatcher and caller in suspected out-of-hospital cardiac arrest calls with focus on agonal breathing. A review of 100 tape recordings of true cardiac arrest cases. Resuscitation. 2003;56:25–34. doi: 10.1016/s0300-9572(02)00278-2
92.
Fukushima H, Panczyk M, Hu C, Dameff C, Chikani V, Vadeboncoeur T, Spaite DW, Bobrow BJ. Description of abnormal breathing is associated with improved outcomes and delayed telephone cardiopulmonary resuscitation instructions. J Am Heart Assoc. 2017;6:e005058. doi: 10.1161/JAHA.116.005058
93.
Bohm K, Rosenqvist M, Hollenberg J, Biber B, Engerstrom L, Svensson L. Dispatcher-assisted telephone-guided cardiopulmonary resuscitation: an underused lifesaving system. Eur J Emerg Med. 2007;14:256–259. doi: 10.1097/MEJ.0b013e32823a3cd1
94.
Dami F, Heymann E, Pasquier M, Fuchs V, Carron PN, Hugli O. Time to identify cardiac arrest and provide dispatch-assisted cardio-pulmonary resuscitation in a criteria-based dispatch system. Resuscitation. 2015;97:27–33. doi: 10.1016/j.resuscitation.2015.09.390
95.
Crabb DB, Elmelige YO, Gibson ZC, Ralston DC, Harrell C, Cohen SA, Fitzpatrick DE, Becker TK. Unrecognized cardiac arrests: a one-year review of audio from emergency medical dispatch calls. Am J Emerg Med. 2022;54:127–130. doi: 10.1016/j.ajem.2022.01.068
96.
Fukushima H, Imanishi M, Iwami T, Seki T, Kawai Y, Norimoto K, Urisono Y, Hata M, Nishio K, Saeki K, et al. Abnormal breathing of sudden cardiac arrest victims described by laypersons and its association with emergency medical service dispatcher-assisted cardiopulmonary resuscitation instruction. Emerg Med J. 2015;32:314–317. doi: 10.1136/emermed-2013-203112
97.
Lewis M, Stubbs BA, Eisenberg MS. Dispatcher-assisted cardiopulmonary resuscitation: time to identify cardiac arrest and deliver chest compression instructions. Circulation. 2013;128:1522–1530. doi: 10.1161/CIRCULATIONAHA.113.002627
98.
Schwarzkoph M, Yin L, Hergert L, Drucker C, Counts CR, Eisenberg M. Seizure-like presentation in OHCA creates barriers to dispatch recognition of cardiac arrest. Resuscitation. 2020;156:230–236. doi: 10.1016/j.resuscitation.2020.06.036
99.
Eisenberg MS, Carter W, Hallstrom A, Cummins R, Litwin P, Hearne T. Identification of cardiac arrest by emergency dispatchers. Am J Emerg Med. 1986;4:299–301. doi: 10.1016/0735-6757(86)90297-4
100.
Kim TH, Jung JH, Song KJ, Hong KJ, Jeong J, Lee SGW. Association between patient age and pediatric cardiac arrest recognition by emergency medical dispatchers. Am J Emerg Med. 2022;58:275–280. doi: 10.1016/j.ajem.2022.05.038
101.
Tzeng CF, Lu CH, Lin CH. Community socioeconomic status and dispatcher-assisted cardiopulmonary resuscitation for patients with out-of-hospital cardiac arrest. Int J Environ Res Public Health. 2021;18:1207. doi: 10.3390/ijerph18031207
102.
Govindarajan P, Lin L, Landman A, McMullan JT, McNally BF, Crouch AJ, Sasson C. Practice variability among the EMS systems participating in cardiac arrest registry to enhance survival (CARES). Resuscitation. 2012;83:76–80. doi: 10.1016/j.resuscitation.2011.06.026
103.
Lee SCL, Mao DR, Ng YY, Leong BS, Supasaovapak J, Gaerlan FJ, Son DN, Chia BY, Do Shin S, Lin CH, et al; PAROS Clinical Research Network. Emergency medical dispatch services across Pan-Asian countries: a web-based survey. BMC Emerg Med. 2020;20:1. doi: 10.1186/s12873-019-0299-1
104.
Tjelmeland IBM, Masterson S, Herlitz J, Wnent J, Bossaert L, Rosell-Ortiz F, Alm-Kruse K, Bein B, Lilja G, Grasner JT; GL2020 Epidemiology group and participating countries. Description of emergency medical services, treatment of cardiac arrest patients and cardiac arrest registries in Europe. Scand J Trauma Resusc Emerg Med. 2020;28:103. doi: 10.1186/s13049-020-00798-7
105.
Beck B, Bray JE, Smith K, Walker T, Grantham H, Hein C, Thorrowgood M, Smith A, Inoue M, Smith T, et al; Aus-ROC Steering Committee. Description of the ambulance services participating in the Aus-ROC Australian and New Zealand out-of-hospital cardiac arrest epistry. Emerg Med Australas. 2016;28:673–683. doi: 10.1111/1742-6723.12690
106.
Dainty KN, Debaty G, Waddick J, Vaillancourt C, Malta Hansen C, Olasveengen T, Bray J; on behalf of the International Liaison Committee on Resuscitation Basic Life Support Task Force. Interventions to optimize dispatcher-assisted CPR instructions: a scoping review. Resusc Plus. 2024;19:100715. doi: 10.1016/j.resplu.2024.100715
107.
Olasveengen TM, de Caen AR, Mancini ME, Maconochie IK, Aickin R, Atkins DL, Berg RA, Bingham RM, Brooks SC, Castren M, et al; ILCOR Collaborators. 2017 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations summary. Resuscitation. 2017;121:201–214. doi: 10.1016/j.resuscitation.2017.10.021
108.
Olasveengen TM, de Caen AR, Mancini ME, Maconochie IK, Aickin R, Atkins DL, Berg RA, Bingham RM, Brooks SC, Castren M, et al; ILCOR Collaborators. 2017 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations summary. Circulation. 2017;136:e424–e440. doi: 10.1161/CIR.0000000000000541
109.
Dainty KN, Debaty G, Vaillancourt C, Smyth M, Olasveengen T, Bray J; on behalf of the International Liaison Committee on Resuscitation Basic Life Support Task Force. Interventions used with dispatcher-assisted CPR: a scoping review. [Internet] Brussels, Belgium: International Liaison Committee on Resuscitation (ILCOR) Basic Life Support Task Force, January 8, 2024. Accessed June 2024. https://costr.ilcor.org/document/optimization-of-dispatcher-assisted-cpr-instructions-a-scoping-review-bls-2113-scr
110.
Ong MEH, Shin SD, Ko PC-I, Lin X, Ma MH-M, Ryoo HW, Wong KD, Supasaowapak J, Lin C-H, Kuo C-W, et al. International multi-center real world implementation trial to increase out-of-hospital cardiac arrest survival with a dispatcher-assisted cardio-pulmonary resuscitation package (Pan-Asian resuscitation outcomes study phase 2). Resuscitation. 2022;171:80–89. doi: 10.1016/j.resuscitation.2021.12.032
111.
Lee DH, Kim CW, Kim SE. The effect of the different methods indicating 100/min to 120/min using the metronome in dispatcher-assisted resuscitation. Am J Emerg Med. 2014;32:1282–1283. doi: 10.1016/j.ajem.2014.07.009
112.
Park SO, Hong CK, Shin DH, Lee JH, Hwang SY. Efficacy of metronome sound guidance via a phone speaker during dispatcher-assisted compression-only cardiopulmonary resuscitation by an untrained layperson: a randomised controlled simulation study using a manikin. Emerg Med J. 2013;30:657–661. doi: 10.1136/emermed-2012-201612
113.
Choa M, Park I, Chung HS, Yoo SK, Shim H, Kim S. The effectiveness of cardiopulmonary resuscitation instruction: animation versus dispatcher through a cellular phone. Resuscitation. 2008;77:87–94. doi: 10.1016/j.resuscitation.2007.10.023
114.
Birkun A, Glotov M, Ndjamen HF, Alaiye E, Adeleke T, Samarin S. Pre-recorded instructional audio vs. dispatchers’ conversational assistance in telephone cardiopulmonary resuscitation: a randomized controlled simulation study. World J Emerg Med. 2018;9:165–171. doi: 10.5847/wjem.j.1920-8642.2018.03.001
115.
Rasmussen SE, Nebsbjerg MA, Krogh LQ, Bjørnshave K, Krogh K, Povlsen JA, Riddervold IS, Grøfte T, Kirkegaard H, Løfgren B. A novel protocol for dispatcher assisted CPR improves CPR quality and motivation among rescuers—a randomized controlled simulation study. Resuscitation. 2017;110:74–80. doi: 10.1016/j.resuscitation.2016.09.009
116.
Brown TB, Saini D, Pepper T, Mirza M, Nandigam HK, Kaza N, Cofield SS. Instructions to “put the phone down” do not improve the quality of bystander initiated dispatcher-assisted cardiopulmonary resuscitation. Resuscitation. 2008;76:249–255. doi: 10.1016/j.resuscitation.2007.07.026
117.
Rodriguez SA, Sutton RM, Berg MD, Nishisaki A, Maltese M, Meaney PA, Niles DE, Leffelman J, Berg RA, Nadkarni VM. Simplified dispatcher instructions improve bystander chest compression quality during simulated pediatric resuscitation. Resuscitation. 2014;85:119–123. doi: 10.1016/j.resuscitation.2013.09.003
118.
Trethewey SP, Vyas H, Evans S, Hall M, Melody T, Perkins GD, Couper K. The impact of resuscitation guideline terminology on quality of dispatcher-assisted cardiopulmonary resuscitation: a randomised controlled manikin study. Resuscitation. 2019;142:91–96. doi: 10.1016/j.resuscitation.2019.07.016
119.
Eisenberg Chavez D, Meischke H, Painter I, Rea TD. Should dispatchers instruct lay bystanders to undress patients before performing CPR? A randomized simulation study. Resuscitation. 2013;84:979–981. doi: 10.1016/j.resuscitation.2012.12.010
120.
Bolle SR, Scholl J, Gilbert M. Can video mobile phones improve CPR quality when used for dispatcher assistance during simulated cardiac arrest? Acta Anaesthesiol Scand. 2009;53:116–120. doi: 10.1111/j.1399-6576.2008.01779.x
121.
Lee JS, Jeon WC, Ahn JH, Cho YJ, Jung YS, Kim GW. The effect of a cellular-phone video demonstration to improve the quality of dispatcher-assisted chest compression-only cardiopulmonary resuscitation as compared with audio coaching. Resuscitation. 2011;82:64–68. doi: 10.1016/j.resuscitation.2010.09.467
122.
Lee HS, You K, Jeon JP, Kim C, Kim S. The effect of video-instructed versus audio-instructed dispatcher-assisted cardiopulmonary resuscitation on patient outcomes following out of hospital cardiac arrest in Seoul. Sci Rep. 2021;11:15555–15555. doi: 10.1038/s41598-021-95077-5
123.
Yang C-W, Wang H-C, Chiang W-C, Hsu C-W, Chang W-T, Yen Z-S, Ko PC-I, Ma MH-M, Chen S-C, Chang S-C. Interactive video instruction improves the quality of dispatcher-assisted chest compression-only cardiopulmonary resuscitation in simulated cardiac arrests. Crit Care Med. 2009;37:490–495. doi: 10.1097/CCM.0b013e31819573a5
124.
Peters M, Stipulante S, Cloes V, Mulder A, Lebrun F, Donneau A-F, Ghuysen A. Can video assistance improve the quality of pediatric dispatcher-assisted cardiopulmonary resuscitation? Pediatr Emerg Care. 2022;38:e451–e457. doi: 10.1097/PEC.0000000000002392
125.
Hwang BN, Lee EH, Park HA, Park JO, Lee CA. Effects of positive dispatcher encouragement on the maintenance of bystander cardiopulmonary resuscitation quality. Medicine (Baltimore). 2020;99:e22728. doi: 10.1097/MD.0000000000022728
126.
Mirza M, Brown TB, Saini D, Pepper TL, Nandigam HK, Kaza N, Cofield SS. Instructions to “push as hard as you can” improve average chest compression depth in dispatcher-assisted cardiopulmonary resuscitation. Resuscitation. 2008;79:97–102. doi: 10.1016/j.resuscitation.2008.05.012
127.
Harjanto S, Na MXB, Hao Y, Ng YY, Doctor N, Goh ES, Leong BS-H, Gan HN, Chia MYC, Tham LP, et al. A before–after interventional trial of dispatcher-assisted cardio-pulmonary resuscitation for out-of-hospital cardiac arrests in Singapore. Resuscitation. 2016;102:85–93. doi: 10.1016/j.resuscitation.2016.02.014
128.
Park GJ, Song KJ, Shin SD, Hong KJ, Kim TH, Park YM, Kong J. Clinical effects of a new dispatcher-assisted basic life support training program in a metropolitan city. Medicine (Baltimore). 2022;101:e29298. doi: 10.1097/MD.0000000000029298
129.
Tsunoyama T, Nakahara S, Yoshida M, Kitamura M, Sakamoto T. Effectiveness of dispatcher training in increasing bystander chest compression for out-of-hospital cardiac arrest patients in Japan. Acute Med Surg. 2017;4:439–445. doi: 10.1002/ams2.303
130.
Lerner EB, Farrell BM, Colella MR, Sternig KJ, Westrich C, Cady CE, Liu JM. A centralized system for providing dispatcher assisted CPR instructions to 9-1-1 callers at multiple municipal public safety answering points. Resuscitation. 2019;142:46–49. doi: 10.1016/j.resuscitation.2019.07.010
131.
Ro YS, Shin SD, Lee SC, Song KJ, Jeong J, Wi DH, Moon S. Association between the centralization of dispatch centers and dispatcher-assisted cardiopulmonary resuscitation programs: a natural experimental study. Resuscitation. 2018;131:29–35. doi: 10.1016/j.resuscitation.2018.07.034
132.
Bray JE, Deasy C, Walsh J, Bacon A, Currell A, Smith K. Changing EMS dispatcher CPR instructions to 400 compressions before mouth-to-mouth improved bystander CPR rates. Resuscitation. 2011;82:1393–1398. doi: 10.1016/j.resuscitation.2011.06.018
133.
Leong PWK, Leong BS-H, Arulanandam S, Ng MXR, Ng YY, Ong MEH, Mao DRH. Simplified instructional phrasing in dispatcher-assisted cardiopulmonary resuscitation – when ‘less is more’. Singapore Med J. 2021;62:647–652. doi: 10.11622/smedj.2020080
134.
Lee SY, Song KJ, Shin SD, Hong KJ, Kim TH. Comparison of the effects of audio-instructed and video-instructed dispatcher-assisted cardiopulmonary resuscitation on resuscitation outcomes after out-of-hospital cardiac arrest. Resuscitation. 2020;147:12–20. doi: 10.1016/j.resuscitation.2019.12.004
135.
Linderoth G, Lippert F, Østergaard D, Ersbøll AK, Meyhoff CS, Folke F, Christensen HC. Live video from bystanders’ smartphones to medical dispatchers in real emergencies. BMC Emerg Med. 2021;21:101. doi: 10.1186/s12873-021-00493-5
136.
Riou M, Ball S, Whiteside A, Bray J, Perkins GD, Smith K, O’Halloran KL, Fatovich DM, Inoue M, Bailey P, et al. ‘We’re going to do CPR’: a linguistic study of the words used to initiate dispatcher-assisted CPR and their association with caller agreement. Resuscitation. 2018;133:95–100. doi: 10.1016/j.resuscitation.2018.10.011
137.
Johnsen E, Bolle SR. To see or not to see—better dispatcher-assisted CPR with video-calls? A qualitative study based on simulated trials. Resuscitation. 2008;78:320–326. doi: 10.1016/j.resuscitation.2008.04.024
138.
Kim H-J, Kim J-H, Park D. Comparing audio- and video-delivered instructions in dispatcher-assisted cardiopulmonary resuscitation with drone-delivered automatic external defibrillator: a mixed methods simulation study. PeerJ. 2021;9:e11761–e11761. doi: 10.7717/peerj.11761
139.
Holmberg MJ, Vognsen M, Andersen MS, Donnino MW, Andersen LW. Bystander automated external defibrillator use and clinical outcomes after out-of-hospital cardiac arrest: a systematic review and meta-analysis. Resuscitation. 2017;120:77–87. doi: 10.1016/j.resuscitation.2017.09.003
140.
Bækgaard JS, Viereck S, Møller TP, Ersbøll AK, Lippert F, Folke F. The effects of public access defibrillation on survival after out-of-hospital cardiac arrest: a systematic review of observational studies. Circulation. 2017;136:954–965. doi: 10.1161/CIRCULATIONAHA.117.029067
141.
Nishiyama C, Kiguchi T, Okubo M, Alihodzic H, Al-Araji R, Baldi E, Beganton F, Booth S, Bray J, Christensen E, et al. Three-year trends in out-of-hospital cardiac arrest across the world: second report from the International Liaison Committee on Resuscitation (ILCOR). Resuscitation. 2023;186:109757. doi: 10.1016/j.resuscitation.2023.109757
142.
Luger M, Edlinger M, Bohm K, Maurer A, Truhlar A, Baubin M. European resuscitation council dispatch centre survey (EDiCeS). A survey on telephone-assisted cardiopulmonary resuscitation. Resuscitation. 2015;96:74. doi: 10.1016/j.resuscitation.2015.09.176
143.
Brooks SC, Clegg GR, Bray J, Deakin CD, Perkins GD, Ringh M, Smith CM, Link MS, Merchant RM, Pezo-Morales J, et al; International Liaison Committee on Resuscitation. Optimizing outcomes after out-of-hospital cardiac arrest with innovative approaches to public-access defibrillation: a scientific statement from the International Liaison Committee on Resuscitation. Resuscitation. 2022;172:204–228. doi: 10.1016/j.resuscitation.2021.11.032
144.
Brooks SC, Clegg GR, Bray J, Deakin CD, Perkins GD, Ringh M, Smith CM, Link MS, Merchant RM, Pezo-Morales J, et al; International Liaison Committee on Resuscitation. Optimizing outcomes after out-of-hospital cardiac arrest with innovative approaches to public-access defibrillation: a scientific statement from the International Liaison Committee on Resuscitation. Circulation. 2022;145:e776–e801. doi: 10.1161/CIR.0000000000001013
145.
Deleted in proof.
146.
Berg KM, Bray JE, Ng KC, Liley HG, Greif R, Carlson JN, Morley PT, Drennan IR, Smyth M, Scholefield BR, et al; Collaborators. 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: summary from the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces. Circulation. 2023;148:e187–e280. doi: 10.1161/CIR.0000000000001179
147.
Smith CM, Snow L, Whiting J, Smyth M, Olasveengen T, Bray J; on behalf of the International Liaison Committee on Resuscitation Basic Life Support Task Force. Dispatcher instructions for public-access AED retrieval and/or use. A scoping review. International Liaison Committee on Resuscitation Basic Life Support Task Force, January 8, 2024. Accessed June 2024. https://costr.ilcor.org/document/optimization-of-dispatcher-assisted-public-access-aed-retrieval-and-use-a-scoping-review-bls-2120
148.
Perera N, Ball S, Birnie T, Morgan A, Riou M, Whiteside A, Perkins GD, Bray J, Fatovich DM, Cameron P, et al. “Sorry, what did you say?” Communicating defibrillator retrieval and use in OHCA emergency calls. Resuscitation. 2020;156:182–189. doi: 10.1016/j.resuscitation.2020.09.006
149.
Gardett I, Broadbent M, Scott G, Clawson JJ, Olola C. Availability and use of an automated external defibrillator at emergency medical dispatch. Prehosp Emerg Care. 2019;23:683–690. doi: 10.1080/10903127.2018.1559565
150.
Kaneko T, Tanaka H, Uezono K. Dispatcher-assisted cardiopulmonary resuscitation improves the neurological outcomes of out-of-hospital cardiac arrest victims: a retrospective analysis of prehospitalization records in Kumamoto city. Crit Care Shock. 2019;22:9–15.
151.
Agerskov M, Nielsen AM, Hansen CM, Hansen MB, Lippert FK, Wissenberg M, Folke F, Rasmussen LS. Public access defibrillation: great benefit and potential but infrequently used. Resuscitation. 2015;96:53–58. doi: 10.1016/j.resuscitation.2015.07.021
152.
Deakin CD, Shewry E, Gray HH. Public access defibrillation remains out of reach for most victims of out-of-hospital sudden cardiac arrest. Heart. 2014;100:619–623. doi: 10.1136/heartjnl-2013-305030
153.
Bang JY, Cho Y, Cho GC, Lee J, Kim IY. Can mobile videocall assist laypersons’ use of automated external defibrillators? a randomized simulation study and qualitative analysis. Biomed Res Int. 2020;2020:4069749. doi: 10.1155/2020/4069749
154.
Ecker R, Rea TD, Meischke H, Schaeffer SM, Kudenchuk P, Eisenberg MS. Dispatcher assistance and automated external defibrillator performance among elders. Acad Emerg Med. 2001;8:968–973. doi: 10.1111/j.1553-2712.2001.tb01096.x
155.
Harve H, Jokela J, Tissari A, Saukko A, Räsänen P, Okkolin T, Pettilä V, Silfvast T. Can untrained laypersons use a defibrillator with dispatcher assistance? Acad Emerg Med. 2007;14:624–628. doi: 10.1197/j.aem.2007.03.1353
156.
Neves Briard J, Grou-Boileau F, El Bashtaly A, Spenard C, de Champlain F, Homier V. Automated external defibrillator geolocalization with a mobile application, verbal assistance or no assistance: a pilot randomized simulation (AED G-MAP). Prehosp Emerg Care. 2019;23:420–429. doi: 10.1080/10903127.2018.1511017
157.
Riyapan S, Lubin J. Emergency dispatcher assistance decreases time to defibrillation in a public venue: a randomized controlled trial. Am J Emerg Med. 2016;34:590–593. doi: 10.1016/j.ajem.2015.12.015
158.
Yang H, Praise K. Study on the ability to use automatic external defibrillators by students [translated title]. Korean J Emerg Med Ser. 2017;21:63–69.
159.
Johnson AM, Cunningham CJ, Zégre-Hemsey JK, Grewe ME, DeBarmore BM, Wong E, Omofoye F, Rosamond WD. Out-of-hospital cardiac arrest bystander defibrillator search time and experience with and without directional assistance: a randomized simulation trial in a community setting. Simul Healthc. 2022;17:22–28. doi: 10.1097/SIH.0000000000000582
160.
Maes F, Marchandise S, Boileau L, le Polain de Waroux J-B, Scavée C. Evaluation of a new semiautomated external defibrillator technology: a live cases video recording study. Emerg Med J. 2015;32:481–485. doi: 10.1136/emermed-2013-202962
161.
Sanfridsson J, Sparrevik J, Hollenberg J, Nordberg P, Djärv T, Ringh M, Svensson L, Forsberg S, Nord A, Andersson-Hagiwara M, et al. Drone delivery of an automated external defibrillator – a mixed method simulation study of bystander experience. Scand J Trauma Resusc Emerg Med. 2019;27:40.
162.
You JS, Park S, Chung SP, Park JW. Performance of cellular phones with video telephony in the use of automated external defibrillators by untrained laypersons. Emerg Med J. 2008;25:597–600. doi: 10.1136/emj.2008.058503
163.
Hansen MV, Lofgren B, Nadkarni VM, Lauridsen KG. Impact of different methods to activate the pediatric mode in automated external defibrillators by laypersons - a randomized controlled simulation study. Resusc Plus. 2022;10:100223. doi: 10.1016/j.resplu.2022.100223
164.
Abelairas-Gomez C, Carballo-Fazanes A, Chang TP, Fijacko N, Rodriguez-Nunez A. Is the AED as intuitive as we think? Potential relevance of “the sound of silence” during AED use. Resusc Plus. 2022;12:100323. doi: 10.1016/j.resplu.2022.100323
165.
Masterson S, Norii T, Yakubi M, Ikeyama T, Nehme Z, Bray J; on behalf of the International Liaison Committee on Resuscitation Basic Life Support Task Force. Real-time feedback for CPR quality: a scoping review. Resusc Plus. 2024;19:100730. doi: 10.1016/j.resplu.2024.100730
166.
Masterson S, Norii T, Ikeyama T, Nehme Z, Considine J, Olasveengen T, Bray J; on behalf of the International Liaison Committee on Resuscitation Basic Life Support Task Force. Real-time feedback for cardiopulmonary resuscitation task force synthesis of a scoping review [Internet] Brussels, Belgium: International Liaison Committee on Resuscitation (ILCOR) Basic Life Support Task Force, January 8, 2024. Accessed June 2024. https://costr.ilcor.org/document/real-time-feedback-for-cpr-quality-scoping-review-bls-2511-scr
167.
Yeung J, Meeks R, Edelson D, Gao F, Soar J, Perkins GD. The use of CPR feedback/prompt devices during training and CPR performance: a systematic review. Resuscitation. 2009;80:743–751. doi: 10.1016/j.resuscitation.2009.04.012
168.
Kirkbright S, Finn J, Tohira H, Bremner A, Jacobs I, Celenza A. Audiovisual feedback device use by health care professionals during CPR: a systematic review and meta-analysis of randomised and non-randomised trials. Resuscitation. 2014;85:460–471. doi: 10.1016/j.resuscitation.2013.12.012
169.
Ko YC, Hsieh MJ, Ma MH, Bigham B, Bhanji F, Greif R. The effect of system performance improvement on patients with cardiac arrest: a systematic review. Resuscitation. 2020;157:156–165. doi: 10.1016/j.resuscitation.2020.10.024
170.
Miller AC, Scissum K, McConnell L, East N, Vahedian-Azimi A, Sewell KA, Zehtabchi S. Real-time audio-visual feedback with handheld nonautomated external defibrillator devices during cardiopulmonary resuscitation for in-hospital cardiac arrest: a meta-analysis. Int J Crit Illn Inj Sci. 2020;10:109–122. doi: 10.4103/IJCIIS.IJCIIS_155_20
171.
Lyngby RM, Händel MN, Christensen AM, Nikoletou D, Folke F, Christensen HC, Barfod C, Quinn T. Effect of real-time and post-event feedback in out-of-hospital cardiac arrest attended by EMS - a systematic review and meta-analysis. Resusc Plus. 2021;6:100101. doi: 10.1016/j.resplu.2021.100101
172.
Ng QX, Han MX, Lim YL, Arulanandam S. A systematic review and meta-analysis of the implementation of high-performance cardiopulmonary resuscitation on out-of-hospital cardiac arrest outcomes. J Clin Med. 2021;10:2098. doi: 10.3390/jcm10102098
173.
Lv GW, Hu QC, Zhang M, Feng SY, Li Y, Zhang Y, Zhang YY, Wang WJ. Effect of real-time feedback on patient’s outcomes and survival after cardiac arrest: a systematic review and meta-analysis. Medicine (Baltim). 2022;101:e30438. doi: 10.1097/MD.0000000000030438
174.
Wang SA, Su CP, Fan HY, Hou WH, Chen YC. Effects of real-time feedback on cardiopulmonary resuscitation quality on outcomes in adult patients with cardiac arrest: a systematic review and meta-analysis. Resuscitation. 2020;155:82–90. doi: 10.1016/j.resuscitation.2020.07.024
175.
Schultz RB, Bigham B, Bhanji F, Lang E. Plenary oral presentations. CJEM. 2015;17:S41–S42. doi: 10.1017/cem.2015.50
176.
Targett C, Harris T. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: can metronomes improve CPR quality? Emerg Med J. 2014;31:251–254. doi: 10.1136/emermed-2014-203617.3
177.
Bohn A, Weber TP, Wecker S, Harding U, Osada N, Van Aken H, Lukas RP. The addition of voice prompts to audiovisual feedback and debriefing does not modify CPR quality or outcomes in out of hospital cardiac arrest--a prospective, randomized trial. Resuscitation. 2011;82:257–262. doi: 10.1016/j.resuscitation.2010.11.006
178.
Hostler D, Everson-Stewart S, Rea TD, Stiell IG, Callaway CW, Kudenchuk PJ, Sears GK, Emerson SS, Nichol G; Resuscitation Outcomes Consortium Investigators. Effect of real-time feedback during cardiopulmonary resuscitation outside hospital: prospective, cluster-randomised trial. BMJ. 2011;342:d512. doi: 10.1136/bmj.d512
179.
Vahedian-Azimi A, Rahimibashar F, Miller AC. A comparison of cardiopulmonary resuscitation with standard manual compressions versus compressions with real-time audiovisual feedback: a randomized controlled pilot study. Int J Crit Illn Inj Sci. 2020;10:32–37. doi: 10.4103/IJCIIS.IJCIIS_84_19
180.
Goharani R, Vahedian-Azimi A, Farzanegan B, Bashar FR, Hajiesmaeili M, Shojaei S, Madani SJ, Gohari-Moghaddam K, Hatamian S, Mosavinasab SMM, et al; MORZAK Collaborative. Real-time compression feedback for patients with in-hospital cardiac arrest: a multi-center randomized controlled clinical trial. J Intensive Care. 2019;7:5. doi: 10.1186/s40560-019-0357-5
181.
Vahedian-Azimi A, Hajiesmaeili M, Amirsavadkouhi A, Jamaati H, Izadi M, Madani SJ, Hashemian SM, Miller AC. Effect of the Cardio First Angel™ device on CPR indices: a randomized controlled clinical trial. Crit Care. 2016;20:147. doi: 10.1186/s13054-016-1296-3
182.
Bolstridge J, Delaney HM, Matos RI. Use of a metronome to improve quality of in-hospital cardiopulmonary resuscitation. Circulation. 2016;134:A18583–A18583.
183.
Khorasani-Zadeh A, Krowl LE, Chowdhry AK, Hantzidiamantis P, Hantzidiamantis K, Siciliano R, Grover MA, Dhamoon AS. Usefulness of a metronome to improve quality of chest compressions during cardiopulmonary resuscitation. Proc (Bayl Univ Med Cent). 2020;34:54–55. doi: 10.1080/08998280.2020.1805840
184.
Rainey K, Birkhoff S. Turn the beat on: an evidenced-based practice journey implementing metronome use in emergency department cardiac arrest. Worldviews Evid Based Nurs. 2021;18:68–70. doi: 10.1111/wvn.12486
185.
Chiang WC, Chen WJ, Chen SY, Ko PC, Lin CH, Tsai MS, Chang WT, Chen SC, Tsan CY, Ma MH. Better adherence to the guidelines during cardiopulmonary resuscitation through the provision of audio-prompts. Resuscitation. 2005;64:297–301. doi: 10.1016/j.resuscitation.2004.09.010
186.
Fletcher D, Galloway R, Chamberlain D, Pateman J, Bryant G, Newcombe RG. Basics in advanced life support: a role for download audit and metronomes. Resuscitation. 2008;78:127–134. doi: 10.1016/j.resuscitation.2008.03.003
187.
Kennedy J, Machado K, Maynard C, Walker RG, Sayre MR, Counts CR. Metronome use improves achievement of a target compression rate in out-of-hospital cardiac arrest: a retrospective analysis. Resusc Plus. 2023;15:100417. doi: 10.1016/j.resplu.2023.100417
188.
Abella BS, Edelson DP, Kim S, Retzer E, Myklebust H, Barry AM, O’Hearn N, Hoek TL, Becker LB. CPR quality improvement during in-hospital cardiac arrest using a real-time audiovisual feedback system. Resuscitation. 2007;73:54–61. doi: 10.1016/j.resuscitation.2006.10.027
189.
Couper K, Kimani PK, Abella BS, Chilwan M, Cooke MW, Davies RP, Field RA, Gao F, Quinton S, Stallard N, et al; Cardiopulmonary Resuscitation Quality Improvement Initiative Collaborators. The system-wide effect of real-time audiovisual feedback and postevent debriefing for in-hospital cardiac arrest: the cardiopulmonary resuscitation quality improvement initiative. Crit Care Med. 2015;43:2321–2331. doi: 10.1097/CCM.0000000000001202
190.
Davis DP, Graham PG, Husa RD, Lawrence B, Minokadeh A, Altieri K, Sell RE. A performance improvement-based resuscitation programme reduces arrest incidence and increases survival from in-hospital cardiac arrest. Resuscitation. 2015;92:63–69. doi: 10.1016/j.resuscitation.2015.04.008
191.
Kramer-Johansen J, Myklebust H, Wik L, Fellows B, Svensson L, Sørebø H, Steen PA. Quality of out-of-hospital cardiopulmonary resuscitation with real time automated feedback: a prospective interventional study. Resuscitation. 2006;71:283–292. doi: 10.1016/j.resuscitation.2006.05.011
192.
Chandra S, Hess EP, Kolb L, Myers L, White RD. Effect of real-time automated and delayed summative feedback on CPR quality in adult out-of-hospital cardiac arrest: a prospective multicenter controlled clinical trial. Acad Emerg Med. 2011;18:S145–S146. doi: 10.1111/j.1553-2712.2011.01073.x
193.
Bobrow BJ, Vadeboncoeur TF, Stolz U, Silver AE, Tobin JM, Crawford SA, Mason TK, Schirmer J, Smith GA, Spaite DW. The influence of scenario-based training and real-time audiovisual feedback on out-of-hospital cardiopulmonary resuscitation quality and survival from out-of-hospital cardiac arrest. Ann Emerg Med. 2013;62:47–56.e1. doi: 10.1016/j.annemergmed.2012.12.020
194.
Leis CC, González VA, Hernandez RDE, Sanchez O, Martin JLM, Hermosa EJM, TORRES EC. Feedback on chest compression quality variables and their relationship to rate of return of spontaneous circulation. Emergencias. 2013;25:99–104.
195.
Sainio M, Kämäräinen A, Huhtala H, Aaltonen P, Tenhunen J, Olkkola KT, Hoppu S. Real-time audiovisual feedback system in a physician-staffed helicopter emergency medical service in Finland: the quality results and barriers to implementation. Scand J Trauma Resusc Emerg Med. 2013;21:50. doi: 10.1186/1757-7241-21-50
196.
Freese J, Menegus M, Rabrich J, Slesinger T, Silverman R, Keller N, Dillworth J, Isaacs D, Ben-Eli D. Addition of real-time CPR feedback improves immediate outcomes for out-of-hospital cardiac arrest. Circulation. 2014;130:A72–A72.
197.
Crowe C, Bobrow BJ, Vadeboncoeur TF, Dameff C, Stolz U, Silver A, Roosa J, Page R, LoVecchio F, Spaite DW. Measuring and improving cardiopulmonary resuscitation quality inside the emergency department. Resuscitation. 2015;93:8–13. doi: 10.1016/j.resuscitation.2015.04.031
198.
Hopkins CL, Burk C, Moser S, Meersman J, Baldwin C, Youngquist ST. Implementation of pit crew approach and cardiopulmonary resuscitation metrics for out-of-hospital cardiac arrest improves patient survival and neurological outcome. J Am Heart Assoc. 2016;5:e002892. doi: 10.1161/JAHA.115.002892
199.
Riyapan S, Naulnark T, Ruangsomboon O, Chaisirin W, Limsuwat C, Prapruetkit N, Chakorn T, Monsomboon A. Improving quality of chest compression in Thai emergency department by using real-time audio-visual feedback cardio-pulmonary resuscitation monitoring. J Med Assoc Thai. 2019;102:245.
200.
Lakomek F, Lukas RP, Brinkrolf P, Mennewisch A, Steinsiek N, Gutendorf P, Sudowe H, Heller M, Kwiecien R, Zarbock A, et al. Real-time feedback improves chest compression quality in out-of-hospital cardiac arrest: a prospective cohort study. PLoS One. 2020;15:e0229431. doi: 10.1371/journal.pone.0229431
201.
Nehme Z, Ball J, Stephenson M, Walker T, Stub D, Smith K. Effect of a resuscitation quality improvement programme on outcomes from out-of-hospital cardiac arrest. Resuscitation. 2021;162:236–244. doi: 10.1016/j.resuscitation.2021.03.007
202.
Alqudah Z, Smith K, Stephenson M, Walker T, Stub D, Nehme Z. The impact of a high-performance cardiopulmonary resuscitation protocol on survival from out-of-hospital cardiac arrests witnessed by paramedics. Resusc Plus. 2022;12:100334. doi: 10.1016/j.resplu.2022.100334
203.
Lyngby RM, Folke F, Oelrich RM, Nikoletou D, Quinn T. 338 Cardio-pulmonary-resuscitation quality in out-of-hospital cardiac arrest – effect of real-time feedback. BMJ Open. 2022;12:A17. doi: https://doi.org/10.1136/bmjopen-2022-EMS.38
204.
Olasveengen TM, Tomlinson AE, Wik L, Sunde K, Steen PA, Myklebust H, Kramer-Johansen J. A failed attempt to improve quality of out-of-hospital CPR through performance evaluation. Prehosp Emerg Care. 2007;11:427–433. doi: 10.1080/10903120701536628
205.
Pearson DA, Darrell Nelson R, Monk L, Tyson C, Jollis JG, Granger CB, Corbett C, Garvey L, Runyon MS. Comparison of team-focused CPR vs standard CPR in resuscitation from out-of-hospital cardiac arrest: results from a statewide quality improvement initiative. Resuscitation. 2016;105:165–172. doi: 10.1016/j.resuscitation.2016.04.008
206.
Couper K, Mason AJ, Gould D, Nolan JP, Soar J, Yeung J, Harrison D, Perkins GD. The impact of resuscitation system factors on in-hospital cardiac arrest outcomes across UK hospitals: an observational study. Resuscitation. 2020;151:166–172. doi: 10.1016/j.resuscitation.2020.04.006
207.
Lukas RP, Gräsner JT, Seewald S, Lefering R, Weber TP, Van Aken H, Fischer M, Bohn A. Chest compression quality management and return of spontaneous circulation: a matched-pair registry study. Resuscitation. 2012;83:1212–1218. doi: 10.1016/j.resuscitation.2012.03.027
208.
Park JH, Shin SD, Ro YS, Song KJ, Hong KJ, Kim TH, Lee EJ, Kong SY. Implementation of a bundle of Utstein cardiopulmonary resuscitation programs to improve survival outcomes after out-of-hospital cardiac arrest in a metropolis: a before and after study. Resuscitation. 2018;130:124–132. doi: 10.1016/j.resuscitation.2018.07.019
209.
Pfeiffer S, Duval-Arnould J, Wenger J, Lauridsen K, Hunt E, Haskell S, Atkins D, Knight L, Cheng A, Gilfoyle E, et al. 345: CPR coach role improves depth, rate, and return of spontaneous circulation. Crit Care Med. 2018;46:155–155. doi: 10.1097/01.ccm.0000528364.64874.50
210.
Sutton RM, Niles D, French B, Maltese MR, Leffelman J, Eilevstjonn J, Wolfe H, Nishisaki A, Meaney PA, Berg RA, et al. First quantitative analysis of cardiopulmonary resuscitation quality during in-hospital cardiac arrests of young children. Resuscitation. 2014;85:70–74. doi: 10.1016/j.resuscitation.2013.08.014
211.
Kern KB, Sanders AB, Raife J, Milander MM, Otto CW, Ewy GA. A study of chest compression rates during cardiopulmonary resuscitation in humans. The importance of rate-directed chest compressions. Arch Intern Med. 1992;152:145–149.
212.
Berg RA, Sanders AB, Milander M, Tellez D, Liu P, Beyda D. Efficacy of audio-prompted rate guidance in improving resuscitator performance of cardiopulmonary resuscitation on children. Acad Emerg Med. 1994;1:35–40.
213.
Niles D, Nysaether J, Sutton R, Nishisaki A, Abella BS, Arbogast K, Maltese MR, Berg RA, Helfaer M, Nadkarni V. Leaning is common during in-hospital pediatric CPR, and decreased with automated corrective feedback. Resuscitation. 2009;80:553–557. doi: 10.1016/j.resuscitation.2009.02.012
214.
Fried DA, Leary M, Smith DA, Sutton RM, Niles D, Herzberg DL, Becker LB, Abella BS. The prevalence of chest compression leaning during in-hospital cardiopulmonary resuscitation. Resuscitation. 2011;82:1019–1024. doi: 10.1016/j.resuscitation.2011.02.032
215.
Setälä P, Virkkunen I, Kämäräinen A, Huhtala H, Virta J, Yli-Hankala A, Hoppu S. Nothing beats quality-controlled manual chest compressions: end-tidal carbon dioxide changes between manual cardiopulmonary resuscitation and with active compression–decompression device. Resuscitation. 2015;96:70–71. doi: 10.1016/j.resuscitation.2015.09.167
216.
Koch M, Mueller M, Warenits AM, Holzer M, Spiel A, Schnaubelt S. Carotid artery ultrasound in the (peri-) arrest setting-a prospective pilot study. J Clin Med. 2022;11:469. doi: 10.3390/jcm11020469
217.
Cho GC. Skin and soft tissue damage caused by use of feedback-sensor during chest compressions. Resuscitation. 2009;80:600. doi: 10.1016/j.resuscitation.2009.02.014
218.
Sainio M, Sutton RM, Huhtala H, Eilevstjønn J, Tenhunen J, Olkkola KT, Nadkarni VM, Hoppu S. Association of arterial blood pressure and CPR quality in a child using three different compression techniques, a case report. Scand J Trauma Resusc Emerg Med. 2013;21:51. doi: 10.1186/1757-7241-21-51
219.
Beaulac G, Teran F, Lecluyse V, Costescu A, Belliveau M, Desjardins G, Denault A. Transesophageal echocardiography in patients in cardiac arrest: the heart and beyond. Can J Cardiol. 2023;39:458–473. doi: 10.1016/j.cjca.2022.12.027
220.
Sutton RM, Maltese MR, Niles D, French B, Nishisaki A, Arbogast KB, Donoghue A, Berg RA, Helfaer MA, Nadkarni V. Quantitative analysis of chest compression interruptions during in-hospital resuscitation of older children and adolescents. Resuscitation. 2009;80:1259–1263. doi: 10.1016/j.resuscitation.2009.08.009
221.
Nakashima T, Noguchi T, Tahara Y, Nishimura K, Yasuda S, Onozuka D, Iwami T, Yonemoto N, Nagao K, Nonogi H, et al; Japanese Circulation Society with Resuscitation Science Study Group. Public-access defibrillation and neurological outcomes in patients with out-of-hospital cardiac arrest in Japan: a population-based cohort study. Lancet. 2019;394:2255–2262. doi: 10.1016/S0140-6736(19)32488-2
222.
Kitamura T, Kiyohara K, Iwami T. Public-access defibrillation in Japan. N Engl J Med. 2017;376:e12. doi: 10.1056/NEJMc1700160
223.
Caffrey SL, Willoughby PJ, Pepe PE, Becker LB. Public use of automated external defibrillators. N Engl J Med. 2002;347:1242–1247. doi: 10.1056/NEJMoa020932
224.
Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med. 2000;343:1206–1209. doi: 10.1056/NEJM200010263431701
225.
Gold LS, Fahrenbruch CE, Rea TD, Eisenberg MS. The relationship between time to arrival of emergency medical services (EMS) and survival from out-of-hospital ventricular fibrillation cardiac arrest. Resuscitation. 2010;81:622–625. doi: 10.1016/j.resuscitation.2010.02.004
225a.
Debaty G, Perkins GD, Dainty KN, Norii T, Olasveengen TM, Bray JE; on behalf of the International Liaison Committee on Resuscitation Basic Life Support Task Force. Effectiveness of ultraportable automated external defibrillators: a scoping review. Resusc Plus. 2024;19:100739. doi: 10.1016/j.resplu.2024.100739
226.
Debaty G, Dainty K, Norii T, Perkins GD, Olasveengen T, Bray J; on behalf of the International Liaison Committee on Resuscitation Basic Life Support Task Force. Effectiveness of ultra-portable or pocket automated external defibrillator Consensus on Science with Treatment Recommendations. [Internet] Brussels, Belgium: International Liaison Committee on Resuscitation (ILCOR) Basic Life Support Task Force, January 8, 2024. Accessed June 2024. https://costr.ilcor.org/document/effectiveness-of-ultra-portable-or-pocket-automated-external-defibrillators-a-scoping-review-bls-2603-scr
227.
Shaker MS, Abrams EM, Oppenheimer J, Singer AG, Shaker M, Fleck D, Greenhawt M, Grove E. Estimation of health and economic benefits of a small automatic external defibrillator for rapid treatment of sudden cardiac arrest (SMART): a cost-effectiveness analysis. Front Cardiovasc Med. 2022;9:771679. doi: 10.3389/fcvm.2022.771679
228.
Todd V, Dicker B, Okyere D, Smith K, Smith T, Howie G, Stub D, Ray M, Stewart R, Scott T, et al. A study protocol for a cluster-randomised controlled trial of smartphone-activated first responders with ultraportable defibrillators in out-of-hospital cardiac arrest: the first responder shock trial (FIRST). Resusc Plus. 2023;16:100466. doi: 10.1016/j.resplu.2023.100466
229.
Todd V, Dicker B, Okyere D, Smith K, Howie G, Smith T, Stub D, Ray M, Stewart R, Scott T, et al. The first responder shock trial (FIRST): can we improve cardiac arrest survival by providing community responders with ultraportable automated external defibrillators? Heart Lung Circ. 2023;32:S88. doi: 10.1016/j.hlc.2023.04.240
230.
Berg KM, Soar J, Andersen LW, Bottiger BW, Cacciola S, Callaway CW, Couper K, Cronberg T, D’Arrigo S, Deakin CD, et al; Adult Advanced Life Support Collaborators. Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2020;142:S92–S139. doi: 10.1161/CIR.0000000000000893
231.
Holmberg MJ, Nicholson T, Nolan JP, Schexnayder S, Reynolds J, Nation K, Welsford M, Morley P, Soar J, Berg KM; Adult Pediatric Advanced Life Support Task Forces at the International Liaison Committee on Resuscitation (ILCOR). Oxygenation and ventilation targets after cardiac arrest: a systematic review and meta-analysis. Resuscitation. 2020;152:107–115. doi: 10.1016/j.resuscitation.2020.04.031
232.
Soar J, Berg KM, Andersen LW, Bottiger BW, Cacciola S, Callaway CW, Couper K, Cronberg T, D’Arrigo S, Deakin CD, et al; Adult Advanced Life Support Collaborators. Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Resuscitation. 2020;156:A80–A119. doi: 10.1016/j.resuscitation.2020.09.012
233.
Holmberg MJ, Ikeyama T, Garg R, Drennan I, Lavonas E, Bray J, Olasveengen T, Berg KM; on behalf of the Advanced Life Support and Basic Life Support Task Forces. Oxygenation and ventilation targets after cardiac arrest: an updated systematic review and meta-analysis: consensus on science with treatment recommendations. Accessed February 8, 2024. https://costr.ilcor.org/document/oxygen-and-carbon-dioxide-targets-in-patients-with-return-of-spontaneous-circulation-after-cardiac-arrest-als-sr
234.
Bernard SA, Bray JE, Smith K, Stephenson M, Finn J, Grantham H, Hein C, Masters S, Stub D, Perkins GD, et al; EXACT Investigators. Effect of lower vs higher oxygen saturation targets on survival to hospital discharge among patients resuscitated after out-of-hospital cardiac arrest: the EXACT randomized clinical trial. JAMA. 2022;328:1818–1826. doi: 10.1001/jama.2022.17701
235.
Eastwood G, Nichol AD, Hodgson C, Parke RL, McGuinness S, Nielsen N, Bernard S, Skrifvars MB, Stub D, Taccone FS, et al. Mild hypercapnia or normocapnia after out-of-hospital cardiac arrest. N Engl J Med. 2023;389:45–57. doi: 10.1056/NEJMoa2214552
236.
Semler MW, Casey JD, Lloyd BD, Hastings PG, Hays MA, Stollings JL, Buell KG, Brems JH, Qian ET, Seitz KP, et al; PILOT Investigators and the Pragmatic Critical Care Research Group. Oxygen-saturation targets for critically ill adults receiving mechanical ventilation. N Engl J Med. 2022;387:1759–1769. doi: 10.1056/NEJMoa2208415
237.
Schmidt H, Kjaergaard J, Hassager C, Molstrom S, Grand J, Borregaard B, Roelsgaard Obling LE, Veno S, Sarkisian L, Mamaev D, et al. Oxygen targets in comatose survivors of cardiac arrest. N Engl J Med. 2022;387:1467–1476. doi: 10.1056/NEJMoa2208686
238.
Crescioli E, Lass Klitgaard T, Perner A, Lilleholt Schjorring O, Steen Rasmussen B. Lower versus higher oxygenation targets in hypoxaemic ICU patients after cardiac arrest. Resuscitation. 2023;188:109838. doi: 10.1016/j.resuscitation.2023.109838
239.
Jakkula P, Reinikainen M, Hastbacka J, Loisa P, Tiainen M, Pettila V, Toppila J, Lahde M, Backlund M, Okkonen M, et al; COMACARE study group. Targeting two different levels of both arterial carbon dioxide and arterial oxygen after cardiac arrest and resuscitation: a randomised pilot trial. Intensive Care Med. 2018;44:2112–2121. doi: 10.1007/s00134-018-5453-9
240.
Thomas M, Voss S, Benger J, Kirby K, Nolan JP. Cluster randomised comparison of the effectiveness of 100% oxygen versus titrated oxygen in patients with a sustained return of spontaneous circulation following out of hospital cardiac arrest: a feasibility study. PROXY: post ROSC OXYgenation study. BMC Emerg Med. 2019;19:16. doi: 10.1186/s12873-018-0214-1
241.
Eastwood GM, Tanaka A, Espinoza ED, Peck L, Young H, Martensson J, Zhang L, Glassford NJ, Hsiao YF, Suzuki S, et al. Conservative oxygen therapy in mechanically ventilated patients following cardiac arrest: a retrospective nested cohort study. Resuscitation. 2016;101:108–114. doi: 10.1016/j.resuscitation.2015.11.026
242.
Young P, Mackle D, Bellomo R, Bailey M, Beasley R, Deane A, Eastwood G, Finfer S, Freebairn R, King V, et al; ICU-ROX Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Conservative oxygen therapy for mechanically ventilated adults with suspected hypoxic ischaemic encephalopathy. Intensive Care Med. 2020;46:2411–2422. doi: 10.1007/s00134-020-06196-y
243.
Bray JE, Hein C, Smith K, Stephenson M, Grantham H, Finn J, Stub D, Cameron P, Bernard S; EXACT Investigators. Oxygen titration after resuscitation from out-of-hospital cardiac arrest: a multi-centre, randomised controlled pilot study (the EXACT pilot trial). Resuscitation. 2018;128:211–215. doi: 10.1016/j.resuscitation.2018.04.019
244.
Kuisma M, Boyd J, Voipio V, Alaspaa A, Roine RO, Rosenberg P. Comparison of 30 and the 100% inspired oxygen concentrations during early post-resuscitation period: a randomised controlled pilot study. Resuscitation. 2006;69:199–206. doi: 10.1016/j.resuscitation.2005.08.010
245.
Mackle D, Bellomo R, Bailey M, Beasley R, Deane A, Eastwood G, Finfer S, Freebairn R, King V, Linke N, et al; ICU-ROX Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Conservative oxygen therapy during mechanical ventilation in the ICU. N Engl J Med. 2020;382:989–998. doi: 10.1056/NEJMoa1903297
246.
Sjoding MW, Dickson RP, Iwashyna TJ, Gay SE, Valley TS. Racial bias in pulse oximetry measurement. N Engl J Med. 2020;383:2477–2478. doi: 10.1056/NEJMc2029240
247.
Wong AI, Charpignon M, Kim H, Josef C, de Hond AAH, Fojas JJ, Tabaie A, Liu X, Mireles-Cabodevila E, Carvalho L, et al. Analysis of discrepancies between pulse oximetry and arterial oxygen saturation measurements by race and ethnicity and association with organ dysfunction and mortality. JAMA Netw Open. 2021;4:e2131674. doi: 10.1001/jamanetworkopen.2021.31674
248.
Jamali H, Castillo LT, Morgan CC, Coult J, Muhammad JL, Osobamiro OO, Parsons EC, Adamson R. Racial disparity in oxygen saturation measurements by pulse oximetry: evidence and implications. Ann Am Thorac Soc. 2022;19:1951–1964. doi: 10.1513/AnnalsATS.202203-270CME
249.
Moon SW, Lee SW, Choi SH, Hong YS, Kim SJ, Kim NH. Arterial minus end-tidal CO2 as a prognostic factor of hospital survival in patients resuscitated from cardiac arrest. Resuscitation. 2007;72:219–225. doi: 10.1016/j.resuscitation.2006.06.034
250.
Mueller M, Jankow E, Grafeneder J, Schoergenhofer C, Poppe M, Schriefl C, Clodi C, Koch M, Ettl F, Holzer M, et al. The difference between arterial pCO(2) and etCO(2) after cardiac arrest - outcome predictor or marker of unfavorable resuscitation circumstances? Am J Emerg Med. 2022;61:120–126. doi: 10.1016/j.ajem.2022.08.058
251.
Kim YW, Hwang SO, Kang HS, Cha KC. The gradient between arterial and end-tidal carbon dioxide predicts in-hospital mortality in post-cardiac arrest patient. Am J Emerg Med. 2019;37:1–4. doi: 10.1016/j.ajem.2018.04.025
252.
Abrahamowicz AA, Counts CR, Danielson KR, Bulger NE, Maynard C, Carlbom DJ, Swenson ER, Latimer AJ, Yang B, Sayre MR, et al. The association between arterial-end-tidal carbon dioxide difference and outcomes after out-of-hospital cardiac arrest. Resuscitation. 2022;181:3–9. doi: 10.1016/j.resuscitation.2022.09.019
253.
Callaway CW, Soar J, Aibiki M, Bottiger BW, Brooks SC, Deakin CD, Donnino MW, Drajer S, Kloeck W, Morley PT, et al; Advanced Life Support Chapter Collaborators. Part 4: Advanced Life Support: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2015;132:S84–145. doi: 10.1161/CIR.0000000000000273
254.
Soar J, Callaway CW, Aibiki M, Bottiger BW, Brooks SC, Deakin CD, Donnino MW, Drajer S, Kloeck W, Morley PT, et al; Advanced Life Support Chapter Collaborators. Part 4: advanced life support: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Resuscitation. 2015;95:e71–120. doi: 10.1016/j.resuscitation.2015.07.042
255.
Niemela V, Siddiqui F, Ameloot K, Reinikainen M, Grand J, Hastbacka J, Hassager C, Kjaergaard J, Aneman A, Tiainen M, et al. Higher versus lower blood pressure targets after cardiac arrest: systematic review with individual patient data meta-analysis. Resuscitation. 2023;189:109862. doi: 10.1016/j.resuscitation.2023.109862
256.
Skrifvars MB, Holmberg M, Ohshimo S, Berg KM, Drennan I; on behalf of the ILCOR ALS Task Force. Mean arterial blood pressure target after cardiac arrest: consensus on science with treatment recommendations. Accessed February 8, 2024. https://costr.ilcor.org/document/mean-arterial-blood-pressure-target-in-post-cardiac-arrest-care-patients-als-new-tfsr
257.
Ameloot K, De Deyne C, Eertmans W, Ferdinande B, Dupont M, Palmers PJ, Petit T, Nuyens P, Maeremans J, Vundelinckx J, et al. Early goal-directed haemodynamic optimization of cerebral oxygenation in comatose survivors after cardiac arrest: the Neuroprotect post-cardiac arrest trial. Eur Heart J. 2019;40:1804–1814. doi: 10.1093/eurheartj/ehz120
258.
Grand J, Meyer AS, Kjaergaard J, Wiberg S, Thomsen JH, Frydland M, Ostrowski SR, Johansson PI, Hassager C. A randomised double-blind pilot trial comparing a mean arterial pressure target of 65 mm Hg versus 72 mm Hg after out-of-hospital cardiac arrest. Eur Heart J Acute Cardiovasc Care. 2020;9:S100–S109. doi: 10.1177/2048872619900095
259.
Jakkula P, Pettila V, Skrifvars MB, Hastbacka J, Loisa P, Tiainen M, Wilkman E, Toppila J, Koskue T, Bendel S, et al; COMACARE study group. Targeting low-normal or high-normal mean arterial pressure after cardiac arrest and resuscitation: a randomised pilot trial. Intensive Care Med. 2018;44:2091–2101. doi: 10.1007/s00134-018-5446-8
260.
Kjaergaard J, Moller JE, Schmidt H, Grand J, Molstrom S, Borregaard B, Veno S, Sarkisian L, Mamaev D, Jensen LO, et al. Blood-pressure targets in comatose survivors of cardiac arrest. N Engl J Med. 2022;387:1456–1466. doi: 10.1056/NEJMoa2208687
261.
Bro-Jeppesen J, Annborn M, Hassager C, Wise MP, Pelosi P, Nielsen N, Erlinge D, Wanscher M, Friberg H, Kjaergaard J; TTM Investigators. Hemodynamics and vasopressor support during targeted temperature management at 33 degrees C versus 36 degrees C after out-of-hospital cardiac arrest: a post hoc study of the target temperature management trial. Crit Care Med. 2015;43:318–327. doi: 10.1097/CCM.0000000000000691
262.
Laurikkala J, Wilkman E, Pettila V, Kurola J, Reinikainen M, Hoppu S, Ala-Kokko T, Tallgren M, Tiainen M, Vaahersalo J, et al; FINNRESUSCI Study Group. Mean arterial pressure and vasopressor load after out-of-hospital cardiac arrest: associations with one-year neurologic outcome. Resuscitation. 2016;105:116–122. doi: 10.1016/j.resuscitation.2016.05.026
263.
McGuigan PJ, Giallongo E, Blackwood B, Doidge J, Harrison DA, Nichol AD, Rowan KM, Shankar-Hari M, Skrifvars MB, Thomas K, et al. The effect of blood pressure on mortality following out-of-hospital cardiac arrest: a retrospective cohort study of the United Kingdom intensive care national audit and research centre database. Crit Care. 2023;27:4. doi: 10.1186/s13054-022-04289-2
264.
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304–377. doi: 10.1007/s00134-017-4683-6
265.
Granfeldt A, Holmberg MJ, Nolan JP, Soar J, Andersen LW; International Liaison Committee on Resuscitation ILCOR Advanced Life Support Task Force. Temperature control after adult cardiac arrest: An updated systematic review and meta-analysis. Resuscitation. 2023;191:109928. doi: 10.1016/j.resuscitation.2023.109928
266.
Granfeldt A, Holmberg MJ, Soar J, Nolan JP, Skrifvars M, Berg KM, Drennan I; on behalf of the ILCOR ALS Task Force. Temperature control in adult cardiac arrest: consensus on science with treatment recommendations. Accessed February 8, 2024. https://costr.ilcor.org/document/temperature-control-in-adult-cardiac-arrest-als-tf-sr
267.
Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346:557–563. doi: 10.1056/NEJMoa003289
268.
Hypothermia after Cardiac Arrest Study G. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:549–556. doi: 10.1056/NEJMoa012689
269.
Laurent I, Adrie C, Vinsonneau C, Cariou A, Chiche JD, Ohanessian A, Spaulding C, Carli P, Dhainaut JF, Monchi M. High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol. 2005;46:432–437. doi: 10.1016/j.jacc.2005.04.039
270.
Lascarrou JB, Merdji H, Le Gouge A, Colin G, Grillet G, Girardie P, Coupez E, Dequin PF, Cariou A, Boulain T, et al. Targeted temperature management for cardiac arrest with nonshockable rhythm. N Engl J Med. 2019;381:2327–2337. doi: 10.1056/NEJMoa1906661
271.
Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, Levin H, Ullen S, Rylander C, Wise MP, Oddo M, Cariou A, et al; TTM2 Trial Investigators. Hypothermia versus normothermia after out-of-hospital cardiac arrest. N Engl J Med. 2021;384:2283–2294. doi: 10.1056/NEJMoa2100591
272.
Wolfrum S, Roedl K, Hanebutte A, Pfeifer R, Kurowski V, Riessen R, Daubmann A, Braune S, Soffker G, Bibiza-Freiwald E, et al; Hypothermia After In-Hospital Cardiac Arrest Study Group. Temperature control after in-hospital cardiac arrest: a randomized clinical trial. Circulation. 2022;146:1357–1366. doi: 10.1161/CIRCULATIONAHA.122.060106
273.
Hachimi-Idrissi S, Zizi M, Nguyen DN, Schiettecate J, Ebinger G, Michotte Y, Huyghens L. The evolution of serum astroglial S-100 beta protein in patients with cardiac arrest treated with mild hypothermia. Resuscitation. 2005;64:187–192. doi: 10.1016/j.resuscitation.2004.08.008
274.
Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, et al; TTM Trial Investigators. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med. 2013;369:2197–2206. doi: 10.1056/NEJMoa1310519
275.
Kwon WY, Jung YS, Suh GJ, Kim T, Kwak H, Kim T, Kim JY, Lee MS, Kim KS, Shin J, et al. Regional cerebral oxygen saturation in cardiac arrest survivors undergoing targeted temperature management 36 degrees C versus 33 degrees C: a randomized clinical trial. Resuscitation. 2021;167:362–371. doi: 10.1016/j.resuscitation.2021.07.026
276.
Tahara Y, Noguchi T, Yonemoto N, Nakashima T, Yasuda S, Kikuchi M, Hashiba K, Arimoto H, Nishioka K, Kokubu N, et al; J-PULSE-Hypo-DC Trial Study Group. Cluster randomized trial of duration of cooling in targeted temperature management after resuscitation for cardiac arrest. Circ Rep. 2021;3:368–374. doi: 10.1253/circrep.CR-21-0062
277.
Kirkegaard H, Soreide E, de Haas I, Pettila V, Taccone FS, Arus U, Storm C, Hassager C, Nielsen JF, Sorensen CA, et al. Targeted temperature management for 48 vs 24 hours and neurologic outcome after out-of-hospital cardiac arrest: a randomized clinical trial. JAMA. 2017;318:341–350. doi: 10.1001/jama.2017.8978
278.
Pittl U, Schratter A, Desch S, Diosteanu R, Lehmann D, Demmin K, Horig J, Schuler G, Klemm T, Mende M, et al. Invasive versus non-invasive cooling after in- and out-of-hospital cardiac arrest: a randomized trial. Clin Res Cardiol. 2013;102:607–614. doi: 10.1007/s00392-013-0572-3
279.
Deye N, Cariou A, Girardie P, Pichon N, Megarbane B, Midez P, Tonnelier JM, Boulain T, Outin H, Delahaye A, et al; Clinical and Economical Impact of Endovascular Cooling in the Management of Cardiac Arrest (ICEREA) Study Group. Endovascular versus external targeted temperature management for patients with out-of-hospital cardiac arrest: a randomized, controlled study. Circulation. 2015;132:182–193. doi: 10.1161/CIRCULATIONAHA.114.012805
280.
Look X, Li H, Ng M, Lim ETS, Pothiawala S, Tan KBK, Sewa DW, Shahidah N, Pek PP, Ong MEH. Randomized controlled trial of internal and external targeted temperature management methods in post- cardiac arrest patients. Am J Emerg Med. 2018;36:66–72. doi: 10.1016/j.ajem.2017.07.017
281.
Lascarrou JB, Guichard E, Reignier J, Le Gouge A, Pouplet C, Martin S, Lacherade JC, Colin G; AfterROSC network. Impact of rewarming rate on interleukin-6 levels in patients with shockable cardiac arrest receiving targeted temperature management at 33 degrees C: the ISOCRATE pilot randomized controlled trial. Crit Care. 2021;25:434. doi: 10.1186/s13054-021-03842-9
282.
Hassager C, Schmidt H, Moller JE, Grand J, Molstrom S, Beske RP, Boesgaard S, Borregaard B, Bekker-Jensen D, Dahl JS, et al. Duration of device-based fever prevention after cardiac arrest. N Engl J Med. 2023;388:888–897. doi: 10.1056/NEJMoa2212528
283.
Wyckoff MH, Greif R, Morley PT, Ng KC, Olasveengen TM, Singletary EM, Soar J, Cheng A, Drennan IR, Liley HG, et al; Collaborators. 2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: summary from the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces. Circulation. 2022;146:e483–e557. doi: 10.1161/CIR.0000000000001095
284.
Wyckoff MH, Greif R, Morley PT, Ng KC, Olasveengen TM, Singletary EM, Soar J, Cheng A, Drennan IR, Liley HG, et al; Collaborators. 2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: summary from the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces. Resuscitation. 2022;181:208–288. doi: 10.1016/j.resuscitation.2022.10.005
285.
Bartlett ES, Valenzuela T, Idris A, Deye N, Glover G, Gillies MA, Taccone FS, Sunde K, Flint AC, Thiele H, et al. Systematic review and meta-analysis of intravascular temperature management vs. surface cooling in comatose patients resuscitated from cardiac arrest. Resuscitation. 2020;146:82–95. doi: 10.1016/j.resuscitation.2019.10.035
286.
Kim JG, Ahn C, Shin H, Kim W, Lim TH, Jang BH, Cho Y, Choi KS, Lee J, Na MK. Efficacy of the cooling method for targeted temperature management in post-cardiac arrest patients: a systematic review and meta-analysis. Resuscitation. 2020;148:14–24. doi: 10.1016/j.resuscitation.2019.12.025
287.
Nicholson TC, Hirsch K, Berg KM, Drennan I, Lavonas E; on behalf of the Advanced Life Support Task Force. Effect of seizure treatment for adults and children following cardiac arrest on patient outcomes: a systematic review. Accessed February 8, 2024. https://costr.ilcor.org/document/effect-of-prophylaxis-and-treatment-of-seizures-on-outcome-of-adults-following-cardiac-arrest-als-tfsr
288.
Brain Resuscitation Clinical Trial I Study Group. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med. 1986;314:397–403. doi: 10.1056/NEJM198602133140701
289.
Longstreth WT, Fahrenbruch CE, Olsufka M, Walsh TR, Copass MK, Cobb LA. Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest. Neurology. 2002;59:506–514. doi: 10.1212/wnl.59.4.506
290.
Monsalve F, Rucabado L, Ruano M, Cuñat J, Lacueva V, Viñuales A. The neurologic effects of thiopental therapy after cardiac arrest. Intensive Care Med. 1987;13:244–248. doi: 10.1007/BF00265112
291.
Ruijter BJ, Keijzer HM, Tjepkema-Cloostermans MC, Blans MJ, Beishuizen A, Tromp SC, Scholten E, Horn J, van Rootselaar AF, Admiraal MM, et al; Investigators T. Treating rhythmic and periodic eeg patterns in comatose survivors of cardiac arrest. N Engl J Med. 2022;386:724–734. doi: 10.1056/NEJMoa2115998
292.
Hirsch LJ, Fong MWK, Leitinger M, LaRoche SM, Beniczky S, Abend NS, Lee JW, Wusthoff CJ, Hahn CD, Westover MB, et al. American Clinical Neurophysiology Society’s standardized critical care EEG terminology: 2021 version. J Clin Neurophysiol. 2021;38:1–29. doi: 10.1097/WNP.0000000000000806
293.
Solanki P, Coppler PJ, Kvaloy JT, Baldwin MA, Callaway CW, Elmer J; Pittsburgh Post-Cardiac Arrest Service. Association of antiepileptic drugs with resolution of epileptiform activity after cardiac arrest. Resuscitation. 2019;142:82–90. doi: 10.1016/j.resuscitation.2019.07.007
294.
Rossetti AO, Schindler K, Sutter R, Ruegg S, Zubler F, Novy J, Oddo M, Warpelin-Decrausaz L, Alvarez V. Continuous vs routine electroencephalogram in critically ill adults with altered consciousness and no recent seizure: a multicenter randomized clinical trial. JAMA Neurol. 2020;77:1225–1232. doi: 10.1001/jamaneurol.2020.2264
295.
Holmberg MJ, Geri G, Wiberg S, Guerguerian AM, Donnino MW, Nolan JP, Deakin CD, Andersen LW; International Liaison Committee on Resuscitation’s (ILCOR) Advanced Life Support and Pediatric Task Forces. Extracorporeal cardiopulmonary resuscitation for cardiac arrest: a systematic review. Resuscitation. 2018;131:91–100. doi: 10.1016/j.resuscitation.2018.07.029
296.
Holmberg MJ, Granfeldt A, Guerguerian AM, Sandroni C, Hsu CH, Gardner RM, Lind PC, Eggertsen MA, Johannsen CM, Andersen LW. Extracorporeal cardiopulmonary resuscitation for cardiac arrest: an updated systematic review. Resuscitation. 2023;182:109665. doi: 10.1016/j.resuscitation.2022.12.003
297.
International Liaison Committee on Resuscitation. Extracorporeal cardiopulmonary resuscitation (ECPR) for cardiac arrest. Accessed February 8, 2024. https://costr.ilcor.org/document/extracorporeal-cardiopulmonary-resuscitation-ecpr-for-cardiac-arrest-als-sr
298.
Suverein MM, Delnoij TSR, Lorusso R, Brandon Bravo Bruinsma GJ, Otterspoor L, Elzo Kraemer CV, Vlaar APJ, van der Heijden JJ, Scholten E, den Uil C, et al. Early extracorporeal CPR for refractory out-of-hospital cardiac arrest. N Engl J Med. 2023;388:299–309. doi: 10.1056/NEJMoa2204511
299.
Yannopoulos D, Bartos J, Raveendran G, Walser E, Connett J, Murray TA, Collins G, Zhang L, Kalra R, Kosmopoulos M, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396:1807–1816. doi: 10.1016/S0140-6736(20)32338-2
300.
Hsu CH, Meurer WJ, Domeier R, Fowler J, Whitmore SP, Bassin BS, Gunnerson KJ, Haft JW, Lynch WR, Nallamothu BK, et al. Extracorporeal cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest (EROCA): results of a randomized feasibility trial of expedited out-of-hospital transport. Ann Emerg Med. 2021;78:92–101. doi: 10.1016/j.annemergmed.2020.11.011
301.
Belohlavek J, Smalcova J, Rob D, Franek O, Smid O, Pokorna M, Horak J, Mrazek V, Kovarnik T, Zemanek D, et al; Prague OHCA Study Group. Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment and treatment on functional neurologic outcome in refractory out-of-hospital cardiac arrest: a randomized clinical trial. JAMA. 2022;327:737–747. doi: 10.1001/jama.2022.1025
302.
Zelop CM, Shamshirsaz A, Drennan I, Berg K; on behalf of the Advanced Life Support Task Force. Resuscitation interventions for cardiac arrest during pregnancy: consensus on science with treatment recommendations. Accessed February 8, 2024. https://costr.ilcor.org/document/resuscitation-interventions-for-cardiac-arrest-during-pregnancy-als-scr
303.
van den Bosch OFC, Chaudhry R, Wicker J, Mubashir T, Limb D, Jogendran R, Munshi L, Balki M. Predictors and hospital outcomes in pregnant patients undergoing extracorporeal membrane oxygenation: a nationwide study. Anesth Analg. 2022;135:1172–1179. doi: 10.1213/ANE.0000000000006210
304.
Naoum EE, Chalupka A, Haft J, MacEachern M, Vandeven CJM, Easter SR, Maile M, Bateman BT, Bauer ME. Extracorporeal life support in pregnancy: a systematic review. J Am Heart Assoc. 2020;9:e016072. doi: 10.1161/JAHA.119.016072
305.
Dohi S, Ichizuka K, Matsuoka R, Seo K, Nagatsuka M, Sekizawa A. Coronary perfusion pressure and compression quality in maternal cardiopulmonary resuscitation in supine and left-lateral tilt positions: a prospective, crossover study using mannequins and swine models. Eur J Obstet Gynecol Reprod Biol. 2017;216:98–103. doi: 10.1016/j.ejogrb.2017.07.019